Annotation Detail for MMP9
Basic Information Top
| Gene Symbol: | MMP9 ( CLG4B,GELB,MANDP2,MMP-9 ) |
|---|---|
| Gene Full Name: | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
| Band: | 20q13.12 |
| Quick Links | Entrez ID:4318; OMIM: 120361; Uniprot ID:MMP9_HUMAN; ENSEMBL ID: ENSG00000100985; HGNC ID: 7176 |
| Relate to Another Database: | SFARIGene; denovo-db |
| No data |
| Pathway ID | Pathway Name |
|---|---|
| hsa04670 | Leukocyte transendothelial migration |
| hsa05219 | Bladder cancer |
| hsa05200 | Pathways in cancer |
| No data |
| Pathway ID | Pathway Name |
|---|---|
| 200189 | FGF signaling pathway |
| 200134 | Syndecan-1-mediated signaling events |
| 200083 | CXCR4-mediated signaling events |
| 200106 | Regulation of Wnt-mediated beta catenin signaling and target gene transcription |
| 200011 | LPA receptor mediated events |
| 200118 | AP-1 transcription factor network |
| 200115 | Syndecan-4-mediated signaling events |
| 200044 | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 200045 | Validated targets of C-MYC transcriptional activation |
| 200042 | Osteopontin-mediated events |
| 200108 | amb2 Integrin signaling |
| 200029 | Plasma membrane estrogen receptor signaling |
| Pathway ID | Pathway Name |
|---|---|
| P00004 | Alzheimer disease-presenilin pathway |
| No data |
| Desease ID | Desease Name |
|---|---|
| Cancers | |
| Cancers of the urinary system and male genital organs | |
| H00025 | Penile cancer |
| Desease ID | Desease Name |
|---|---|
| 1731 | Growth retardation |
| 1739 | Oral cancer |
| 1782 | Henoch-Schoenlein purpura |
| 1749 | Transient hypertension of pregnancy |
| 1759 | Skin cancer |
| 1761 | Respiratory tract disease |
| 1795 | Amnionitis |
| 1800 | Lupus vulgaris |
| 1803 | Periodontitis |
| 1804 | Chronic obstructive airway disease |
| 1806 | Arteriopathy |
| 1807 | Autoimmune disease |
| 1818 | Systemic scleroderma |
| 1826 | Cystic fibrosis |
| 1838 | Lichen planus |
| 1856 | Obesity |
| 1869 | Behcet syndrome |
| 1878 | Ischemia |
| 2243 | Bronchiolitis obliterans |
| 1893 | Esotropia |
| 1901 | Endometriosis |
| 1918 | Atherosclerosis |
| 1934 | Cancer |
| 1940 | Ovarian disease |
| 1942 | Emphysema |
| 1947 | Subacute sclerosing panencephalitis |
| 1954 | Stroke |
| 1958 | Glomerulonephritis |
| 1995 | Varicosity |
| 1997 | Dental plaque |
| 2036 | Tropical spastic paraparesis |
| 2038 | Gastritis |
| 2091 | Hypertension |
| 2044 | Pre-Eclampsia |
| 2054 | Bronchopulmonary dysplasia |
| 2060 | Glaucoma |
| 2068 | Skin disease |
| 2075 | Heart failure |
| 2077 | Sinusitis |
| 2083 | IGA glomerulonephritis |
| 2099 | Hepatitis B |
| 2111 | Systemic infection |
| 2131 | Keratoconjunctivitis Sicca |
| 2134 | Amyotrophic lateral sclerosis |
| 2175 | HTLV-I infection |
| 2193 | Helicobacter infection |
| 2197 | Metabolism disease |
| 2199 | Takayasu's arteritis |
| 2219 | Mucocutaneous lymph node syndrome |
| 2231 | Arthritis |
| 1846 | Pleural effusion, Malignant |
| Desease Name |
|---|
| periodontitis |
| Macular Degeneration |
| oral cancer |
| emphysema |
| Atherosclerosis |
| atherosclerosis, coronary |
| colorectal cancer |
| CARDIOVASCULAR |
| myocardial infarct |
| atherosclerosis, carotid |
| prostate cancer |
| nephropathy |
| Alzheimer's disease dementia, vascular |
| myelopathy/tropical spastic paraparesis |
| CANCER |
| throracic aortic aneurysm throracic aortic dissection |
| stomach cancer |
| Kidney Failure, Chronic |
| bone density |
| endometrial cancer |
| brain hemorrhage |
| Asthma |
| bladder cancer |
| RENAL |
| breast cancer |
| abdominal aortic aneurysm |
| IMMUNE |
| NEUROLOGICAL |
| glaucoma, primary open-angle |
| arterial stiffness |
| METABOLIC |
| VISION |
| chronic obstructive pulmonary disease/COPD |
| preterm delivery |
| ocular Chlamydia trachomatis infection |
| lung cancer |
| left ventricular dysfunction |
| aortic dissection |
| diabetes, type 2 |
| INFECTION |
| No data |
| Desease Name |
|---|
| Metaphyseal anadysplasia 2 |
| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
|---|---|---|---|---|
| C025205 | 1,10-phenanthroline | 1,10-phenanthroline inhibits the reaction [PLAU protein results in increased activity of MMP9 protein] | decreases reaction|increases activity | 20177776 |
| C025205 | 1,10-phenanthroline | 1,10-phenanthroline inhibits the reaction [Adenosine Triphosphate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 20195827 |
| C025603 | 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid | 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Acrolein results in increased expression of MMP9 protein] | decreases reaction|increases expression | 19371603 |
| D014013 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Acrolein results in increased expression of MMP9 protein] | decreases reaction|increases expression | 19371603 |
| C063609 | 1,2-dimethyl-4-nitrobenzene | 1,2-dimethyl-4-nitrobenzene results in decreased expression of MMP9 mRNA | decreases expression | 19784758 |
| C047948 | 1'-acetoxychavicol acetate | 1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | decreases reaction|increases expression | 15905586 |
| C094210 | 2,2'-(hydroxynitrosohydrazono)bis-ethanamine | 2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [IL1B protein results in increased activity of MMP9 protein] | decreases reaction|increases activity | 16378139 |
| C094210 | 2,2'-(hydroxynitrosohydrazono)bis-ethanamine | 2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 16378139 |
| C061282 | 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine | 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine results in decreased activity of MMP9 protein | decreases activity | 16783407 |
| C061282 | 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine | 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine results in decreased expression of MMP9 mRNA | decreases expression | 16783407 |
| C010914 | 2,4-diaminotoluene | 2,4-diaminotoluene results in increased expression of MMP9 mRNA | increases expression | 20713471 |
| C490707 | 2-(4-isobutylphenyl)propionylmethanesulfonamide | 2-(4-isobutylphenyl)propionylmethanesulfonamide inhibits the reaction [IL8 protein results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 15652230 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased activity of MMP9 protein | decreases activity | 19393235 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of MMP9 mRNA | decreases expression | 19393235 |
| C012177 | 2-aminofluorene | 2-aminofluorene promotes the reaction [Diethylnitrosamine results in increased activity of MMP9 protein] | increases activity|increases reaction | 19052882 |
| C012177 | 2-aminofluorene | 2-aminofluorene results in increased activity of MMP9 protein | increases activity | 19052882 |
| C012177 | 2-aminofluorene | [Diethylnitrosamine co-treated with 2-aminofluorene] results in increased expression of MMP9 protein | affects cotreatment|increases expression | 19052882 |
| C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide inhibits the reaction [pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]] | decreases reaction|increases activity | 17055343 |
| C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]] | decreases reaction|increases activity | 17055343 |
| C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in increased activity of MMP9 protein] | decreases reaction|increases activity | 17531121 |
| C028145 | 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine | [2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine results in decreased activity of NOTCH1 protein] which affects the expression of MMP9 protein | affects expression|decreases activity | 20348013 |
| C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [sodium arsenite results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 15504454 |
| C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole results in decreased activity of MMP9 protein | decreases activity | 15657063 |
| C095170 | 4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid | 4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 15131573 |
| C095170 | 4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid | 4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 protein] | decreases reaction|increases expression | 15131573 |
| C010024 | 4-aminophenylmercuriacetate | [Zymosan co-treated with 4-aminophenylmercuriacetate] results in increased activity of MMP9 protein | affects cotreatment|increases activity | 18557954 |
| C010024 | 4-aminophenylmercuriacetate | Acetylcysteine inhibits the reaction [4-aminophenylmercuriacetate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 17015178 |
| C010024 | 4-aminophenylmercuriacetate | Glutathione inhibits the reaction [4-aminophenylmercuriacetate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 17015178 |
| C106538 | abacavir | abacavir results in increased expression of MMP9 protein | increases expression | 19891054 |
| D000079 | Acetaldehyde | Acetaldehyde results in increased expression of and results in increased activity of MMP9 protein | increases activity|increases expression | 19110045 |
| D000079 | Acetaldehyde | Acetaldehyde results in increased expression of MMP9 mRNA | increases expression | 19110045 |
| D000079 | Acetaldehyde | Hesperidin inhibits the reaction [Acetaldehyde results in increased expression of and results in increased activity of MMP9 protein] | decreases reaction|increases activity|increases expression | 19110045 |
| D000079 | Acetaldehyde | Hesperidin inhibits the reaction [Acetaldehyde results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 19110045 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of MMP9 mRNA | affects expression | 17562736 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of MMP9 mRNA | increases expression | 12392966 14550746 |
| D000082 | Acetaminophen | TNFRSF1A protein affects the reaction [Acetaminophen results in increased expression of MMP9 mRNA] | affects reaction|increases expression | 14550746 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of MMP9 mRNA | affects expression | 19784758 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of MMP9 mRNA | decreases expression | 19784758 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of MMP9 mRNA | increases expression | 19784758 |
| D000109 | Acetylcholine | MMP9 protein affects the susceptibility to Acetylcholine | affects response to substance | 16979597 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [4-aminophenylmercuriacetate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 17015178 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Acrolein results in increased expression of MMP9 protein] | decreases reaction|increases expression | 19371603 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of MMP9 mRNA] | decreases expression|decreases reaction | 19350554 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Homocysteine results in increased activity of MMP9 protein] | decreases reaction|increases activity | 16251475 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Homocysteine results in increased expression of MMP9 protein] | decreases reaction|increases expression | 16251475 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 15557194 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 16213474 |
| D000171 | Acrolein | 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Acrolein results in increased expression of MMP9 protein] | decreases reaction|increases expression | 19371603 |
| D000171 | Acrolein | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Acrolein results in increased expression of MMP9 protein] | decreases reaction|increases expression | 19371603 |
| D000171 | Acrolein | Acetylcysteine inhibits the reaction [Acrolein results in increased expression of MMP9 protein] | decreases reaction|increases expression | 19371603 |
| D000171 | Acrolein | Acrolein results in increased activity of MMP9 protein | increases activity | 15531749 18006877 |
| D000171 | Acrolein | Acrolein results in increased cleavage of MMP9 protein | increases cleavage | 18006877 |
| D000171 | Acrolein | Acrolein results in increased expression of and results in increased secretion of MMP9 protein | increases expression|increases secretion | 19371603 |
| D000171 | Acrolein | Acrolein results in increased expression of MMP9 mRNA | increases expression | 18006877 15531749 |
| D000171 | Acrolein | Acrolein results in increased expression of MMP9 protein | increases expression | 15531749 |
| D000171 | Acrolein | Acrolein results in increased secretion of MMP9 protein | increases secretion | 15531749 |
| D000171 | Acrolein | Allopurinol inhibits the reaction [Acrolein results in increased expression of MMP9 protein] | decreases reaction|increases expression | 19371603 |
| D000171 | Acrolein | GM 6001 inhibits the reaction [Acrolein results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 18006877 |
| D000171 | Acrolein | MMP9 protein promotes the reaction [Acrolein results in increased expression of MUC5AC mRNA] | increases expression|increases reaction | 15531749 |
| D000171 | Acrolein | Oxypurinol inhibits the reaction [Acrolein results in increased expression of MMP9 protein] | decreases reaction|increases expression | 19371603 |
| D000171 | Acrolein | PD 98059 inhibits the reaction [Acrolein results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 18006877 |
| D000171 | Acrolein | tyrphostin AG 1478 inhibits the reaction [Acrolein results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 18006877 |
| D000171 | Acrolein | Acrolein results in increased activity of MMP9 protein | increases activity | 18006877 17950725 |
| D000171 | Acrolein | Acrolein results in increased expression of MMP9 mRNA | increases expression | 18006877 |
| D000171 | Acrolein | Acrolein results in increased expression of MMP9 protein | increases expression | 18006877 |
| D000171 | Acrolein | CD8A gene mutant form inhibits the reaction [Acrolein results in increased activity of MMP9 protein] | decreases reaction|increases activity | 17950725 |
| D000171 | Acrolein | MMP9 gene mutant form inhibits the reaction [Acrolein results in increased expression of MUC5AC mRNA] | decreases reaction|increases expression | 18006877 |
| D000255 | Adenosine Triphosphate | 1,10-phenanthroline inhibits the reaction [Adenosine Triphosphate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 20195827 |
| D000255 | Adenosine Triphosphate | Adenosine Triphosphate results in increased activity of MMP9 protein | increases activity | 20195827 |
| D000255 | Adenosine Triphosphate | Adenosine Triphosphate results in increased secretion of MMP9 protein | increases secretion | 20195827 |
| D000255 | Adenosine Triphosphate | GM 6001 inhibits the reaction [Adenosine Triphosphate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 20195827 |
| D000255 | Adenosine Triphosphate | SB 3CT compound inhibits the reaction [Adenosine Triphosphate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 20195827 |
| D000255 | Adenosine Triphosphate | wortmannin inhibits the reaction [Adenosine Triphosphate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 20195827 |
| C412373 | AG 1879 | [AG 1879 co-treated with chelerythrine] inhibits the reaction [IL8 protein results in increased secretion of MMP9 protein] | affects cotreatment|decreases reaction|increases secretion | 15831558 |
| C412373 | AG 1879 | [PD 98059 co-treated with AG 1879] inhibits the reaction [IL8 protein results in increased secretion of MMP9 protein] | affects cotreatment|decreases reaction|increases secretion | 15831558 |
| C000188 | alachlor | alachlor results in increased expression of MMP9 mRNA | increases expression | 12419858 |
| D000493 | Allopurinol | Allopurinol inhibits the reaction [Acrolein results in increased expression of MMP9 protein] | decreases reaction|increases expression | 19371603 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 19022365 |
| D000535 | Aluminum | Aluminum results in increased expression of MMP9 protein | increases expression | 16052892 |
| D000537 | Aluminum Oxide | Aluminum Oxide results in increased expression of MMP9 mRNA | increases expression | 16488289 |
| D006710 | Homocysteine | Acetylcysteine inhibits the reaction [Homocysteine results in increased activity of MMP9 protein] | decreases reaction|increases activity | 16251475 |
| D006710 | Homocysteine | Acetylcysteine inhibits the reaction [Homocysteine results in increased expression of MMP9 protein] | decreases reaction|increases expression | 16251475 |
| D006710 | Homocysteine | Homocysteine results in increased activity of MMP9 protein | increases activity | 16251475 |
| D006710 | Homocysteine | Homocysteine results in increased expression of MMP9 protein | increases expression | 16251475 |
| D006710 | Homocysteine | PD 98059 inhibits the reaction [Homocysteine results in increased activity of MMP9 protein] | decreases reaction|increases activity | 16251475 |
| D006710 | Homocysteine | PD 98059 inhibits the reaction [Homocysteine results in increased expression of MMP9 protein] | decreases reaction|increases expression | 16251475 |
| D006710 | Homocysteine | Staurosporine inhibits the reaction [Homocysteine results in increased activity of MMP9 protein] | decreases reaction|increases activity | 16251475 |
| D006710 | Homocysteine | Staurosporine inhibits the reaction [Homocysteine results in increased expression of MMP9 protein] | decreases reaction|increases expression | 16251475 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of MMP9 mRNA | affects expression | 16483693 |
| D000728 | Androgens | Androgens affects the activity of MMP9 protein | affects activity | 17607299 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [Doxorubicin results in increased expression of MMP9 mRNA] | increases expression|increases reaction | 16213474 |
| D016718 | Arachidonic Acid | Arachidonic Acid results in increased expression of MMP9 mRNA | increases expression | 16185265 |
| D016718 | Arachidonic Acid | Arachidonic Acid results in increased secretion of MMP9 protein | increases secretion | 16185265 |
| D016718 | Arachidonic Acid | Isotretinoin inhibits the reaction [Arachidonic Acid results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 16185265 |
| D016718 | Arachidonic Acid | Isotretinoin inhibits the reaction [Arachidonic Acid results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 16185265 |
| D001151 | Arsenic | Arsenic results in increased expression of and results in increased activity of MMP9 protein | increases activity|increases expression | 18539681 |
| D001151 | Arsenic | Arsenic results in increased expression of MMP9 mRNA | increases expression | 19654921 |
| C006632 | arsenic trioxide | Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of MMP9 mRNA] | decreases expression|decreases reaction | 19350554 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of MMP9 mRNA | decreases expression | 19128835 19804631 19350554 16624393 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of MMP9 protein | decreases expression | 16624393 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of MMP9 | increases expression | 15949266 |
| C015001 | arsenite | arsenite results in increased expression of MMP9 mRNA | increases expression | 18296743 |
| C015001 | arsenite | Dietary Fats promotes the reaction [arsenite results in increased expression of MMP9 mRNA] | increases expression|increases reaction | 18296743 |
| C015001 | arsenite | arsenite affects the expression of MMP9 mRNA | affects expression | 15738583 |
| C015001 | arsenite | arsenite results in decreased expression of MMP9 mRNA | decreases expression | 18929588 |
| C015001 | arsenite | TRP53 protein affects the reaction [arsenite results in decreased expression of MMP9 mRNA] | affects reaction|decreases expression | 18929588 |
| D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in increased expression of MMP9 protein | increases expression | 16966607 |
| D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in increased expression of MMP9 protein | increases expression | 16966607 |
| D001374 | Azacitidine | metacept-1 inhibits the reaction [Azacitidine results in increased expression of MMP9] | decreases reaction|increases expression | 19148494 |
| C500175 | bacoside A | bacoside A inhibits the reaction [Diethylnitrosamine results in increased expression of and results in increased activity of MMP9 protein] | decreases reaction|increases activity|increases expression | 20084675 |
| C006680 | baicalein | baicalein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 19804834 |
| C416282 | BAY 11-7085 | BAY 11-7085 inhibits the reaction [TNF protein results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 16606632 |
| D001542 | Benomyl | Benomyl results in decreased expression of MMP9 protein | decreases expression | 10026946 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of MMP9 mRNA | decreases expression | 20106945 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased activity of MMP9 protein | increases activity | 15922868 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of MMP9 mRNA | increases expression | 15922868 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of MMP9 mRNA | decreases expression | 20713471 |
| D001564 | Benzo(a)pyrene | alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 19022365 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of MMP9 mRNA | increases expression | 19022365 |
| C023888 | beta-hexachlorocyclohexane | beta-hexachlorocyclohexane results in increased expression of MMP9 protein | increases expression | 12948864 |
| C004541 | biochanin A | biochanin A results in decreased activity of MMP9 protein | decreases activity | 16598420 |
| C034786 | bis(4-hydroxycinnamoyl)methane | bis(4-hydroxycinnamoyl)methane results in decreased secretion of and results in decreased activity of MMP9 protein | decreases activity|decreases secretion | 18495463 |
| C002791 | bismuth tripotassium dicitrate | bismuth tripotassium dicitrate results in decreased expression of MMP9 mRNA | decreases expression | 15912405 |
| C002791 | bismuth tripotassium dicitrate | bismuth tripotassium dicitrate results in increased expression of MMP9 mRNA | increases expression | 15912405 |
| C086539 | BQ 788 | [BQ 788 co-treated with cyclo(Trp-Asp-Pro-Val-Leu)] inhibits the reaction [EDN1 protein results in increased secretion of and results in increased activity of MMP9 protein] | affects cotreatment|decreases reaction|increases activity|increases secretion | 12875994 |
| C086539 | BQ 788 | BQ 788 inhibits the reaction [EDN1 protein results in increased secretion of and results in increased activity of MMP9 protein] | decreases reaction|increases activity|increases secretion | 12875994 |
| D019819 | Budesonide | Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 15734790 |
| D002070 | Butadienes | Butadienes results in increased activity of MMP9 protein | increases activity | 15922868 |
| D002070 | Butadienes | Butadienes results in increased expression of MMP9 mRNA | increases expression | 15922868 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [Phenylephrine results in increased activity of MMP9 protein] | decreases reaction|increases activity | 18539131 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of MMP9 mRNA | increases expression | 17961207 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased activity of MMP9 protein | increases activity | 14999682 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of MMP9 mRNA | increases expression | 15056808 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of MMP9 protein | increases expression | 17944888 |
| D002251 | Carbon Tetrachloride | MMP9 protein inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] | decreases reaction|increases expression | 16507762 |
| D002251 | Carbon Tetrachloride | MMP9 protein mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] | decreases reaction|increases expression | 16507762 |
| D002251 | Carbon Tetrachloride | MMP9 protein mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of MMP2 mRNA] | decreases reaction|increases expression | 16507762 |
| D002251 | Carbon Tetrachloride | MMP9 protein mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of TIMP1 mRNA] | decreases reaction|increases expression | 16507762 |
| D002251 | Carbon Tetrachloride | OSMR protein affects the reaction [Carbon Tetrachloride results in increased activity of MMP9 protein] | affects reaction|increases activity | 14999682 |
| D002251 | Carbon Tetrachloride | PLAT protein affects the reaction [Carbon Tetrachloride results in increased expression of MMP9 protein] | affects reaction|increases expression | 17944888 |
| D002251 | Carbon Tetrachloride | PPARD protein affects the reaction [Carbon Tetrachloride results in increased expression of MMP9 mRNA] | affects reaction|increases expression | 18038451 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of MMP9 mRNA | increases expression | 15963578 |
| D002251 | Carbon Tetrachloride | [Carbon Tetrachloride co-treated with Interleukin 1 Receptor Antagonist Protein] results in increased expression of MMP9 mRNA | affects cotreatment|increases expression | 16762003 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased activity of MMP9 protein | decreases activity | 17156884 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of MMP9 mRNA | decreases expression | 17056239 19784758 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of MMP9 protein | decreases expression | 17156884 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased activity of MMP9 protein | increases activity | 16097048 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of MMP9 mRNA | increases expression | 17631135 18481824 16420518 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of MMP9 protein | increases expression | 17631135 |
| D002251 | Carbon Tetrachloride | celecoxib promotes the reaction [Carbon Tetrachloride results in increased expression of MMP9 mRNA] | increases expression|increases reaction | 16420518 |
| D002251 | Carbon Tetrachloride | Perindopril inhibits the reaction [Carbon Tetrachloride results in increased activity of MMP9 protein] | decreases reaction|increases activity | 16097048 |
| D002251 | Carbon Tetrachloride | PLAU protein promotes the reaction [Carbon Tetrachloride results in increased expression of MMP9 mRNA] | increases expression|increases reaction | 18481824 |
| C043211 | carvedilol | carvedilol affects the activity of MMP9 protein | affects activity | 16574429 |
| C043211 | carvedilol | carvedilol inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 16213474 |
| C105934 | celecoxib | celecoxib promotes the reaction [Carbon Tetrachloride results in increased expression of MMP9 mRNA] | increases expression|increases reaction | 16420518 |
| C016299 | chelerythrine | [AG 1879 co-treated with chelerythrine] inhibits the reaction [IL8 protein results in increased secretion of MMP9 protein] | affects cotreatment|decreases reaction|increases secretion | 15831558 |
| C055162 | clopidogrel | clopidogrel results in decreased activity of MMP9 protein | decreases activity | 20195827 |
| C513821 | CPU0213 | CPU0213 inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 18594475 |
| D003474 | Curcumin | Curcumin inhibits the reaction [IL1B protein results in increased expression of MMP9 protein] | decreases reaction|increases expression | 17291458 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Paclitaxel results in increased expression of MMP9 protein] | decreases reaction|increases expression | 16243823 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] | decreases reaction|increases activity|increases expression | 18628248 |
| D003474 | Curcumin | Curcumin inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 16219905 |
| D003474 | Curcumin | Curcumin inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | decreases reaction|increases expression | 17291458 17640567 |
| D003474 | Curcumin | Curcumin inhibits the reaction [VIP protein results in increased activity of MMP9 protein] | decreases reaction|increases activity | 19189304 |
| D003474 | Curcumin | Curcumin results in decreased activity of MMP9 protein | decreases activity | 17996675 |
| D003474 | Curcumin | Curcumin results in decreased expression of MMP9 protein | decreases expression | 18226269 17996675 |
| D003474 | Curcumin | Curcumin results in decreased secretion of and results in decreased activity of MMP9 protein | decreases activity|decreases secretion | 18495463 |
| D003474 | Curcumin | Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased expression of MMP9 protein]] | decreases reaction|increases expression | 17640567 |
| D003474 | Curcumin | TNFSF10 protein promotes the reaction [Curcumin results in decreased expression of MMP9 protein] | decreases expression|increases reaction | 18226269 |
| D003474 | Curcumin | [Curcumin co-treated with gemcitabine] results in decreased expression of MMP9 protein | affects cotreatment|decreases expression | 17440100 |
| D003474 | Curcumin | Curcumin results in decreased expression of MMP9 protein | decreases expression | 18829502 17440100 |
| D003474 | Curcumin | 2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in increased activity of MMP9 protein] | decreases reaction|increases activity | 17531121 |
| D003474 | Curcumin | Curcumin affects the expression of MMP9 mRNA | affects expression | 18379247 |
| D003474 | Curcumin | Curcumin affects the expression of MMP9 protein | affects expression | 18379247 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Ethanol results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 17887948 |
| D003474 | Curcumin | Curcumin results in increased activity of MMP9 protein | increases activity | 17531121 |
| C072247 | cyclo(Trp-Asp-Pro-Val-Leu) | [BQ 788 co-treated with cyclo(Trp-Asp-Pro-Val-Leu)] inhibits the reaction [EDN1 protein results in increased secretion of and results in increased activity of MMP9 protein] | affects cotreatment|decreases reaction|increases activity|increases secretion | 12875994 |
| C072247 | cyclo(Trp-Asp-Pro-Val-Leu) | cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [EDN1 protein results in increased secretion of and results in increased activity of MMP9 protein] | decreases reaction|increases activity|increases secretion | 12875994 |
| C107676 | deguelin | deguelin inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | decreases reaction|increases expression | 17015749 |
| C050229 | demethoxycurcumin | demethoxycurcumin results in decreased secretion of and results in decreased activity of MMP9 protein | decreases activity|decreases secretion | 18495463 |
| D003907 | Dexamethasone | Dexamethasone results in increased activity of MMP9 protein | increases activity | 18281261 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of MMP9 mRNA | increases expression | 18281261 |
| D003907 | Dexamethasone | Mifepristone inhibits the reaction [Dexamethasone results in increased activity of MMP9 protein] | decreases reaction|increases activity | 18281261 |
| D003907 | Dexamethasone | Mifepristone inhibits the reaction [Dexamethasone results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 18281261 |
| D003907 | Dexamethasone | Dexamethasone affects the expression of MMP9 mRNA | affects expression | 18379247 |
| D003907 | Dexamethasone | Dexamethasone affects the expression of MMP9 protein | affects expression | 18379247 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [IL1B protein results in increased activity of MMP9 protein] | decreases reaction|increases activity | 15963473 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 15963473 |
| D003907 | Dexamethasone | Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased activity of MMP9 protein]] | decreases reaction|increases activity | 15963473 |
| D003907 | Dexamethasone | Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]] | decreases reaction|increases expression | 15963473 |
| D003907 | Dexamethasone | RU 43044 inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased activity of MMP9 protein]] | decreases reaction|increases activity | 15963473 |
| D003907 | Dexamethasone | RU 43044 inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]] | decreases reaction|increases expression | 15963473 |
| D001728 | Dicumarol | Dicumarol inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein] | decreases reaction|increases expression|increases secretion | 17669387 |
| D001728 | Dicumarol | Dicumarol inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 17669387 |
| D001728 | Dicumarol | hydroquinone inhibits the reaction [Dicumarol inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]] | decreases reaction|increases expression|increases secretion | 17669387 |
| D004041 | Dietary Fats | Dietary Fats promotes the reaction [arsenite results in increased expression of MMP9 mRNA] | increases expression|increases reaction | 18296743 |
| D004052 | Diethylnitrosamine | 2-aminofluorene promotes the reaction [Diethylnitrosamine results in increased activity of MMP9 protein] | increases activity|increases reaction | 19052882 |
| D004052 | Diethylnitrosamine | bacoside A inhibits the reaction [Diethylnitrosamine results in increased expression of and results in increased activity of MMP9 protein] | decreases reaction|increases activity|increases expression | 20084675 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with 2-aminofluorene] results in increased expression of MMP9 protein | affects cotreatment|increases expression | 19052882 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased activity of MMP9 protein | increases activity | 19052882 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of and results in increased activity of MMP9 protein | increases activity|increases expression | 20084675 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of MMP9 protein | increases expression | 19539802 |
| D004052 | Diethylnitrosamine | morin inhibits the reaction [Diethylnitrosamine results in increased expression of MMP9 protein] | decreases reaction|increases expression | 19539802 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased activity of MMP9 protein | increases activity | 15161499 |
| D004144 | Diosgenin | Diosgenin inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | decreases reaction|increases expression | 16331273 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 19804834 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 15557194 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium promotes the reaction [Doxorubicin results in increased expression of MMP9 mRNA] | increases expression|increases reaction | 16213474 |
| D004221 | Disulfiram | Disulfiram results in decreased expression of MMP9 | decreases expression | 18047805 |
| D004317 | Doxorubicin | Doxorubicin affects the expression of MMP9 mRNA | affects expression | 15205334 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of MMP9 mRNA | increases expression | 16455267 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of MMP9 protein | increases expression | 17609194 |
| D004317 | Doxorubicin | Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 16213474 |
| D004317 | Doxorubicin | anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [Doxorubicin results in increased expression of MMP9 mRNA] | increases expression|increases reaction | 16213474 |
| D004317 | Doxorubicin | carvedilol inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 16213474 |
| D004317 | Doxorubicin | diphenyleneiodonium promotes the reaction [Doxorubicin results in increased expression of MMP9 mRNA] | increases expression|increases reaction | 16213474 |
| D004317 | Doxorubicin | Doxorubicin results in increased activity of MMP9 protein | increases activity | 16213474 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of MMP9 mRNA | increases expression | 16213474 |
| D004317 | Doxorubicin | Razoxane inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 16213474 |
| D004317 | Doxorubicin | SB 203580 inhibits the reaction [Doxorubicin results in increased activity of MMP9 protein] | decreases reaction|increases activity | 16213474 |
| D004317 | Doxorubicin | SB 203580 inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 16213474 |
| D004318 | Doxycycline | Doxycycline inhibits the reaction [Mustard Gas results in increased activity of MMP9 protein] | decreases reaction|increases activity | 15778244 |
| D004318 | Doxycycline | Doxycycline inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 15131573 |
| D004318 | Doxycycline | Doxycycline inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 protein] | decreases reaction|increases expression | 15131573 |
| D004391 | Dust | Dust results in increased expression of MMP9 mRNA | increases expression | 17805423 |
| C529593 | EMD 527040 | EMD 527040 results in increased expression of and results in increased activity of MMP9 protein | increases activity|increases expression | 18221819 |
| C529593 | EMD 527040 | EMD 527040 results in increased expression of MMP9 mRNA | increases expression | 18221819 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of and results in increased activity of MMP9 protein] | decreases reaction|increases activity|increases expression | 16516891 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 16516891 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate results in decreased activity of MMP9 protein | decreases activity | 11746506 |
| C007366 | erythritol anhydride | erythritol anhydride results in decreased activity of MMP9 protein | decreases activity | 12242682 |
| D004958 | Estradiol | Estradiol results in increased expression of MMP9 protein | increases expression | 12948864 |
| D004958 | Estradiol | [Progesterone co-treated with Estradiol] results in decreased expression of MMP9 mRNA | affects cotreatment|decreases expression | 17404688 |
| D004958 | Estradiol | Estradiol results in increased activity of MMP9 protein | increases activity | 19279558 |
| D000431 | Ethanol | Curcumin inhibits the reaction [Ethanol results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 17887948 |
| D000431 | Ethanol | Ethanol results in increased expression of MMP9 mRNA | increases expression | 17887948 |
| D000431 | Ethanol | Lipopolysaccharides promotes the reaction [Ethanol results in increased expression of MMP9 mRNA] | increases expression|increases reaction | 17887948 |
| D000431 | Ethanol | lipostabil inhibits the reaction [Ethanol results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 17887948 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of MMP9 mRNA | affects expression | 17555576 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of MMP9 protein | decreases expression | 12538720 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of MMP9 mRNA | increases expression | 17942748 |
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MMP9 mRNA | affects cotreatment|increases expression | 17942748 |
| C049639 | evodiamine | evodiamine inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | decreases reaction|increases expression | 15710601 |
| C093323 | farnesylthiosalicylic acid | farnesylthiosalicylic acid results in increased activity of MMP9 protein | increases activity | 15288472 |
| C093230 | fexofenadine | fexofenadine inhibits the reaction [TNF protein results in increased activity of MMP9 protein] | decreases reaction|increases activity | 15663564 |
| C093230 | fexofenadine | fexofenadine inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 15663564 |
| C093230 | fexofenadine | fexofenadine inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | decreases reaction|increases expression | 15663564 |
| D005419 | Flavonoids | Flavonoids results in decreased expression of MMP9 mRNA | decreases expression | 18035473 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in increased expression of MMP9 mRNA | increases expression | 18678246 |
| D005472 | Fluorouracil | Fluorouracil affects the expression of MMP9 mRNA | affects expression | 15205334 |
| D005620 | Freund's Adjuvant | [Urethane co-treated with Freund's Adjuvant] results in decreased expression of MMP9 mRNA | affects cotreatment|decreases expression | 12400877 |
| C492995 | fumigaclavine C | fumigaclavine C results in decreased activity of MMP9 protein | decreases activity | 16023606 |
| C492995 | fumigaclavine C | fumigaclavine C results in decreased expression of MMP9 mRNA | decreases expression | 16023606 |
| D005707 | Gallic Acid | Gallic Acid results in decreased expression of MMP9 mRNA | decreases expression | 16304905 |
| C056507 | gemcitabine | [Curcumin co-treated with gemcitabine] results in decreased expression of MMP9 protein | affects cotreatment|decreases expression | 17440100 |
| D019833 | Genistein | Genistein results in decreased activity of MMP9 protein | decreases activity | 16598420 |
| D019833 | Genistein | Genistein results in decreased expression of MMP9 mRNA | decreases expression | 15256057 15754008 |
| D019833 | Genistein | Genistein results in decreased expression of MMP9 protein | decreases expression | 15256057 |
| C007845 | gingerol | gingerol results in decreased activity of MMP9 protein | decreases activity | 17683926 |
| C007845 | gingerol | gingerol results in decreased expression of MMP9 mRNA | decreases expression | 17683926 |
| D005978 | Glutathione | Glutathione binds to MMP9 protein | affects binding | 17015178 |
| D005978 | Glutathione | Glutathione inhibits the reaction [4-aminophenylmercuriacetate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 17015178 |
| D005978 | Glutathione | Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased expression of MMP9 protein]] | decreases reaction|increases expression | 17640567 |
| D005978 | Glutathione | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Glutathione binds to MMP9 protein] | affects binding|decreases reaction | 17015178 |
| C078131 | GM 6001 | GM 6001 inhibits the reaction [Zymosan results in increased expression of MMP9 protein] | decreases reaction|increases expression | 18557954 |
| C078131 | GM 6001 | GM 6001 inhibits the reaction [Acrolein results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 18006877 |
| C078131 | GM 6001 | GM 6001 inhibits the reaction [Adenosine Triphosphate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 20195827 |
| C081021 | Go 6976 | Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 19804834 |
| D006569 | Hesperidin | Hesperidin inhibits the reaction [Acetaldehyde results in increased expression of and results in increased activity of MMP9 protein] | decreases reaction|increases activity|increases expression | 19110045 |
| D006569 | Hesperidin | Hesperidin inhibits the reaction [Acetaldehyde results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 19110045 |
| D006569 | Hesperidin | Hesperidin results in decreased secretion of MMP9 protein | decreases secretion | 19110045 |
| D006581 | Hexachlorobenzene | Hexachlorobenzene results in increased expression of MMP9 mRNA | increases expression | 15159207 |
| D017313 | Fenretinide | Fenretinide inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | decreases reaction|increases expression | 16230421 |
| D006812 | Humic Substances | Humic Substances results in increased activity of MMP9 protein | increases activity | 19686714 |
| D006820 | Hyaluronic Acid | Hyaluronic Acid affects the activity of MMP9 protein | affects activity | 15597151 |
| D006851 | Hydrochloric Acid | Hydrochloric Acid results in increased expression of MMP9 protein | increases expression | 18339021 |
| D006851 | Hydrochloric Acid | Oxygen inhibits the reaction [Hydrochloric Acid results in increased expression of MMP9 protein] | decreases reaction|increases expression | 18339021 |
| D006854 | Hydrocortisone | Hydrocortisone results in increased activity of MMP9 protein | increases activity | 18281261 |
| D006854 | Hydrocortisone | Hydrocortisone results in increased expression of MMP9 mRNA | increases expression | 18281261 |
| D006854 | Hydrocortisone | Mifepristone inhibits the reaction [Hydrocortisone results in increased activity of MMP9 protein] | decreases reaction|increases activity | 18281261 |
| D006854 | Hydrocortisone | Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 18281261 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased activity of MMP9 protein | increases activity | 15531749 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of MMP9 protein | increases expression | 15531749 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased secretion of MMP9 protein | increases secretion | 15531749 |
| C031927 | hydroquinone | hydroquinone inhibits the reaction [Dicumarol inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]] | decreases reaction|increases expression|increases secretion | 17669387 |
| C031927 | hydroquinone | hydroquinone promotes the reaction [TNF protein results in increased secretion of MMP9 protein] | increases reaction|increases secretion | 17669387 |
| D007052 | Ibuprofen | Ibuprofen inhibits the reaction [EGF protein results in increased activity of MMP9 protein] | decreases reaction|increases activity | 16340751 |
| D007052 | Ibuprofen | Ibuprofen inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 16340751 |
| C056493 | imiquimod | imiquimod results in decreased expression of MMP9 | decreases expression | 16302556 |
| D019469 | Indinavir | Indinavir inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 14662518 |
| D019469 | Indinavir | Indinavir inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein] | decreases reaction|increases expression | 14662518 |
| D019469 | Indinavir | Indinavir inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 14662518 |
| C016517 | indole-3-carbinol | indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | decreases reaction|increases expression | 15811958 |
| D007213 | Indomethacin | Indomethacin results in decreased expression of and results in decreased activity of MMP9 protein | decreases activity|decreases expression | 11719597 |
| D007213 | Indomethacin | [Indomethacin co-treated with Medroxyprogesterone Acetate] results in decreased activity of MMP9 protein | affects cotreatment|decreases activity | 16537180 |
| D007213 | Indomethacin | Indomethacin results in decreased activity of MMP9 protein | decreases activity | 16537180 |
| D007213 | Indomethacin | Indomethacin results in increased activity of MMP9 protein | increases activity | 17000239 |
| D007213 | Indomethacin | Indomethacin results in decreased activity of MMP9 protein | decreases activity | 10231640 |
| D007213 | Indomethacin | Indomethacin results in increased activity of MMP9 protein | increases activity | 10878458 |
| D007213 | Indomethacin | Indomethacin results in increased expression of and results in increased secretion of and results in increased activity of MMP9 protein | increases activity|increases expression|increases secretion | 16934674 |
| D007213 | Indomethacin | Indomethacin results in increased expression of and results in increased secretion of MMP9 protein | increases expression|increases secretion | 16150113 |
| D007213 | Indomethacin | Melatonin inhibits the reaction [Indomethacin results in increased expression of and results in increased secretion of MMP9 protein] | decreases reaction|increases expression|increases secretion | 16150113 |
| D053590 | Interleukin 1 Receptor Antagonist Protein | [Carbon Tetrachloride co-treated with Interleukin 1 Receptor Antagonist Protein] results in increased expression of MMP9 mRNA | affects cotreatment|increases expression | 16762003 |
| C051890 | irinotecan | irinotecan metabolite results in increased expression of MMP9 mRNA | increases expression | 15956246 |
| C051890 | irinotecan | irinotecan results in increased expression of MMP9 mRNA | increases expression | 15956246 |
| D007545 | Isoproterenol | Isoproterenol results in increased expression of MMP9 mRNA | increases expression | 16574429 |
| D007545 | Isoproterenol | Propranolol inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 16574429 |
| D007545 | Isoproterenol | CPU0213 inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 18594475 |
| D007545 | Isoproterenol | Isoproterenol results in increased expression of MMP9 mRNA | increases expression | 18594475 |
| D007545 | Isoproterenol | pimagedine inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 18594475 |
| C016527 | isoquercitrin | isoquercitrin results in decreased expression of and results in decreased activity of MMP9 protein | decreases activity|decreases expression | 18715546 |
| C432511 | isorhamnetin 3-O-glucoside | isorhamnetin 3-O-glucoside results in decreased expression of and results in decreased activity of MMP9 protein | decreases activity|decreases expression | 18715546 |
| C050016 | lipoarabinomannan | lipoarabinomannan results in increased activity of MMP9 protein | increases activity | 11839551 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 15734790 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of MMP9 mRNA | increases expression | 15734790 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | resveratrol affects the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of MMP9 mRNA] | affects reaction|increases expression | 15734790 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of MMP9 mRNA | increases expression | 18557954 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of MMP9 protein | increases expression | 18557954 |
| D008070 | Lipopolysaccharides | Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 15557194 |
| D008070 | Lipopolysaccharides | diphenyleneiodonium inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 15557194 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with Zymosan] results in increased activity of MMP9 protein | affects cotreatment|increases activity | 15259001 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with Zymosan] results in increased expression of MMP9 mRNA | affects cotreatment|increases expression | 15259001 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with Zymosan] results in increased expression of MMP9 protein | affects cotreatment|increases expression | 15259001 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of MMP9 mRNA | increases expression | 15557194 |
| D008070 | Lipopolysaccharides | Reactive Oxygen Species affects the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] | affects reaction|increases expression | 15557194 |
| D008070 | Lipopolysaccharides | Rotenone inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 15557194 |
| D008070 | Lipopolysaccharides | rottlerin inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 15557194 |
| D008070 | Lipopolysaccharides | Indinavir inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 14662518 |
| D008070 | Lipopolysaccharides | Indinavir inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein] | decreases reaction|increases expression | 14662518 |
| D008070 | Lipopolysaccharides | Indinavir inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 14662518 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein | affects cotreatment|increases activity | 14700523 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides promotes the reaction [Ethanol results in increased expression of MMP9 mRNA] | increases expression|increases reaction | 17887948 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of MMP9 mRNA | increases expression | 14662518 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of MMP9 protein | increases expression | 14662518 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased secretion of MMP9 protein | increases secretion | 14662518 |
| D008070 | Lipopolysaccharides | Quercetin inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein] | affects cotreatment|decreases reaction|increases activity | 14700523 |
| D008070 | Lipopolysaccharides | wogonin inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein] | affects cotreatment|decreases reaction|increases activity | 14700523 |
| D008070 | Lipopolysaccharides | Zidovudine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 14662518 |
| D008070 | Lipopolysaccharides | Zidovudine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein] | decreases reaction|increases expression | 14662518 |
| D008070 | Lipopolysaccharides | Zidovudine inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 14662518 |
| C005152 | lipostabil | lipostabil inhibits the reaction [Ethanol results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 17887948 |
| C115354 | lonafarnib | lonafarnib inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | decreases reaction|increases expression | 15090542 |
| D047311 | Luteolin | Luteolin inhibits the reaction [EGF protein results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 15135307 |
| D047311 | Luteolin | Luteolin results in decreased secretion of MMP9 protein | decreases secretion | 15135307 |
| D008351 | Mannans | Mannans results in increased activity of MMP9 protein | increases activity | 11839551 |
| D017258 | Medroxyprogesterone Acetate | [Indomethacin co-treated with Medroxyprogesterone Acetate] results in decreased activity of MMP9 protein | affects cotreatment|decreases activity | 16537180 |
| D017258 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate results in decreased activity of MMP9 protein | decreases activity | 16537180 |
| D008550 | Melatonin | Melatonin inhibits the reaction [Indomethacin results in increased expression of and results in increased secretion of MMP9 protein] | decreases reaction|increases expression|increases secretion | 16150113 |
| C527236 | metacept-1 | metacept-1 inhibits the reaction [Azacitidine results in increased expression of MMP9] | decreases reaction|increases expression | 19148494 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of MMP9 mRNA | increases expression | 17961207 |
| D008767 | Methylmercury Compounds | Methylmercury Compounds results in increased expression of MMP9 mRNA | increases expression | 16966085 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Dexamethasone results in increased activity of MMP9 protein] | decreases reaction|increases activity | 18281261 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Dexamethasone results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 18281261 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Hydrocortisone results in increased activity of MMP9 protein] | decreases reaction|increases activity | 18281261 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 18281261 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased activity of MMP9 protein]] | decreases reaction|increases activity | 15963473 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]] | decreases reaction|increases expression | 15963473 |
| D008911 | Minocycline | Minocycline inhibits the reaction [FMR1 gene mutant form results in increased expression of and results in increased activity of MMP9 protein] | decreases reaction|increases activity|increases expression | 18835858 |
| C008548 | morin | morin results in decreased expression of MMP9 mRNA | decreases expression | 16304905 |
| C008548 | morin | morin inhibits the reaction [Diethylnitrosamine results in increased expression of MMP9 protein] | decreases reaction|increases expression | 19539802 |
| D009151 | Mustard Gas | Doxycycline inhibits the reaction [Mustard Gas results in increased activity of MMP9 protein] | decreases reaction|increases activity | 15778244 |
| D009151 | Mustard Gas | Mustard Gas results in increased activity of MMP9 protein | increases activity | 15778244 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of MMP9 protein | increases expression | 10330031 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of MMP9 mRNA | increases expression | 18955075 16489579 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of MMP9 protein | increases expression | 16489579 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of MMP9 mRNA | increases expression | 12481301 |
| C040015 | myricetin | myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 19804834 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 19804834 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 19804834 |
| D037742 | Nanotubes, Carbon | Nanotubes, Carbon results in increased expression of MMP9 mRNA | increases expression | 15585362 |
| D009578 | Nitrobenzenes | Nitrobenzenes analog results in decreased expression of MMP9 mRNA | decreases expression | 19784758 |
| D005996 | Nitroglycerin | Nitroglycerin results in increased activity of MMP9 protein | increases activity | 12084592 |
| D005996 | Nitroglycerin | Nitroglycerin results in increased expression of MMP9 mRNA | increases expression | 12084592 |
| C044387 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Glutathione binds to MMP9 protein] | affects binding|decreases reaction | 17015178 |
| C069741 | norcantharidin | norcantharidin results in decreased activity of MMP9 protein | decreases activity | 15711181 |
| C069741 | norcantharidin | norcantharidin results in decreased expression of and results in decreased activity of MMP9 protein | decreases activity|decreases expression | 19616522 |
| C069741 | norcantharidin | norcantharidin results in decreased expression of MMP9 mRNA | decreases expression | 19616522 |
| C069741 | norcantharidin | SP1 protein affects the reaction [norcantharidin results in decreased expression of MMP9 mRNA] | affects reaction|decreases expression | 19616522 |
| D010100 | Oxygen | Oxygen inhibits the reaction [Hydrochloric Acid results in increased expression of MMP9 protein] | decreases reaction|increases expression | 18339021 |
| D010117 | Oxypurinol | Oxypurinol inhibits the reaction [Acrolein results in increased expression of MMP9 protein] | decreases reaction|increases expression | 19371603 |
| D010126 | Ozone | MMP9 gene mutant form promotes the reaction [Ozone results in increased activity of MMP2 protein] | increases activity|increases reaction | 18007984 |
| D010126 | Ozone | MMP9 gene mutant form promotes the reaction [Ozone results in increased expression of CXCL1 mRNA] | increases expression|increases reaction | 18007984 |
| D010126 | Ozone | MMP9 gene mutant form promotes the reaction [Ozone results in increased expression of CXCL1 protein] | increases expression|increases reaction | 18007984 |
| D010126 | Ozone | MMP9 gene mutant form promotes the reaction [Ozone results in increased expression of CXCL2 mRNA] | increases expression|increases reaction | 18007984 |
| D010126 | Ozone | MMP9 gene mutant form promotes the reaction [Ozone results in increased expression of CXCL2 protein] | increases expression|increases reaction | 18007984 |
| D010126 | Ozone | MMP9 protein results in decreased susceptibility to Ozone | decreases response to substance | 18007984 |
| D010126 | Ozone | Ozone results in increased activity of MMP9 protein | increases activity | 18007984 12763055 |
| D010126 | Ozone | Ozone results in increased expression of MMP9 mRNA | increases expression | 18007984 12763055 |
| D010126 | Ozone | Ozone results in increased expression of MMP9 protein | increases expression | 18007984 |
| D017239 | Paclitaxel | Curcumin inhibits the reaction [Paclitaxel results in increased expression of MMP9 protein] | decreases reaction|increases expression | 16243823 |
| C519374 | Panax notoginseng extract | Panax notoginseng extract analog results in decreased expression of MMP9 protein | decreases expression | 18637019 |
| D010269 | Paraquat | Paraquat results in increased expression of MMP9 mRNA | increases expression | 17215068 |
| C093973 | PD 98059 | [PD 98059 co-treated with AG 1879] inhibits the reaction [IL8 protein results in increased secretion of MMP9 protein] | affects cotreatment|decreases reaction|increases secretion | 15831558 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Acrolein results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 18006877 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Homocysteine results in increased activity of MMP9 protein] | decreases reaction|increases activity | 16251475 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Homocysteine results in increased expression of MMP9 protein] | decreases reaction|increases expression | 16251475 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [IL8 protein results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 15831558 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [sodium arsenite results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 15504454 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 19804834 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] | decreases reaction|increases activity|increases expression | 18628248 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 19804834 |
| C093973 | PD 98059 | PD 98059 results in decreased activity of MMP9 protein | decreases activity | 15657063 |
| C093973 | PD 98059 | PD 98059 results in decreased expression of MMP9 mRNA | decreases expression | 15657063 |
| D020913 | Perindopril | Perindopril inhibits the reaction [Carbon Tetrachloride results in increased activity of MMP9 protein] | decreases reaction|increases activity | 16097048 |
| D010618 | Phenanthrolines | Phenanthrolines results in decreased activity of MMP9 protein | decreases activity | 14662518 |
| D010656 | Phenylephrine | 1-Butanol inhibits the reaction [Phenylephrine results in increased activity of MMP9 protein] | decreases reaction|increases activity | 18539131 |
| D010656 | Phenylephrine | Phenylephrine results in increased activity of MMP9 protein | increases activity | 18539131 |
| D010656 | Phenylephrine | SLC9A1 protein affects the reaction [Phenylephrine results in increased activity of MMP9 protein] | affects reaction|increases activity | 18539131 |
| D010656 | Phenylephrine | Phenylephrine results in increased expression of MMP9 mRNA | increases expression | 16574429 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone inhibits the reaction [PLAT protein results in increased expression of and results in increased activity of MMP9 protein] | decreases reaction|increases activity|increases expression | 19095969 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone inhibits the reaction [PLAT protein results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 19095969 |
| C004479 | pimagedine | pimagedine inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 18594475 |
| C060836 | pioglitazone | 2-chloro-5-nitrobenzanilide inhibits the reaction [pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]] | decreases reaction|increases activity | 17055343 |
| C060836 | pioglitazone | pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 17055343 |
| C008922 | piperine | piperine results in decreased expression of MMP9 protein | decreases expression | 15531295 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | decreases reaction|increases expression | 18841906 |
| D010936 | Plant Extracts | Plant Extracts affects the expression of and affects the activity of MMP9 protein | affects activity|affects expression | 18097624 |
| D017035 | Pravastatin | Pravastatin results in decreased activity of MMP9 protein | decreases activity | 16935385 |
| D017035 | Pravastatin | Pravastatin results in decreased expression of MMP9 mRNA | decreases expression | 16935385 |
| C023617 | pregna-4,17-diene-3,16-dione | pregna-4,17-diene-3,16-dione inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 15322087 |
| D011374 | Progesterone | [Progesterone co-treated with Estradiol] results in decreased expression of MMP9 mRNA | affects cotreatment|decreases expression | 17404688 |
| D011433 | Propranolol | Propranolol inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 16574429 |
| D015237 | Dinoprost | Dinoprost results in increased expression of and results in increased activity of MMP9 protein | increases activity|increases expression | 11719597 |
| D011509 | Proteoglycans | Proteoglycans affects the secretion of MMP9 protein | affects secretion | 14511379 |
| C526689 | punarnavine | punarnavine results in decreased expression of MMP9 mRNA | decreases expression | 19171408 |
| C526689 | punarnavine | punarnavine results in decreased expression of MMP9 protein | decreases expression | 19171408 |
| C030984 | pyrene | pyrene results in decreased expression of MMP9 mRNA | decreases expression | 15963578 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [EGF protein results in increased activity of MMP9 protein] | decreases reaction|increases activity | 16340751 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 16340751 |
| D011794 | Quercetin | Quercetin inhibits the reaction [EGF protein results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 15135307 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 19804834 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] | decreases reaction|increases activity|increases expression | 18628248 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 18628248 |
| D011794 | Quercetin | Quercetin inhibits the reaction [TNF protein results in increased activity of MMP9 protein] | decreases reaction|increases activity | 12589822 |
| D011794 | Quercetin | Quercetin inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 12589822 |
| D011794 | Quercetin | Quercetin results in decreased secretion of MMP9 protein | decreases secretion | 15135307 |
| D011794 | Quercetin | Quercetin inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 19495926 |
| D011794 | Quercetin | Quercetin results in decreased expression of MMP9 mRNA | decreases expression | 16304905 |
| D011794 | Quercetin | Quercetin inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein] | affects cotreatment|decreases reaction|increases activity | 14700523 |
| D020849 | Raloxifene | Raloxifene results in decreased activity of MMP9 protein | decreases activity | 17582780 |
| D020849 | Raloxifene | Raloxifene results in decreased expression of MMP9 mRNA | decreases expression | 17582780 |
| D020849 | Raloxifene | Raloxifene results in decreased expression of MMP9 mRNA | decreases expression | 17582780 |
| D011929 | Razoxane | Razoxane inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 16213474 |
| D017382 | Reactive Oxygen Species | Reactive Oxygen Species affects the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | affects reaction|increases activity | 19804834 |
| D017382 | Reactive Oxygen Species | Reactive Oxygen Species affects the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] | affects reaction|increases expression | 15557194 |
| C059514 | resveratrol | 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]] | decreases reaction|increases activity | 17055343 |
| C059514 | resveratrol | resveratrol inhibits the reaction [NRG1 protein alternative form results in increased expression of MMP9 protein] | decreases reaction|increases expression | 17651959 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of MMP9 protein] | decreases reaction|increases activity | 19371443 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 19371443 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 17055343 |
| C059514 | resveratrol | resveratrol inhibits the reaction [TNF protein results in increased expression of and results in increased activity of MMP9 protein] | decreases reaction|increases activity|increases expression | 16317118 |
| C059514 | resveratrol | resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 16317118 |
| C059514 | resveratrol | resveratrol results in decreased activity of MMP9 protein | decreases activity | 17935668 15688415 |
| C059514 | resveratrol | resveratrol results in decreased expression of and results in decreased activity of MMP9 protein | decreases activity|decreases expression | 17049120 |
| C059514 | resveratrol | resveratrol results in decreased expression of MMP9 mRNA | decreases expression | 17935668 |
| C059514 | resveratrol | resveratrol results in decreased expression of MMP9 protein | decreases expression | 16490592 |
| C059514 | resveratrol | resveratrol results in decreased expression of and results in decreased activity of MMP9 protein | decreases activity|decreases expression | 16321402 |
| C059514 | resveratrol | resveratrol results in decreased expression of MMP9 mRNA | decreases expression | 16321402 16304905 |
| C059514 | resveratrol | resveratrol affects the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of MMP9 mRNA] | affects reaction|increases expression | 15734790 |
| D015474 | Isotretinoin | Isotretinoin inhibits the reaction [Arachidonic Acid results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 16185265 |
| D015474 | Isotretinoin | Isotretinoin inhibits the reaction [Arachidonic Acid results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 16185265 |
| D015474 | Isotretinoin | Isotretinoin results in decreased expression of MMP9 protein | decreases expression | 16185265 |
| C014794 | retinol palmitate | retinol palmitate promotes the reaction [EP300 protein binds to MMP9 protein] | affects binding|increases reaction | 17164434 |
| C014794 | retinol palmitate | retinol palmitate promotes the reaction [RARA protein binds to MMP9 protein] | affects binding|increases reaction | 17164434 |
| C014794 | retinol palmitate | retinol palmitate results in increased expression of MMP9 mRNA | increases expression | 17164434 |
| C453902 | Ro 28-2653 | Ro 28-2653 results in decreased activity of MMP9 protein | decreases activity | 16178123 |
| D012402 | Rotenone | Rotenone inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 15557194 |
| C085746 | rottlerin | rottlerin inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 15557194 |
| C423603 | RU 24858 | RU 24858 inhibits the reaction [IL1B protein results in increased activity of MMP9 protein] | decreases reaction|increases activity | 15963473 |
| C423603 | RU 24858 | RU 24858 inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 15963473 |
| C085917 | RU 43044 | RU 43044 inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased activity of MMP9 protein]] | decreases reaction|increases activity | 15963473 |
| C085917 | RU 43044 | RU 43044 inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]] | decreases reaction|increases expression | 15963473 |
| D012431 | Rutin | Rutin results in decreased expression of MMP9 mRNA | decreases expression | 16304905 |
| C503948 | S 3304 | S 3304 results in decreased activity of MMP9 protein | decreases activity | 15968885 |
| D012503 | Saponins | Saponins analog results in decreased expression of MMP9 protein | decreases expression | 18637019 |
| C093642 | SB 203580 | SB 203580 results in decreased activity of MMP9 protein | decreases activity | 15657063 |
| C093642 | SB 203580 | SB 203580 results in decreased expression of MMP9 mRNA | decreases expression | 15657063 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Doxorubicin results in increased activity of MMP9 protein] | decreases reaction|increases activity | 16213474 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 16213474 |
| C112019 | SB 225002 | SB 225002 inhibits the reaction [CXCL1 protein results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 15831558 |
| C112019 | SB 225002 | SB 225002 inhibits the reaction [IL8 protein results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 15831558 |
| C429533 | SB 3CT compound | SB 3CT compound inhibits the reaction [PLAU protein results in increased activity of MMP9 protein] | decreases reaction|increases activity | 20177776 |
| C429533 | SB 3CT compound | SB 3CT compound inhibits the reaction [Adenosine Triphosphate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 20195827 |
| D012643 | Selenium | Selenium results in decreased expression of MMP9 mRNA | decreases expression | 17390030 |
| D017632 | Asbestos, Serpentine | Asbestos, Serpentine results in increased activity of MMP9 protein | increases activity | 16571779 |
| D017632 | Asbestos, Serpentine | Asbestos, Serpentine results in increased expression of MMP9 mRNA | increases expression | 18039278 |
| C017947 | sodium arsenite | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [sodium arsenite results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 15504454 |
| C017947 | sodium arsenite | PD 98059 inhibits the reaction [sodium arsenite results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 15504454 |
| C017947 | sodium arsenite | sodium arsenite results in increased secretion of and results in increased activity of MMP9 protein | increases activity|increases secretion | 18572023 |
| C017947 | sodium arsenite | sodium arsenite results in increased secretion of MMP9 protein | increases secretion | 15504454 20056578 19524636 |
| C017947 | sodium arsenite | tyrphostin AG 1478 inhibits the reaction [sodium arsenite results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 15504454 |
| C017947 | sodium arsenite | U 0126 inhibits the reaction [sodium arsenite results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 15504454 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of MMP9 mRNA | increases expression | 16014739 |
| D019311 | Staurosporine | Staurosporine inhibits the reaction [Homocysteine results in increased activity of MMP9 protein] | decreases reaction|increases activity | 16251475 |
| D019311 | Staurosporine | Staurosporine inhibits the reaction [Homocysteine results in increased expression of MMP9 protein] | decreases reaction|increases expression | 16251475 |
| D014284 | Triiodothyronine | tetrabromobisphenol A inhibits the reaction [Triiodothyronine results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 16678281 |
| D014284 | Triiodothyronine | Triiodothyronine results in increased expression of MMP9 mRNA | increases expression | 16678281 |
| D014284 | Triiodothyronine | Triiodothyronine results in decreased expression of MMP9 mRNA | decreases expression | 17403546 |
| D013629 | Tamoxifen | Tamoxifen affects the expression of MMP9 mRNA | affects expression | 14699072 |
| D013629 | Tamoxifen | Tamoxifen affects the expression of MMP9 mRNA | affects expression | 17555576 |
| D013629 | Tamoxifen | Tamoxifen results in decreased activity of MMP9 protein | decreases activity | 19393235 |
| D013629 | Tamoxifen | Tamoxifen results in decreased expression of MMP9 mRNA | decreases expression | 19393235 |
| D013629 | Tamoxifen | Tamoxifen results in increased activity of MMP9 protein | increases activity | 19279558 |
| D013629 | Tamoxifen | Tamoxifen results in decreased activity of MMP9 protein | decreases activity | 15696052 |
| C480848 | tephrosin | tephrosin inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | decreases reaction|increases expression | 18841906 |
| C041359 | terbinafine | terbinafine results in decreased expression of MMP9 mRNA | decreases expression | 17172416 |
| C020806 | tetrabromobisphenol A | tetrabromobisphenol A inhibits the reaction [Triiodothyronine results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 16678281 |
| C020806 | tetrabromobisphenol A | tetrabromobisphenol A results in increased expression of MMP9 mRNA | increases expression | 16678281 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased activity of MMP9 protein | increases activity | 17003102 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA | increases expression | 18495758 17003102 |
| D013749 | Tetrachlorodibenzodioxin | JUN protein affects the reaction [Tetrachlorodibenzodioxin results in increased activity of MMP9 protein] | affects reaction|increases activity | 19371443 |
| D013749 | Tetrachlorodibenzodioxin | JUN protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA] | affects reaction|increases expression | 19371443 |
| D013749 | Tetrachlorodibenzodioxin | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of MMP9 protein] | decreases reaction|increases activity | 19371443 |
| D013749 | Tetrachlorodibenzodioxin | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 19371443 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased activity of MMP9 protein | increases activity | 19371443 15922868 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of MMP9 protein | increases activity|increases expression | 15982688 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of MMP9 | increases expression | 17003102 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA | increases expression | 19371443 19755661 15922868 12377990 16704738 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MMP9 mRNA | affects cotreatment|increases expression | 17942748 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA | increases expression | 17586704 19372248 17975115 |
| C117155 | tetracycline CMT-3 | tetracycline CMT-3 results in decreased activity of MMP9 protein | decreases activity | 16003065 |
| C117153 | tetracycline CMT-8 | tetracycline CMT-8 results in decreased activity of MMP9 protein | decreases activity | 11983005 |
| D013754 | Tetracyclines | Tetracyclines results in decreased activity of MMP9 protein | decreases activity | 11172685 |
| D013755 | Tetradecanoylphorbol Acetate | 2-chloro-5-nitrobenzanilide inhibits the reaction [pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]] | decreases reaction|increases activity | 17055343 |
| D013755 | Tetradecanoylphorbol Acetate | 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]] | decreases reaction|increases activity | 17055343 |
| D013755 | Tetradecanoylphorbol Acetate | baicalein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 19804834 |
| D013755 | Tetradecanoylphorbol Acetate | Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] | decreases reaction|increases activity|increases expression | 18628248 |
| D013755 | Tetradecanoylphorbol Acetate | diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 19804834 |
| D013755 | Tetradecanoylphorbol Acetate | Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 19804834 |
| D013755 | Tetradecanoylphorbol Acetate | myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 19804834 |
| D013755 | Tetradecanoylphorbol Acetate | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 19804834 |
| D013755 | Tetradecanoylphorbol Acetate | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 19804834 |
| D013755 | Tetradecanoylphorbol Acetate | PD 98059 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 19804834 |
| D013755 | Tetradecanoylphorbol Acetate | PD 98059 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] | decreases reaction|increases activity|increases expression | 18628248 |
| D013755 | Tetradecanoylphorbol Acetate | PD 98059 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 19804834 |
| D013755 | Tetradecanoylphorbol Acetate | pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 17055343 |
| D013755 | Tetradecanoylphorbol Acetate | Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 19804834 |
| D013755 | Tetradecanoylphorbol Acetate | Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] | decreases reaction|increases activity|increases expression | 18628248 |
| D013755 | Tetradecanoylphorbol Acetate | Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 18628248 |
| D013755 | Tetradecanoylphorbol Acetate | Reactive Oxygen Species affects the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | affects reaction|increases activity | 19804834 |
| D013755 | Tetradecanoylphorbol Acetate | resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 17055343 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein | increases activity | 19804834 17055343 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein | increases activity|increases expression | 18628248 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA | increases expression | 19804834 16574429 18628248 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein | increases activity | 17332158 |
| D013755 | Tetradecanoylphorbol Acetate | [Thiram co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein | affects cotreatment|increases activity | 17332158 |
| D013755 | Tetradecanoylphorbol Acetate | [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein | affects cotreatment|increases activity | 14700523 |
| D013755 | Tetradecanoylphorbol Acetate | Quercetin inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein] | affects cotreatment|decreases reaction|increases activity | 14700523 |
| D013755 | Tetradecanoylphorbol Acetate | wogonin inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein] | affects cotreatment|decreases reaction|increases activity | 14700523 |
| D013853 | Thioacetamide | Thioacetamide results in decreased expression of MMP9 mRNA | decreases expression | 19784758 |
| D013853 | Thioacetamide | Thioacetamide results in increased expression of MMP9 protein | increases expression | 15095483 |
| D013893 | Thiram | [Thiram co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein | affects cotreatment|increases activity | 17332158 |
| D013893 | Thiram | [Thiram co-treated with Tretinoin] results in increased activity of MMP9 protein | affects cotreatment|increases activity | 17332158 |
| D014025 | Titanium | Titanium results in increased expression of MMP9 mRNA | increases expression | 14661256 |
| D014051 | Toluene 2,4-Diisocyanate | Toluene 2,4-Diisocyanate results in decreased expression of MMP9 protein | decreases expression | 12534559 |
| D014051 | Toluene 2,4-Diisocyanate | 4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 15131573 |
| D014051 | Toluene 2,4-Diisocyanate | 4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 protein] | decreases reaction|increases expression | 15131573 |
| D014051 | Toluene 2,4-Diisocyanate | Doxycycline inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 15131573 |
| D014051 | Toluene 2,4-Diisocyanate | Doxycycline inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 protein] | decreases reaction|increases expression | 15131573 |
| D014051 | Toluene 2,4-Diisocyanate | epigallocatechin gallate inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of and results in increased activity of MMP9 protein] | decreases reaction|increases activity|increases expression | 16516891 |
| D014051 | Toluene 2,4-Diisocyanate | epigallocatechin gallate inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 16516891 |
| D014051 | Toluene 2,4-Diisocyanate | Toluene 2,4-Diisocyanate results in increased activity of MMP9 protein | increases activity | 11742282 |
| D014051 | Toluene 2,4-Diisocyanate | Toluene 2,4-Diisocyanate results in increased expression of and results in increased activity of MMP9 protein | increases activity|increases expression | 16516891 |
| D014051 | Toluene 2,4-Diisocyanate | Toluene 2,4-Diisocyanate results in increased expression of MMP9 mRNA | increases expression | 12789230 14987308 15131573 16516891 |
| D014051 | Toluene 2,4-Diisocyanate | Toluene 2,4-Diisocyanate results in increased expression of MMP9 protein | increases expression | 12789230 14987308 15131573 |
| D014212 | Tretinoin | Tretinoin results in increased activity of MMP9 protein | increases activity | 17332158 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of and results in decreased secretion of MMP9 protein | decreases expression|decreases secretion | 16914095 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of MMP9 mRNA | decreases expression | 16914095 |
| D014212 | Tretinoin | Tretinoin results in increased expression of MMP9 mRNA | increases expression | 16788091 |
| D014212 | Tretinoin | [Thiram co-treated with Tretinoin] results in increased activity of MMP9 protein | affects cotreatment|increases activity | 17332158 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [Acrolein results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 18006877 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [sodium arsenite results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 15504454 |
| C113580 | U 0126 | U 0126 inhibits the reaction [sodium arsenite results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 15504454 |
| C113580 | U 0126 | U 0126 results in decreased activity of MMP9 protein | decreases activity | 19393235 |
| C113580 | U 0126 | U 0126 results in decreased expression of MMP9 mRNA | decreases expression | 19393235 |
| D014520 | Urethane | [Urethane co-treated with Freund's Adjuvant] results in decreased expression of MMP9 mRNA | affects cotreatment|decreases expression | 12400877 |
| D014520 | Urethane | Urethane results in decreased expression of MMP9 mRNA | decreases expression | 12400877 |
| C085514 | wogonin | wogonin inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein] | affects cotreatment|decreases reaction|increases activity | 14700523 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Adenosine Triphosphate results in increased activity of MMP9 protein] | decreases reaction|increases activity | 20195827 |
| C010807 | xylosides | xylosides results in decreased secretion of MMP9 protein | decreases secretion | 14511379 |
| C403304 | zerumbone | zerumbone results in decreased expression of MMP9 mRNA | decreases expression | 16007145 |
| D015215 | Zidovudine | Zidovudine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 14662518 |
| D015215 | Zidovudine | Zidovudine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein] | decreases reaction|increases expression | 14662518 |
| D015215 | Zidovudine | Zidovudine inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 14662518 |
| C063449 | zileuton | zileuton results in decreased activity of MMP9 protein | decreases activity | 19309543 |
| C063449 | zileuton | zileuton results in decreased expression of MMP9 mRNA | decreases expression | 19309543 |
| D015032 | Zinc | Zinc binds to MMP9 protein | affects binding | 17137715 |
| D015032 | Zinc | Zinc inhibits the reaction [TNF protein results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 16606632 |
| D019287 | Zinc Sulfate | Zinc Sulfate inhibits the reaction [TNF protein results in increased secretion of MMP9 protein] | decreases reaction|increases secretion | 16606632 |
| C028541 | zirconium oxide | zirconium oxide results in decreased expression of MMP9 mRNA | decreases expression | 14661256 |
| C088658 | zoledronic acid | zoledronic acid results in decreased expression of and results in decreased activity of MMP9 protein | decreases activity|decreases expression | 15343380 |
| D015054 | Zymosan | GM 6001 inhibits the reaction [Zymosan results in increased expression of MMP9 protein] | decreases reaction|increases expression | 18557954 |
| D015054 | Zymosan | [Zymosan co-treated with 4-aminophenylmercuriacetate] results in increased activity of MMP9 protein | affects cotreatment|increases activity | 18557954 |
| D015054 | Zymosan | Zymosan results in increased expression of MMP9 mRNA | increases expression | 18557954 |
| D015054 | Zymosan | Zymosan results in increased expression of MMP9 protein | increases expression | 18557954 |
| D015054 | Zymosan | [Lipopolysaccharides co-treated with Zymosan] results in increased activity of MMP9 protein | affects cotreatment|increases activity | 15259001 |
| D015054 | Zymosan | [Lipopolysaccharides co-treated with Zymosan] results in increased expression of MMP9 mRNA | affects cotreatment|increases expression | 15259001 |
| D015054 | Zymosan | [Lipopolysaccharides co-treated with Zymosan] results in increased expression of MMP9 protein | affects cotreatment|increases expression | 15259001 |
| D015054 | Zymosan | MMP9 protein affects the reaction [Zymosan affects the activity of ELA2 protein] | affects activity|affects reaction | 19088179 |
| D015054 | Zymosan | MMP9 protein affects the reaction [Zymosan affects the expression of ELA2 mRNA] | affects expression|affects reaction | 19088179 |
| D015054 | Zymosan | NCF1 protein affects the reaction [Zymosan results in increased expression of MMP9 mRNA] | affects reaction|increases expression | 14507659 |
| D015054 | Zymosan | Zymosan results in increased activity of MMP9 protein | increases activity | 18241695 11839551 17826846 |
| D015054 | Zymosan | Zymosan results in increased expression of MMP9 mRNA | increases expression | 17826846 14507659 18241695 |
| D015054 | Zymosan | Zymosan results in increased expression of MMP9 protein | increases expression | 18241695 17826846 |
| D015054 | Zymosan | Zymosan results in increased secretion of MMP9 protein | increases secretion | 17826846 |
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
|---|---|---|---|---|---|
| MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 3.29 | 14745880 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Disulfiram | 14.04 | 17676605 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Ethanol | 14.04 | 18926900 17676605 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Isotretinoin | 14.04 | 18769834 | |
| MESH:D000014 | Abnormalities, Drug-Induced | methylmercuric chloride | 14.04 | 6734493 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 14.04 | 15322242 14514962 11752688 | |
| MESH:D000015 | Abnormalities, Multiple | Isotretinoin | 3.84 | 18769834 | |
| MESH:D000138 | Acidosis | Ammonium Chloride | 15.49 | 18287403 | |
| MESH:D000138 | Acidosis | Ethanol | 15.49 | 11192467 | |
| MESH:D000138 | Acidosis | Hydrochloric Acid | 15.49 | 16144966 11574821 15920416 20872349 12771618 19262391 | |
| MESH:D000138 | Acidosis | Zinc Sulfate | 15.49 | 7265320 | |
| MESH:D000141 | Acidosis, Renal Tubular | Hydrochloric Acid | 4.55 | 17183249 | |
| MESH:D000142 | Acidosis, Respiratory | Hydrochloric Acid | 4.56 | 20597076 | |
| MESH:D017486 | Acneiform Eruptions | Isotretinoin | 5.02 | 16232082 | |
| MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 13.25 | 17505938 | |
| MESH:D000152 | Acne Vulgaris | Isotretinoin | 13.25 | 16185265 18769834 | |
| MESH:D000152 | Acne Vulgaris | zileuton | 13.25 | 20436887 | |
| MESH:D000163 | Acquired Immunodeficiency Syndrome | Disulfiram | 7.74 | 9207937 | |
| MESH:D000163 | Acquired Immunodeficiency Syndrome | Zidovudine | 7.74 | 9612607 | |
| MESH:D000168 | Acrocephalosyndactylia | U 0126 | 4.27 | 17694057 | |
| MESH:D000169 | Acrodermatitis | Zinc | 4.16 | 17202136 17190629 16889938 | |
| MESH:D054058 | Acute Coronary Syndrome | clopidogrel | 4.76 | 19106084 | |
| MESH:D058186 | Acute Kidney Injury | Ibuprofen | 8.15 | 6375363 | |
| MESH:D058186 | Acute Kidney Injury | resveratrol | 8.15 | 16538975 | |
| MESH:D058186 | Acute Kidney Injury | zoledronic acid | 8.15 | 19715164 | |
| MESH:D055371 | Acute Lung Injury | Acrolein | 16.47 | 21297076 20525806 | |
| MESH:D055371 | Acute Lung Injury | Hydrochloric Acid | 16.47 | 19060228 11850527 11953099 15970105 19760209 16759491 19094174 | |
| MESH:D055371 | Acute Lung Injury | Lipopolysaccharides | 16.47 | 11850527 18653653 | |
| MESH:D055371 | Acute Lung Injury | Oxygen | 16.47 | 16759491 | |
| MESH:D055371 | Acute Lung Injury | zileuton | 16.47 | 17118201 | |
| MESH:D000210 | Acute-Phase Reaction | zoledronic acid | 4.24 | 20200999 | |
| MESH:D000230 | Adenocarcinoma | arsenic trioxide | 26.33 | 19825857 11798837 | |
| MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 26.33 | 20127859 20464547 | |
| MESH:D000230 | Adenocarcinoma | Dimethylnitrosamine | 26.33 | 16033868 | |
| MESH:D000230 | Adenocarcinoma | Doxorubicin | 26.33 | 17418594 | |
| MESH:D000230 | Adenocarcinoma | Estradiol | 26.33 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 26.33 | 14692618 | |
| MESH:D000230 | Adenocarcinoma | Fenretinide | 26.33 | 10697514 | |
| MESH:D000230 | Adenocarcinoma | Fluorouracil | 26.33 | 17638652 | |
| MESH:D000230 | Adenocarcinoma | Genistein | 26.33 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Ibuprofen | 26.33 | 10697514 | |
| MESH:D000230 | Adenocarcinoma | Indomethacin | 26.33 | 16537180 | |
| MESH:D000230 | Adenocarcinoma | Urethane | 26.33 | 18316556 | |
| MESH:D002282 | Adenocarcinoma, Bronchiolo-Alveolar | Urethane | 4.45 | 15814487 | |
| MESH:D000236 | Adenoma | 2-Acetylaminofluorene | 21.73 | 10737359 | |
| MESH:D000236 | Adenoma | Benzo(a)pyrene | 21.73 | 6695378 | |
| MESH:D000236 | Adenoma | Diethylnitrosamine | 21.73 | 10737359 6695378 | |
| MESH:D000236 | Adenoma | Dimethylnitrosamine | 21.73 | 19555203 | |
| MESH:D000236 | Adenoma | Indomethacin | 21.73 | 11497255 | |
| MESH:D000236 | Adenoma | Melatonin | 21.73 | 17195641 | |
| MESH:D000236 | Adenoma | resveratrol | 21.73 | 15688382 | |
| MESH:D000236 | Adenoma | Urethane | 21.73 | 6695378 11497255 10822126 17093202 16926031 17195641 10530776 | |
| MESH:D002759 | Adenoma, Bile Duct | 2-Acetylaminofluorene | 4.75 | 6705139 | |
| MESH:D018248 | Adenoma, Liver Cell | 2-aminofluorene | 10.56 | 19052882 | |
| MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 10.56 | 19052882 17162532 17620307 16434500 19061943 18056438 | |
| MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 10.56 | 16835633 | |
| MESH:D011125 | Adenomatous Polyposis Coli | celecoxib | 3.97 | 16215675 19003578 | |
| MESH:D000310 | Adrenal Gland Neoplasms | sodium arsenite | 3.44 | 15276417 | |
| MESH:D018246 | Adrenocortical Adenoma | Arsenic | 9.63 | 17306315 | |
| MESH:D018246 | Adrenocortical Adenoma | sodium arsenite | 9.63 | 16712894 17306315 | |
| MESH:D000382 | Agricultural Workers' Diseases | alachlor | 5.10 | 14769641 11874814 | |
| MESH:D000382 | Agricultural Workers' Diseases | Paraquat | 5.10 | 11874814 | |
| MESH:D000419 | Albuminuria | Doxorubicin | 7.51 | 21441931 | |
| MESH:D000419 | Albuminuria | Raloxifene | 7.51 | 17308373 17451421 | |
| MESH:D020268 | Alcohol-Induced Disorders, Nervous System | Ethanol | 4.06 | 15451039 15451040 | |
| MESH:D000437 | Alcoholism | Disulfiram | 3.94 | 18968458 17079463 10841824 | |
| MESH:D019973 | Alcohol-Related Disorders | Curcumin | 9.67 | 17887948 | |
| MESH:D019973 | Alcohol-Related Disorders | lipostabil | 9.67 | 17887948 | |
| OMIM:607154 | ALLERGIC RHINITIS | fexofenadine | 4.60 | 16037679 | |
| MESH:D000505 | Alopecia | Tretinoin | 2.56 | 15955085 | |
| MESH:D016301 | Alveolar Bone Loss | Indomethacin | 4.11 | 17225004 | |
| MESH:D000544 | Alzheimer Disease | Acrolein | 24.47 | 14715435 17570602 15207723 | |
| MESH:D000544 | Alzheimer Disease | Aluminum | 24.47 | 10721010 17662457 | |
| MESH:D000544 | Alzheimer Disease | Androgens | 24.47 | 17917157 17182789 | |
| MESH:D000544 | Alzheimer Disease | bis(4-hydroxycinnamoyl)methane | 24.47 | 19090986 | |
| MESH:D000544 | Alzheimer Disease | Curcumin | 24.47 | 15590663 | |
| MESH:D000544 | Alzheimer Disease | Ibuprofen | 24.47 | 18351690 | |
| MESH:D000544 | Alzheimer Disease | Indomethacin | 24.47 | 15579461 17627676 | |
| MESH:D000544 | Alzheimer Disease | Ozone | 24.47 | 15513908 | |
| MESH:D000544 | Alzheimer Disease | Plant Extracts | 24.47 | 16962711 | |
| MESH:D000544 | Alzheimer Disease | Raloxifene | 24.47 | 15800139 | |
| MESH:D000544 | Alzheimer Disease | resveratrol | 24.47 | 16162502 16183991 | |
| MESH:D000544 | Alzheimer Disease | Zinc | 24.47 | 16410023 17119284 16580781 16325427 | |
| MESH:D000707 | Anaphylaxis | Ibuprofen | 4.03 | 9532969 | |
| MESH:D000740 | Anemia | Fluorouracil | 8.50 | 17963324 15504547 16511603 | |
| MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 8.50 | 11748828 | |
| MESH:D000740 | Anemia | Zymosan | 8.50 | 18664788 | |
| MESH:D000743 | Anemia, Hemolytic | Quercetin | 3.10 | 17084956 | |
| MESH:D000755 | Anemia, Sickle Cell | Zinc | 3.71 | 16916123 | |
| MESH:D000799 | Angioedema | Acetaminophen | 2.59 | 10982225 | |
| MESH:D000853 | Anophthalmos | Benomyl | 8.40 | 15907663 | |
| MESH:D000853 | Anophthalmos | Ethanol | 8.40 | 15513904 | |
| MESH:D000860 | Anoxia | Hydrochloric Acid | 11.77 | 15090967 | |
| MESH:D000860 | Anoxia | Oxygen | 11.77 | 20872349 | |
| MESH:D000860 | Anoxia | Zinc Sulfate | 11.77 | 7265320 | |
| MESH:D001008 | Anxiety Disorders | Ethanol | 2.96 | 11141031 | |
| MESH:D001014 | Aortic Aneurysm | marker/mechanism | 10231640 | ||
| MESH:D001014 | Aortic Aneurysm | Indomethacin | 3.65 | 10231640 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 7.69 | 19183758 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Indomethacin | 7.69 | 10388637 | |
| MESH:D001145 | Arrhythmias, Cardiac | Phenylephrine | 3.02 | 17460149 | |
| MESH:D020261 | Arsenic Poisoning | Arsenic | 2.35 | 12569548 16251483 18414634 16835338 | |
| MESH:D001161 | Arteriosclerosis | Acrolein | 10.18 | 15014928 | |
| MESH:D001161 | Arteriosclerosis | Dietary Fats | 10.18 | 15238619 | |
| MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 10.18 | 11256880 | |
| MESH:D018771 | Arthralgia | Indomethacin | 3.91 | 2160914 | |
| MESH:D001169 | Arthritis, Experimental | Dexamethasone | 16.89 | 17659584 | |
| MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 16.89 | 15885639 | |
| MESH:D001169 | Arthritis, Experimental | Plant Extracts | 16.89 | 14686799 | |
| MESH:D001169 | Arthritis, Experimental | resveratrol | 16.89 | 17115116 | |
| MESH:D001169 | Arthritis, Experimental | Tretinoin | 16.89 | 16412693 | |
| MESH:D001169 | Arthritis, Experimental | Zymosan | 16.89 | 15142272 16872482 17659584 15944321 15188379 | |
| MESH:D001172 | Arthritis, Rheumatoid | Curcumin | 10.65 | 16807698 | |
| MESH:D001172 | Arthritis, Rheumatoid | Indomethacin | 10.65 | 11248219 | |
| MESH:D001172 | Arthritis, Rheumatoid | Minocycline | 10.65 | 14528503 | |
| MESH:D001172 | Arthritis, Rheumatoid | Ozone | 10.65 | 15570426 | |
| MESH:D001172 | Arthritis, Rheumatoid | phenylmethylpyrazolone | 10.65 | 16390820 | |
| MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 10.65 | 16292516 | |
| MESH:D001195 | Asbestosis | Asbestos, Serpentine | 4.47 | 10751356 | |
| MESH:D001249 | Asthma | marker/mechanism | 11742282 15131573 | ||
| MESH:D001249 | Asthma | Acetaldehyde | 18.89 | 9600491 | |
| MESH:D001249 | Asthma | Budesonide | 18.89 | 18489783 15136378 10893010 15572850 12604023 20004779 12113382 | |
| MESH:D001249 | Asthma | epigallocatechin gallate | 18.89 | 16516891 | |
| MESH:D001249 | Asthma | Mustard Gas | 18.89 | 10378619 | |
| MESH:D001249 | Asthma | Ozone | 18.89 | 17854713 16373670 | |
| MESH:D001249 | Asthma | Toluene 2,4-Diisocyanate | 18.89 | 15590890 6091946 170078 16210060 10934080 6091945 16792590 10797510 19187332 12585506 15590891 11467998 17015710 12762349 3040596 11077013 18394133 20032816 15855793 8156442 7684630 11742282 12684321 | |
| MESH:D001249 | Asthma | Tretinoin | 18.89 | 16456186 | |
| MESH:D001249 | Asthma | zileuton | 18.89 | 17944539 10181070 19214143 10764316 8598621 20332717 9620945 | |
| MESH:D001249 | Asthma | Zinc | 18.89 | 17085522 | |
| MESH:D001250 | Asthma, Exercise-Induced | zileuton | 4.35 | 10984370 | |
| MESH:D001259 | Ataxia | 1-Butanol | 4.41 | 7820390 | |
| MESH:D001260 | Ataxia Telangiectasia | Quercetin | 3.74 | 15336622 | |
| MESH:D050197 | Atherosclerosis | Acrolein | 17.38 | 17363696 16037261 16126721 | |
| MESH:D050197 | Atherosclerosis | Arsenic | 17.38 | 19371607 12928151 | |
| MESH:D050197 | Atherosclerosis | Curcumin | 17.38 | 18704882 | |
| MESH:D050197 | Atherosclerosis | Oxygen | 17.38 | 16391483 | |
| MESH:D050197 | Atherosclerosis | Panax notoginseng extract | 17.38 | 18637019 | |
| MESH:D050197 | Atherosclerosis | resveratrol | 17.38 | 17967414 16873680 | |
| MESH:D050197 | Atherosclerosis | Saponins | 17.38 | 18637019 | |
| MESH:D001321 | Autistic Disorder | Acetaminophen | 3.35 | 18445737 | |
| MESH:D001321 | Autistic Disorder | Arachidonic Acid | 3.35 | 18582451 | |
| MESH:D001321 | Autistic Disorder | Glutathione | 3.35 | 16917939 18929414 19267885 19056591 | |
| MESH:D001321 | Autistic Disorder | Homocysteine | 3.35 | 20468076 16297937 | |
| MESH:D001321 | Autistic Disorder | Melatonin | 3.35 | 16897403 16919138 | |
| MESH:D001321 | Autistic Disorder | pioglitazone | 3.35 | 17207275 | |
| MESH:D001321 | Autistic Disorder | Propranolol | 3.35 | 18766980 | |
| MESH:D001327 | Autoimmune Diseases | Curcumin | 11.23 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | epigallocatechin gallate | 11.23 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | Quercetin | 11.23 | 19761891 | |
| MESH:D001471 | Barrett Esophagus | Tretinoin | 3.21 | 16935849 | |
| MESH:D001477 | Bartter Syndrome | Indomethacin | 3.77 | 10684365 | |
| MESH:D001768 | Blister | Mustard Gas | 3.92 | 19167455 | |
| MESH:D001778 | Blood Coagulation Disorders | arsenic trioxide | 16.95 | 16206674 | |
| MESH:D001778 | Blood Coagulation Disorders | Hydrochloric Acid | 16.95 | 15920416 | |
| MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 16.95 | 12125929 | |
| MESH:D001778 | Blood Coagulation Disorders | Thioacetamide | 16.95 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 16.95 | 16206674 16197459 | |
| MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 2.54 | 15340226 | |
| MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 1.83 | 15746008 | |
| MESH:D019046 | Bone Marrow Neoplasms | Doxorubicin | 3.45 | 14601052 | |
| MESH:D001859 | Bone Neoplasms | marker/mechanism | 16475674 | ||
| MESH:D001859 | Bone Neoplasms | Paclitaxel | 6.97 | 15867366 | |
| MESH:D001859 | Bone Neoplasms | zoledronic acid | 6.97 | 16778634 19442620 15867366 11697798 17312309 16121404 | |
| MESH:D001862 | Bone Resorption | Freund's Adjuvant | 6.49 | 16769263 | |
| MESH:D001862 | Bone Resorption | zoledronic acid | 6.49 | 15845617 18496637 11869084 16769263 18404659 8053405 | |
| MESH:D001913 | Bowen's Disease | imiquimod | 5.19 | 11207687 | |
| MESH:D001919 | Bradycardia | Isoproterenol | 10.83 | 6740701 | |
| MESH:D001919 | Bradycardia | Phenylephrine | 10.83 | 15306635 | |
| MESH:D001919 | Bradycardia | Propranolol | 10.83 | 6740701 | |
| MESH:D001929 | Brain Edema | Indomethacin | 8.72 | 11481608 | |
| MESH:D001929 | Brain Edema | zileuton | 8.72 | 19309543 | |
| MESH:D020201 | Brain Hemorrhage, Traumatic | Progesterone | 4.08 | 17868700 | |
| MESH:D001930 | Brain Injuries | Progesterone | 11.50 | 15845082 15380490 15665606 | |
| MESH:D001930 | Brain Injuries | Raloxifene | 11.50 | 16580743 | |
| MESH:D001930 | Brain Injuries | Zinc | 11.50 | 17109824 | |
| MESH:D002545 | Brain Ischemia | Curcumin | 18.93 | 16770732 | |
| MESH:D002545 | Brain Ischemia | Ibuprofen | 18.93 | 15837124 | |
| MESH:D002545 | Brain Ischemia | Indomethacin | 18.93 | 12524144 | |
| MESH:D002545 | Brain Ischemia | Plant Extracts | 18.93 | 16041641 | |
| MESH:D002545 | Brain Ischemia | resveratrol | 18.93 | 17600658 | |
| MESH:D001932 | Brain Neoplasms | Butadienes | 11.92 | 12562636 | |
| MESH:D001932 | Brain Neoplasms | Curcumin | 11.92 | 17596214 | |
| MESH:D001932 | Brain Neoplasms | Doxorubicin | 11.92 | 17150277 | |
| MESH:D001932 | Brain Neoplasms | Fenretinide | 11.92 | 16187019 | |
| MESH:D001943 | Breast Neoplasms | 2,4-diaminotoluene | 31.19 | 11921183 | |
| MESH:D001943 | Breast Neoplasms | Androgens | 31.19 | 17018787 | |
| MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 31.19 | 20146248 17474063 | |
| MESH:D001943 | Breast Neoplasms | beta-hexachlorocyclohexane | 31.19 | 17640349 12948864 | |
| MESH:D001943 | Breast Neoplasms | Curcumin | 31.19 | 18462866 18593918 16243823 19250217 | |
| MESH:D001943 | Breast Neoplasms | deguelin | 31.19 | 17035597 18593368 | |
| MESH:D001943 | Breast Neoplasms | Dietary Fats | 31.19 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 31.19 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Disulfiram | 31.19 | 17026967 | |
| MESH:D001943 | Breast Neoplasms | Doxorubicin | 31.19 | 18695136 15994142 19526202 16595493 15567936 16935488 17426702 15692762 15939500 15634643 16264153 16115903 18628466 15668708 16096432 15993339 15136595 11325840 16322301 18382427 18234424 16826403 17983394 17369602 | |
| MESH:D001943 | Breast Neoplasms | Estradiol | 31.19 | 12948864 17289903 14630087 17261762 19861407 16675129 18497071 17018787 | |
| MESH:D001943 | Breast Neoplasms | Fenretinide | 31.19 | 16601279 | |
| MESH:D001943 | Breast Neoplasms | Fluorouracil | 31.19 | 16595493 18357371 15136595 18608205 19217205 16110121 16557594 | |
| MESH:D001943 | Breast Neoplasms | gemcitabine | 31.19 | 17039268 18382427 | |
| MESH:D001943 | Breast Neoplasms | Genistein | 31.19 | 17200150 16541309 16873071 | |
| MESH:D001943 | Breast Neoplasms | gingerol | 31.19 | 17683926 | |
| MESH:D001943 | Breast Neoplasms | Hexachlorobenzene | 31.19 | 15061365 12709520 | |
| MESH:D001943 | Breast Neoplasms | indole-3-carbinol | 31.19 | 16082211 | |
| MESH:D001943 | Breast Neoplasms | Indomethacin | 31.19 | 17401462 | |
| MESH:D001943 | Breast Neoplasms | Oxygen | 31.19 | 17263869 | |
| MESH:D001943 | Breast Neoplasms | Paclitaxel | 31.19 | 15136595 16273361 18234424 18323546 18223236 16244791 11325840 16115903 | |
| MESH:D001943 | Breast Neoplasms | Progesterone | 31.19 | 15562024 17614352 16175315 | |
| MESH:D001943 | Breast Neoplasms | Quercetin | 31.19 | 18628248 | |
| MESH:D001943 | Breast Neoplasms | Raloxifene | 31.19 | 15572757 15758505 17049068 16912660 17595753 15775269 16837676 17952589 17893378 17242785 17261762 17440819 | |
| MESH:D001943 | Breast Neoplasms | resveratrol | 31.19 | 17651959 16393696 17534123 | |
| MESH:D001943 | Breast Neoplasms | Tamoxifen | 31.19 | 16273361 19221464 18984771 15668708 20065188 19155303 18997820 17261762 18821012 19189212 19200415 19084267 18425577 19288272 19244106 19011961 16818667 18629630 17440819 19189210 16873071 19142967 19066611 18855134 19103187 11161223 20005174 17893378 17049068 20390343 19487384 19115204 20859285 16202921 19059307 20135344 17242785 18351453 21152245 20544844 19289846 18815881 21138602 15565566 19410462 | |
| MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 31.19 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Toluene 2,4-Diisocyanate | 31.19 | 11921183 | |
| MESH:D001943 | Breast Neoplasms | Tretinoin | 31.19 | 16166294 16873071 16443354 | |
| MESH:D001943 | Breast Neoplasms | zoledronic acid | 31.19 | 18695136 16096432 | |
| MESH:D016535 | Bronchial Hyperreactivity | Hydrochloric Acid | 15.39 | 12378975 | |
| MESH:D016535 | Bronchial Hyperreactivity | Ozone | 15.39 | 19059883 15516495 17626835 18417511 16777450 18315731 14754758 | |
| MESH:D016535 | Bronchial Hyperreactivity | Toluene 2,4-Diisocyanate | 15.39 | 12507178 8156442 15590891 | |
| MESH:D016535 | Bronchial Hyperreactivity | tyrphostin AG 1478 | 15.39 | 12794006 | |
| MESH:D016535 | Bronchial Hyperreactivity | zileuton | 15.39 | 12654629 12794006 12388339 | |
| MESH:D001986 | Bronchial Spasm | Hydrochloric Acid | 4.22 | 15578804 | |
| MESH:D001989 | Bronchiolitis Obliterans | Mustard Gas | 3.92 | 15286001 | |
| MESH:D029481 | Bronchitis, Chronic | Mustard Gas | 3.72 | 17687719 10378619 | |
| MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 3.35 | 16813970 | |
| MESH:D002051 | Burkitt Lymphoma | arsenic trioxide | 3.16 | 11589617 | |
| MESH:D002056 | Burns | Ethanol | 7.36 | 16374292 | |
| MESH:D002056 | Burns | Indomethacin | 7.36 | 10459503 | |
| MESH:D002057 | Burns, Chemical | Plant Extracts | 4.08 | 9625245 | |
| MESH:D002100 | Cachexia | Ibuprofen | 14.05 | 15141370 | |
| MESH:D002100 | Cachexia | Indomethacin | 14.05 | 15141370 16537180 11239499 15625704 | |
| MESH:D002100 | Cachexia | Ozone | 14.05 | 16183385 | |
| MESH:D002105 | Cadmium Poisoning | Quercetin | 4.28 | 16962696 | |
| MESH:D002177 | Candidiasis | Disulfiram | 4.62 | 15325261 | |
| MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 3.22 | 16111702 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Carbon Tetrachloride | 10.33 | 10355542 18705752 15700767 3786805 15721981 16050911 15673190 16192424 16227642 16011737 16124888 16097048 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Melatonin | 10.33 | 15700767 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Perindopril | 10.33 | 16097048 | |
| MESH:D002276 | Carcinoid Tumor | Doxorubicin | 8.20 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Fluorouracil | 8.20 | 16051944 | |
| MESH:D002277 | Carcinoma | Curcumin | 15.11 | 18593918 | |
| MESH:D002277 | Carcinoma | Dimethylnitrosamine | 15.11 | 19555203 | |
| MESH:D002277 | Carcinoma | Disulfiram | 15.11 | 17026967 | |
| MESH:D002277 | Carcinoma | Fluorouracil | 15.11 | 17121937 | |
| MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 15.11 | 16835633 | |
| MESH:D002280 | Carcinoma, Basal Cell | Arsenic | 5.69 | 17687452 15504454 | |
| MESH:D002280 | Carcinoma, Basal Cell | imiquimod | 5.69 | 16302556 | |
| MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 3.29 | 19066611 | |
| MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 3.90 | 16168501 | |
| MESH:D006528 | Carcinoma, Hepatocellular | marker/mechanism | 20084675 | ||
| MESH:D006528 | Carcinoma, Hepatocellular | 2-Acetylaminofluorene | 53.84 | 10737359 3084413 6705139 17761372 3581430 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 2-aminofluorene | 53.84 | 19052882 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 53.84 | 3084413 | |
| MESH:D006528 | Carcinoma, Hepatocellular | anthra(1,9-cd)pyrazol-6(2H)-one | 53.84 | 19418558 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Arsenic | 53.84 | 16507464 17306315 | |
| MESH:D006528 | Carcinoma, Hepatocellular | arsenic trioxide | 53.84 | 14691202 15073043 11135700 16217749 15553829 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Carbon Tetrachloride | 53.84 | 18788625 | |
| MESH:D006528 | Carcinoma, Hepatocellular | deguelin | 53.84 | 18575727 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 53.84 | 16569478 19418558 19208518 20084675 19539802 17162532 17978847 20524982 3084413 16502159 17761372 18494052 19052882 18978308 19171122 17428255 17138121 19335982 17055752 18785209 18393292 19822196 20514400 19519916 19919837 3581430 10672840 16807293 16288022 11831363 16935385 20727157 20214788 21159647 20935162 19107877 19701751 18056438 17173139 20007298 18210153 20512989 18506893 19394651 18788625 16830150 16878318 16328049 16681979 16698587 18691550 10737359 18665156 18971187 20432363 19383236 20101231 16779866 16540662 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Doxorubicin | 53.84 | 18059187 16234567 16023760 17876044 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 53.84 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Ethanol | 53.84 | 18788625 15763234 15289165 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Fenretinide | 53.84 | 16270382 17159502 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Fluorouracil | 53.84 | 17045692 17971768 16332177 18930000 16799960 17088986 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Genistein | 53.84 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Indomethacin | 53.84 | 16391822 | |
| MESH:D006528 | Carcinoma, Hepatocellular | morin | 53.84 | 19539802 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Paclitaxel | 53.84 | 16313753 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Plant Extracts | 53.84 | 18834353 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Quercetin | 53.84 | 12508355 19519916 | |
| MESH:D006528 | Carcinoma, Hepatocellular | resveratrol | 53.84 | 19321006 16227395 | |
| MESH:D006528 | Carcinoma, Hepatocellular | sodium arsenite | 53.84 | 16507464 17306315 15276417 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 53.84 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Thioacetamide | 53.84 | 17997003 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 53.84 | 1917145 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Indomethacin | 7.34 | 11053908 | |
| MESH:D018827 | Carcinoma, Lewis Lung | resveratrol | 7.34 | 16675471 | |
| MESH:D018276 | Carcinoma, Medullary | Indomethacin | 4.11 | 14736730 11352223 18791128 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Curcumin | 5.40 | 18414057 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Disulfiram | 5.40 | 17026967 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | zoledronic acid | 5.40 | 19233551 | |
| MESH:D021441 | Carcinoma, Pancreatic Ductal | Quercetin | 3.74 | 17234771 | |
| MESH:D002291 | Carcinoma, Papillary | arsenic trioxide | 3.62 | 19014326 | |
| MESH:D002292 | Carcinoma, Renal Cell | celecoxib | 11.86 | 16369983 | |
| MESH:D002292 | Carcinoma, Renal Cell | Doxorubicin | 11.86 | 16201981 1485588 | |
| MESH:D002292 | Carcinoma, Renal Cell | Fluorouracil | 11.86 | 18695887 | |
| MESH:D002292 | Carcinoma, Renal Cell | Indomethacin | 11.86 | 17341418 | |
| MESH:D002292 | Carcinoma, Renal Cell | zoledronic acid | 11.86 | 18507039 | |
| MESH:D018288 | Carcinoma, Small Cell | arsenic trioxide | 2.99 | 12490120 | |
| MESH:D002294 | Carcinoma, Squamous Cell | marker/mechanism | 18572023 | ||
| MESH:D002294 | Carcinoma, Squamous Cell | Acetylcysteine | 51.33 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Arsenic | 51.33 | 18922899 17687452 15504454 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 51.33 | 20419170 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Curcumin | 51.33 | 18462866 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Dimethylnitrosamine | 51.33 | 16033868 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Doxorubicin | 51.33 | 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | erythritol anhydride | 51.33 | 10925838 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Fenretinide | 51.33 | 16274795 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Fluorouracil | 51.33 | 16280240 18986760 17066447 16757204 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Glutathione | 51.33 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | imiquimod | 51.33 | 16302556 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Indomethacin | 51.33 | 15482327 12636206 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Isotretinoin | 51.33 | 11237771 | |
| MESH:D002294 | Carcinoma, Squamous Cell | resveratrol | 51.33 | 16227395 | |
| MESH:D002294 | Carcinoma, Squamous Cell | retinol palmitate | 51.33 | 15984520 | |
| MESH:D002294 | Carcinoma, Squamous Cell | sodium arsenite | 51.33 | 18572023 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tetradecanoylphorbol Acetate | 51.33 | 18922899 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 51.33 | 16051514 16096774 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Zinc | 51.33 | 16543248 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Arsenic | 9.47 | 18640142 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Raloxifene | 9.47 | 17572228 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 9.47 | 17572228 | |
| MESH:D006332 | Cardiomegaly | Ethanol | 15.63 | 19332462 | |
| MESH:D006332 | Cardiomegaly | Isoproterenol | 15.63 | 7544033 11179087 | |
| MESH:D006332 | Cardiomegaly | Phenylephrine | 15.63 | 11754973 17124262 11179087 16170337 15728586 17287366 | |
| MESH:D006332 | Cardiomegaly | Plant Extracts | 15.63 | 17645561 | |
| MESH:D006332 | Cardiomegaly | Quercetin | 15.63 | 19794523 | |
| MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 15.63 | 18670907 16120746 18850075 | |
| MESH:D009202 | Cardiomyopathies | carvedilol | 10.93 | 15476868 | |
| MESH:D009202 | Cardiomyopathies | Doxorubicin | 10.93 | 16612575 16651473 16278810 15505089 16952015 15792986 17007740 17308081 17924179 15476868 16455267 17351982 17928571 18627295 16242529 15811867 17974986 17329180 17382496 16269455 16731534 17131338 16364871 17519947 16109756 | |
| MESH:D009202 | Cardiomyopathies | pimagedine | 10.93 | 16612575 | |
| MESH:D009202 | Cardiomyopathies | Razoxane | 10.93 | 17519947 | |
| MESH:D002310 | Cardiomyopathy, Alcoholic | Acetaldehyde | 5.22 | 10525098 | |
| MESH:D002311 | Cardiomyopathy, Dilated | carvedilol | 4.41 | 19477965 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Doxorubicin | 4.41 | 16243910 17334414 | |
| MESH:D002318 | Cardiovascular Diseases | abacavir | 23.10 | 18753925 | |
| MESH:D002318 | Cardiovascular Diseases | Arsenic | 23.10 | 15738583 19152805 17938729 | |
| MESH:D002318 | Cardiovascular Diseases | clopidogrel | 23.10 | 20180610 | |
| MESH:D002318 | Cardiovascular Diseases | Genistein | 23.10 | 16332659 | |
| MESH:D002318 | Cardiovascular Diseases | Hydrogen Peroxide | 23.10 | 16936243 | |
| MESH:D002318 | Cardiovascular Diseases | Raloxifene | 23.10 | 15775269 | |
| MESH:D002318 | Cardiovascular Diseases | resveratrol | 23.10 | 15458977 | |
| MESH:D002318 | Cardiovascular Diseases | Zinc | 23.10 | 16936243 | |
| MESH:D002340 | Carotid Artery Diseases | Arsenic | 3.20 | 18022660 16973168 | |
| MESH:D020212 | Carotid Artery Injuries | tetracycline CMT-3 | 5.31 | 14507662 | |
| MESH:D002386 | Cataract | Acetaminophen | 13.81 | 10977129 | |
| MESH:D002386 | Cataract | Adenosine Triphosphate | 13.81 | 15003327 | |
| MESH:D002386 | Cataract | Disulfiram | 13.81 | 15003327 17936468 | |
| MESH:D002386 | Cataract | pimagedine | 13.81 | 15003327 17936468 | |
| MESH:D002386 | Cataract | Tretinoin | 13.81 | 17460283 | |
| MESH:D002471 | Cell Transformation, Neoplastic | marker/mechanism | 14700523 | ||
| MESH:D002471 | Cell Transformation, Neoplastic | Acetylcysteine | 10.97 | 18226522 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 10.97 | 17174075 21159647 2727394 7505956 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Dinoprost | 10.97 | 16192471 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 10.97 | 18566989 | |
| MESH:D002471 | Cell Transformation, Neoplastic | sodium arsenite | 10.97 | 20056578 19524636 | |
| MESH:D002543 | Cerebral Hemorrhage | marker/mechanism | 19095969 | ||
| MESH:D002543 | Cerebral Hemorrhage | phenylmethylpyrazolone | 4.62 | 19095969 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Fenretinide | 8.88 | 16154183 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 8.88 | 16129372 | |
| MESH:D018281 | Cholangiocarcinoma | 2-aminofluorene | 14.20 | 19052882 | |
| MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 14.20 | 19052882 | |
| MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 14.20 | 16835633 | |
| MESH:D018281 | Cholangiocarcinoma | Thioacetamide | 14.20 | 18291259 | |
| MESH:D002764 | Cholecystitis | Indomethacin | 3.91 | 11181007 | |
| MESH:D002779 | Cholestasis | Diosgenin | 5.25 | 16105132 | |
| MESH:D002779 | Cholestasis | Ethinyl Estradiol | 5.25 | 16105132 15861022 11677210 17110522 17681005 17333356 16919318 | |
| MESH:D002822 | Choriocarcinoma | Tretinoin | 3.90 | 16461808 | |
| MESH:D002971 | Cleft Lip | Ethanol | 2.77 | 15513904 | |
| MESH:D002972 | Cleft Palate | Ethanol | 10.74 | 15513904 | |
| MESH:D002972 | Cleft Palate | Hydrocortisone | 10.74 | 15826874 | |
| MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 10.74 | 8697196 15668235 15340226 16354765 12621046 | |
| MESH:D002972 | Cleft Palate | Tretinoin | 10.74 | 9407595 | |
| MESH:D002972 | Cleft Palate | Urethane | 10.74 | 12810352 | |
| MESH:D019970 | Cocaine-Related Disorders | Disulfiram | 4.51 | 19462300 | |
| MESH:D003072 | Cognition Disorders | Raloxifene | 3.41 | 15800139 | |
| MESH:D003092 | Colitis | Curcumin | 17.37 | 16782535 18200517 16804969 | |
| MESH:D003092 | Colitis | resveratrol | 17.37 | 16474422 | |
| MESH:D003092 | Colitis | Rutin | 17.37 | 15652231 | |
| MESH:D003092 | Colitis | Selenium | 17.37 | 17936198 | |
| MESH:D003092 | Colitis | Tretinoin | 17.37 | 17035595 | |
| MESH:D003103 | Coloboma | Curcumin | 3.40 | 18809619 | |
| MESH:D003110 | Colonic Neoplasms | marker/mechanism | 15725655 | ||
| MESH:D003110 | Colonic Neoplasms | arsenite | 19.59 | 15037631 | |
| MESH:D003110 | Colonic Neoplasms | celecoxib | 19.59 | 16004971 | |
| MESH:D003110 | Colonic Neoplasms | Curcumin | 19.59 | 19359593 16340194 | |
| MESH:D003110 | Colonic Neoplasms | Dexamethasone | 19.59 | 15824018 | |
| MESH:D003110 | Colonic Neoplasms | Fluorouracil | 19.59 | 18772588 17287894 17169374 16510598 15001691 17725105 17016597 17172411 17018589 16340194 | |
| MESH:D003110 | Colonic Neoplasms | Genistein | 19.59 | 17182828 | |
| MESH:D003110 | Colonic Neoplasms | Indomethacin | 19.59 | 15936596 15625704 11260862 15786552 15963497 15637740 | |
| MESH:D003110 | Colonic Neoplasms | irinotecan | 19.59 | 17725105 17287894 | |
| MESH:D003110 | Colonic Neoplasms | Quercetin | 19.59 | 17191121 17148506 19056647 19440933 15741050 11134977 16640504 | |
| MESH:D003110 | Colonic Neoplasms | resveratrol | 19.59 | 16338953 | |
| MESH:D003110 | Colonic Neoplasms | zileuton | 19.59 | 18927292 | |
| MESH:D015179 | Colorectal Neoplasms | Acrolein | 14.69 | 17597105 | |
| MESH:D015179 | Colorectal Neoplasms | arsenic trioxide | 14.69 | 20501625 | |
| MESH:D015179 | Colorectal Neoplasms | Azacitidine | 14.69 | 19934284 | |
| MESH:D015179 | Colorectal Neoplasms | celecoxib | 14.69 | 18349538 11197048 | |
| MESH:D015179 | Colorectal Neoplasms | Doxorubicin | 14.69 | 18259882 18802399 | |
| MESH:D015179 | Colorectal Neoplasms | Fenretinide | 14.69 | 17273769 | |
| MESH:D015179 | Colorectal Neoplasms | Fluorouracil | 14.69 | 15289873 18448328 15148649 20501625 16331619 18802399 18383874 18949393 17454858 17255274 17401013 16391804 18509181 17094418 16282729 17594712 17695437 14970324 16524972 18288408 16303861 17016601 | |
| MESH:D015179 | Colorectal Neoplasms | Indomethacin | 14.69 | 12606626 17054584 11197048 18059344 | |
| MESH:D015179 | Colorectal Neoplasms | irinotecan | 14.69 | 17454858 17159606 16303861 16391804 18509181 18259882 15273666 | |
| MESH:D015179 | Colorectal Neoplasms | Paclitaxel | 14.69 | 18802399 | |
| MESH:D015179 | Colorectal Neoplasms | Quercetin | 14.69 | 18095365 18852136 | |
| MESH:D015179 | Colorectal Neoplasms | resveratrol | 14.69 | 16550006 | |
| MESH:D003218 | Condylomata Acuminata | imiquimod | 5.88 | 11362904 16302556 | |
| MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 1.97 | 17141729 14669216 | |
| MESH:D016510 | Corneal Neovascularization | Curcumin | 3.68 | 18497527 | |
| MESH:D003324 | Coronary Artery Disease | Homocysteine | 3.14 | 16379339 | |
| MESH:D003327 | Coronary Disease | resveratrol | 2.82 | 16507316 | |
| MESH:D023903 | Coronary Restenosis | arsenic trioxide | 3.00 | 12609071 | |
| MESH:D018352 | Coronavirus Infections | Indomethacin | 4.46 | 17302372 | |
| MESH:D019465 | Craniofacial Abnormalities | arsenic trioxide | 10.31 | 10525206 | |
| MESH:D019465 | Craniofacial Abnormalities | Dexamethasone | 10.31 | 17728286 | |
| MESH:D019465 | Craniofacial Abnormalities | Ethanol | 10.31 | 11198716 19302082 10194807 15451039 15513904 15451040 11873399 | |
| MESH:D019465 | Craniofacial Abnormalities | Hydrocortisone | 10.31 | 17728286 | |
| MESH:D019465 | Craniofacial Abnormalities | Isotretinoin | 10.31 | 18769834 9879862 | |
| MESH:D019465 | Craniofacial Abnormalities | Reactive Oxygen Species | 10.31 | 15736158 | |
| MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 10.31 | 20055451 10048152 15322242 | |
| MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 10.31 | 16925845 8800419 10589399 9664655 9224671 9142499 17551590 9125849 9211117 14991402 | |
| MESH:D019465 | Craniofacial Abnormalities | Zinc | 10.31 | 19302082 | |
| MESH:D016638 | Critical Illness | Androgens | 4.82 | 16670151 | |
| MESH:D003550 | Cystic Fibrosis | Acetylcysteine | 8.29 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Glutathione | 8.29 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | pioglitazone | 8.29 | 19747007 | |
| MESH:D003556 | Cystitis | Acrolein | 8.12 | 12161096 | |
| MESH:D003556 | Cystitis | Hydrochloric Acid | 8.12 | 12853844 19279288 12599022 20719367 | |
| MESH:D018856 | Cystitis, Interstitial | Hydrochloric Acid | 4.56 | 17714534 | |
| MESH:D007644 | Darier Disease | Fluorouracil | 3.55 | 16733453 | |
| MESH:D016757 | Death, Sudden, Cardiac | arsenic trioxide | 2.93 | 15213294 | |
| MESH:D003665 | Decompression Sickness | zileuton | 4.97 | 18309904 | |
| MESH:D003704 | Dementia | Methylmercury Compounds | 3.86 | 16140633 | |
| MESH:D003711 | Demyelinating Diseases | Tamoxifen | 3.15 | 19031437 | |
| MESH:D003715 | Dengue | Doxycycline | 4.83 | 17502914 | |
| MESH:D003865 | Depressive Disorder, Major | Raloxifene | 3.07 | 17474826 | |
| MESH:D017449 | Dermatitis, Allergic Contact | alachlor | 5.30 | 8428444 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Dexamethasone | 5.30 | 12438553 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Toluene 2,4-Diisocyanate | 5.30 | 15491423 12956900 18759878 | |
| MESH:D003876 | Dermatitis, Atopic | fexofenadine | 4.02 | 17133778 | |
| MESH:D003877 | Dermatitis, Contact | Toluene 2,4-Diisocyanate | 3.65 | 17010967 | |
| MESH:D003920 | Diabetes Mellitus | Zinc | 3.12 | 16479319 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Quercetin | 8.21 | 19496084 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | resveratrol | 8.21 | 16873680 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Tetracyclines | 8.21 | 11172685 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Curcumin | 10.05 | 18403477 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 10.05 | 20387270 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | epigallocatechin gallate | 10.05 | 16988119 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Genistein | 10.05 | 16647724 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | pioglitazone | 10.05 | 16023994 12642470 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 10.05 | 17107852 | |
| MESH:D003928 | Diabetic Nephropathies | Curcumin | 25.54 | 18204486 | |
| MESH:D003928 | Diabetic Nephropathies | Estradiol | 25.54 | 19279558 | |
| MESH:D003928 | Diabetic Nephropathies | Perindopril | 25.54 | 11427623 | |
| MESH:D003928 | Diabetic Nephropathies | Plant Extracts | 25.54 | 19706694 | |
| MESH:D003928 | Diabetic Nephropathies | Raloxifene | 25.54 | 15920148 17451421 17308373 | |
| MESH:D003928 | Diabetic Nephropathies | resveratrol | 25.54 | 16286809 | |
| MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 25.54 | 19279558 | |
| MESH:D003929 | Diabetic Neuropathies | Progesterone | 3.28 | 17187935 | |
| MESH:D003967 | Diarrhea | Dexamethasone | 6.88 | 7237001 | |
| MESH:D003967 | Diarrhea | Hydrocortisone | 6.88 | 7237001 | |
| MESH:D003967 | Diarrhea | Indomethacin | 6.88 | 7907874 7237001 | |
| MESH:D004283 | Dog Diseases | Allopurinol | 5.02 | 10449224 | |
| MESH:D004342 | Drug Hypersensitivity | abacavir | 4.45 | 15867870 15024131 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 18.53 | 18071297 19164858 16227642 19085960 10915739 12392966 19416960 12594235 14550746 11739529 17906064 16485898 11834606 19420014 17522070 11743745 16081117 18713872 19739265 16393943 14725611 12153990 12958197 10663392 12540782 19370779 14986274 19923254 11287661 2444490 11421492 10774834 12705907 15619225 11461765 16177239 16781746 15968718 16109766 17562736 11529661 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetylcysteine | 18.53 | 11287661 | |
| MESH:D056486 | Drug-Induced Liver Injury | Carbon Tetrachloride | 18.53 | 11566570 21278145 6623471 19085960 15027814 4309450 15998439 17522070 10092053 16177239 6884620 9327722 7179309 7120509 19336974 3732212 3786805 2869522 15968718 7440962 16227642 10915739 | |
| MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 18.53 | 19107877 | |
| MESH:D056486 | Drug-Induced Liver Injury | Dimethylnitrosamine | 18.53 | 8172417 | |
| MESH:D056486 | Drug-Induced Liver Injury | Doxorubicin | 18.53 | 17416283 | |
| MESH:D056486 | Drug-Induced Liver Injury | Ethanol | 18.53 | 11566570 | |
| MESH:D056486 | Drug-Induced Liver Injury | Selenium | 18.53 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 18.53 | 20420201 | |
| MESH:D056486 | Drug-Induced Liver Injury | Thioacetamide | 18.53 | 12963478 | |
| MESH:D056486 | Drug-Induced Liver Injury | zileuton | 18.53 | 17944539 | |
| MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 2.84 | 19426721 | |
| MESH:D004362 | Drug Toxicity | Doxorubicin | 11.39 | 18602426 | |
| MESH:D004362 | Drug Toxicity | phenylmethylpyrazolone | 11.39 | 12231392 12649298 | |
| MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 11.39 | 11462148 | |
| MESH:D004362 | Drug Toxicity | Zidovudine | 11.39 | 15040536 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Ibuprofen | 9.13 | 18446180 18450898 16133044 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Indomethacin | 9.13 | 17190690 18043480 16326151 16133044 18446180 12774134 | |
| MESH:D004381 | Duodenal Ulcer | Curcumin | 5.53 | 17351913 | |
| MESH:D004381 | Duodenal Ulcer | Indomethacin | 5.53 | 17045617 17351913 17151854 10671773 11535926 11991626 17202747 11595415 17329845 16699067 11595431 | |
| MESH:D004387 | Dupuytren Contracture | imiquimod | 5.53 | 16368197 | |
| MESH:D050171 | Dyslipidemias | Dietary Fats | 2.46 | 18367378 | |
| MESH:D004417 | Dyspnea | Budesonide | 6.91 | 20016425 | |
| MESH:D004417 | Dyspnea | Oxygen | 6.91 | 20016425 | |
| MESH:D004485 | Eczema | Dexamethasone | 3.28 | 12438553 | |
| MESH:D004487 | Edema | Arachidonic Acid | 40.36 | 9599246 15177302 7990266 9831321 16716910 11698051 | |
| MESH:D004487 | Edema | bis(4-hydroxycinnamoyl)methane | 40.36 | 18449507 | |
| MESH:D004487 | Edema | demethoxycurcumin | 40.36 | 18449507 | |
| MESH:D004487 | Edema | Dexamethasone | 40.36 | 19703484 | |
| MESH:D004487 | Edema | Indomethacin | 40.36 | 7990266 7907874 8273558 16100529 19703484 10653021 8985016 | |
| MESH:D004487 | Edema | Mustard Gas | 40.36 | 11428631 9260866 11402378 11428647 | |
| MESH:D004487 | Edema | Plant Extracts | 40.36 | 12787963 | |
| MESH:D004487 | Edema | Raloxifene | 40.36 | 15860553 | |
| MESH:D004487 | Edema | resveratrol | 40.36 | 8985016 | |
| MESH:D004487 | Edema | Staurosporine | 40.36 | 8273558 | |
| MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 40.36 | 11000095 12711302 | |
| MESH:D004487 | Edema | Tetradecanoylphorbol Acetate | 40.36 | 8273558 15177302 8113982 11698051 16716910 9599246 7812673 | |
| MESH:D004487 | Edema | zileuton | 40.36 | 11698051 19703484 9831321 8273558 7990266 17118201 7812673 | |
| MESH:D004487 | Edema | Zymosan | 40.36 | 7907874 | |
| MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 7.79 | 15322242 18230668 16714409 | |
| MESH:D004489 | Edema, Cardiac | Tretinoin | 7.79 | 18230668 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 20.72 | 12538720 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Minocycline | 20.72 | 11835378 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Progesterone | 20.72 | 17692515 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Raloxifene | 20.72 | 15845917 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | resveratrol | 20.72 | 17872969 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 20.72 | 19031437 | |
| MESH:D004714 | Endometrial Hyperplasia | Genistein | 3.36 | 16402032 | |
| MESH:D016889 | Endometrial Neoplasms | Doxorubicin | 13.36 | 17359293 | |
| MESH:D016889 | Endometrial Neoplasms | Estradiol | 13.36 | 19148513 11473722 18566989 | |
| MESH:D016889 | Endometrial Neoplasms | Genistein | 13.36 | 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 13.36 | 19155303 20544844 16202921 17893378 | |
| MESH:D016889 | Endometrial Neoplasms | Tretinoin | 13.36 | 16569247 | |
| MESH:D004715 | Endometriosis | celecoxib | 21.37 | 15652904 | |
| MESH:D004715 | Endometriosis | Ibuprofen | 21.37 | 15652904 | |
| MESH:D004715 | Endometriosis | Indomethacin | 21.37 | 15652904 | |
| MESH:D004715 | Endometriosis | Mifepristone | 21.37 | 16134523 | |
| MESH:D004715 | Endometriosis | Progesterone | 21.37 | 16134523 | |
| MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 21.37 | 10568697 9294722 | |
| MESH:D004719 | Endomyocardial Fibrosis | Doxorubicin | 9.90 | 18037988 | |
| MESH:D004719 | Endomyocardial Fibrosis | Plant Extracts | 9.90 | 15268973 | |
| MESH:D019446 | Endotoxemia | Ibuprofen | 25.17 | 11545620 | |
| MESH:D019446 | Endotoxemia | Indomethacin | 25.17 | 18509659 | |
| MESH:D019446 | Endotoxemia | lipopolysaccharide, Escherichia coli 0111 B4 | 25.17 | 12954792 | |
| MESH:D019446 | Endotoxemia | Lipopolysaccharides | 25.17 | 15821434 15328337 17637181 | |
| MESH:D019446 | Endotoxemia | phenylmethylpyrazolone | 25.17 | 12954792 | |
| MESH:D019446 | Endotoxemia | zileuton | 25.17 | 15328337 | |
| MESH:D004751 | Enteritis | Indomethacin | 3.50 | 10567023 16328016 17763956 | |
| MESH:D020345 | Enterocolitis, Necrotizing | Indomethacin | 8.34 | 17980183 | |
| MESH:D020345 | Enterocolitis, Necrotizing | resveratrol | 8.34 | 17923197 | |
| MESH:D004802 | Eosinophilia | Indomethacin | 8.28 | 11298111 | |
| MESH:D004802 | Eosinophilia | Toluene 2,4-Diisocyanate | 8.28 | 8156442 | |
| MESH:D004802 | Eosinophilia | zileuton | 8.28 | 10764316 8621850 | |
| MESH:D004827 | Epilepsy | Plant Extracts | 2.95 | 19700373 19439326 | |
| MESH:D004890 | Erythema | Mustard Gas | 3.92 | 9357497 | |
| MESH:D004892 | Erythema Multiforme | Thiram | 5.39 | 16750123 | |
| MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 3.86 | 16302075 | |
| MESH:D004935 | Esophageal Diseases | Hydrochloric Acid | 4.55 | 19566590 | |
| MESH:D004938 | Esophageal Neoplasms | arsenic trioxide | 15.18 | 12903497 | |
| MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 15.18 | 16530937 | |
| MESH:D004938 | Esophageal Neoplasms | Dimethylnitrosamine | 15.18 | 17016578 | |
| MESH:D004938 | Esophageal Neoplasms | Ethanol | 15.18 | 16704527 | |
| MESH:D004938 | Esophageal Neoplasms | Fluorouracil | 15.18 | 17638652 16337965 16481741 15173087 16785472 | |
| MESH:D004938 | Esophageal Neoplasms | Indomethacin | 15.18 | 11005569 | |
| MESH:D004938 | Esophageal Neoplasms | Paclitaxel | 15.18 | 16481741 | |
| MESH:D004938 | Esophageal Neoplasms | Zinc | 15.18 | 16543248 | |
| MESH:D004941 | Esophagitis | Hydrochloric Acid | 4.75 | 12928072 | |
| MESH:D004942 | Esophagitis, Peptic | Hydrochloric Acid | 4.76 | 11346197 20516732 14621274 | |
| MESH:D005076 | Exanthema | terbinafine | 5.33 | 18833041 | |
| MESH:D017889 | Exfoliation Syndrome | Homocysteine | 4.46 | 16504073 | |
| MESH:D005124 | Eye Abnormalities | Benomyl | 9.47 | 1914497 | |
| MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 9.47 | 11564622 | |
| MESH:D005124 | Eye Abnormalities | Tretinoin | 9.47 | 16938888 9664655 | |
| MESH:D005128 | Eye Diseases | Toluene 2,4-Diisocyanate | 4.51 | 18447907 | |
| MESH:D005218 | Fat Necrosis | Thioacetamide | 4.46 | 16456712 | |
| MESH:D005234 | Fatty Liver | arsenic trioxide | 45.03 | 15073043 | |
| MESH:D005234 | Fatty Liver | arsenite | 45.03 | 18296743 | |
| MESH:D005234 | Fatty Liver | Carbon Tetrachloride | 45.03 | 17595544 19224547 15959796 16045604 12795759 61145 16239168 12631006 | |
| MESH:D005234 | Fatty Liver | Curcumin | 45.03 | 19297423 | |
| MESH:D005234 | Fatty Liver | Dietary Fats | 45.03 | 17967931 18296743 19004024 19551842 | |
| MESH:D005234 | Fatty Liver | Diethylnitrosamine | 45.03 | 20387270 21071580 | |
| MESH:D005234 | Fatty Liver | Ethanol | 45.03 | 19236843 16409862 18620774 | |
| MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 45.03 | 15345470 | |
| MESH:D005234 | Fatty Liver | phenylmethylpyrazolone | 45.03 | 12795759 | |
| MESH:D005234 | Fatty Liver | Plant Extracts | 45.03 | 15975614 | |
| MESH:D005234 | Fatty Liver | Raloxifene | 45.03 | 17473493 | |
| MESH:D005234 | Fatty Liver | Tamoxifen | 45.03 | 19224547 14986274 | |
| MESH:D005234 | Fatty Liver | Zidovudine | 45.03 | 18299183 | |
| MESH:D005235 | Fatty Liver, Alcoholic | Ethanol | 4.40 | 17920746 | |
| MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 2.33 | 16709447 | |
| MESH:D005264 | Femoral Fractures | zoledronic acid | 4.59 | 16234978 | |
| MESH:D005310 | Fetal Alcohol Syndrome | Ethanol | 4.06 | 10194807 16946407 15513904 15451040 | |
| MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 2.25 | 11858732 | |
| MESH:D005334 | Fever | Arachidonic Acid | 21.02 | 11852909 | |
| MESH:D005334 | Fever | Dinoprost | 21.02 | 11852909 | |
| MESH:D005334 | Fever | Ibuprofen | 21.02 | 16997862 | |
| MESH:D005334 | Fever | Indomethacin | 21.02 | 17627676 11852909 10431976 | |
| MESH:D005334 | Fever | lipopolysaccharide, Escherichia coli 0111 B4 | 21.02 | 16997862 | |
| MESH:D005334 | Fever | Lipopolysaccharides | 21.02 | 11852909 9205823 | |
| MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 3.29 | 14745880 | |
| MESH:D018222 | Fibromatosis, Aggressive | Doxorubicin | 7.35 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 7.35 | 19069698 | |
| MESH:D005354 | Fibrosarcoma | Indomethacin | 3.66 | 10962813 | |
| MESH:D005355 | Fibrosis | arsenite | 37.24 | 18296743 | |
| MESH:D005355 | Fibrosis | baicalein | 37.24 | 19474275 | |
| MESH:D005355 | Fibrosis | Carbon Tetrachloride | 37.24 | 18705752 | |
| MESH:D005355 | Fibrosis | Curcumin | 37.24 | 18705752 | |
| MESH:D005355 | Fibrosis | Dietary Fats | 37.24 | 18296743 | |
| MESH:D005355 | Fibrosis | Hydrochloric Acid | 37.24 | 18497604 | |
| MESH:D005355 | Fibrosis | Indomethacin | 37.24 | 17994277 | |
| MESH:D005355 | Fibrosis | Quercetin | 37.24 | 19474275 | |
| MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 37.24 | 20067830 | |
| MESH:D005355 | Fibrosis | Tretinoin | 37.24 | 17994277 | |
| MESH:D005499 | Folliculitis | Indomethacin | 3.91 | 11298111 | |
| MESH:D005534 | Foot Diseases | Arsenic | 4.30 | 6392382 | |
| MESH:D005596 | Fractures, Closed | zileuton | 4.62 | 19544365 | |
| MESH:D005600 | Fragile X Syndrome | Minocycline | 5.51 | 18835858 | |
| MESH:D005706 | Gallbladder Neoplasms | arsenic trioxide | 8.07 | 16904648 | |
| MESH:D005706 | Gallbladder Neoplasms | norcantharidin | 8.07 | 16681930 | |
| MESH:D005739 | Gas Poisoning | Budesonide | 12.83 | 20016425 | |
| MESH:D005739 | Gas Poisoning | Hydrochloric Acid | 12.83 | 12378975 | |
| MESH:D005739 | Gas Poisoning | Oxygen | 12.83 | 20016425 | |
| MESH:D005756 | Gastritis | Acetaminophen | 17.19 | 16983495 | |
| MESH:D005756 | Gastritis | Ethanol | 17.19 | 15046732 | |
| MESH:D005756 | Gastritis | Indomethacin | 17.19 | 15046732 | |
| MESH:D005756 | Gastritis | Zinc | 17.19 | 17241300 | |
| MESH:D005764 | Gastroesophageal Reflux | Hydrochloric Acid | 4.14 | 19957777 19951613 12212954 20516732 20616304 20545468 | |
| MESH:D005770 | Gastrointestinal Neoplasms | Curcumin | 3.48 | 18462866 | |
| MESH:D005833 | Genital Neoplasms, Female | sodium arsenite | 3.44 | 16452187 | |
| MESH:D005901 | Glaucoma | Homocysteine | 4.12 | 16504073 | |
| MESH:D005909 | Glioblastoma | marker/mechanism | 16598420 | ||
| MESH:D005909 | Glioblastoma | baicalein | 30.63 | 19804834 | |
| MESH:D005909 | Glioblastoma | biochanin A | 30.63 | 16598420 | |
| MESH:D005909 | Glioblastoma | Curcumin | 30.63 | 17596214 | |
| MESH:D005909 | Glioblastoma | Doxorubicin | 30.63 | 17150277 | |
| MESH:D005909 | Glioblastoma | Fenretinide | 30.63 | 16187019 | |
| MESH:D005909 | Glioblastoma | Genistein | 30.63 | 16598420 | |
| MESH:D005909 | Glioblastoma | Indomethacin | 30.63 | 12870263 | |
| MESH:D005909 | Glioblastoma | myricetin | 30.63 | 19804834 | |
| MESH:D005909 | Glioblastoma | Quercetin | 30.63 | 19804834 | |
| MESH:D005909 | Glioblastoma | Tretinoin | 30.63 | 17312396 | |
| MESH:D005910 | Glioma | Fluorouracil | 5.82 | 16145905 | |
| MESH:D005910 | Glioma | Indomethacin | 5.82 | 18371953 16487511 | |
| MESH:D005910 | Glioma | Quercetin | 5.82 | 17643826 | |
| MESH:D005911 | Gliosis | Paraquat | 3.90 | 11124998 | |
| MESH:D005923 | Glomerulosclerosis, Focal Segmental | Indomethacin | 6.77 | 11849393 | |
| MESH:D005923 | Glomerulosclerosis, Focal Segmental | pioglitazone | 6.77 | 16687628 | |
| MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 3.33 | 10696789 | |
| MESH:D006073 | Gout | Indomethacin | 4.11 | 11248219 | |
| MESH:D017789 | Granuloma, Pyogenic | imiquimod | 5.88 | 16302556 | |
| MESH:D006130 | Growth Disorders | Zinc | 3.03 | 17217573 | |
| MESH:D006261 | Headache | Nitroglycerin | 3.95 | 11554966 11284996 | |
| MESH:D006258 | Head and Neck Neoplasms | Curcumin | 17.77 | 18829502 18462866 | |
| MESH:D006258 | Head and Neck Neoplasms | Doxorubicin | 17.77 | 15692506 | |
| MESH:D006258 | Head and Neck Neoplasms | Fluorouracil | 17.77 | 15162350 18337622 15102660 | |
| MESH:D006258 | Head and Neck Neoplasms | Indomethacin | 17.77 | 15482327 | |
| MESH:D006258 | Head and Neck Neoplasms | retinol palmitate | 17.77 | 15984520 | |
| MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 17.77 | 16096774 | |
| MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 3.90 | 16084493 | |
| MESH:D006356 | Heartburn | Hydrochloric Acid | 4.55 | 19566590 | |
| MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 9.08 | 20471113 | |
| MESH:D006330 | Heart Defects, Congenital | Homocysteine | 9.08 | 19638421 | |
| MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 9.08 | 10048152 11294989 | |
| MESH:D006330 | Heart Defects, Congenital | Tretinoin | 9.08 | 9664655 14991402 | |
| MESH:D006331 | Heart Diseases | Doxorubicin | 10.23 | 17875725 16144979 16244372 16244371 16495754 12587719 18006777 16330681 14766674 16707910 16879835 18674790 17888722 | |
| MESH:D006331 | Heart Diseases | Raloxifene | 10.23 | 11110106 | |
| MESH:D006331 | Heart Diseases | Razoxane | 10.23 | 17875725 | |
| MESH:D006331 | Heart Diseases | Urethane | 10.23 | 16046796 | |
| MESH:D006333 | Heart Failure | Doxorubicin | 15.89 | 17481944 | |
| MESH:D006333 | Heart Failure | Isoproterenol | 15.89 | 18097624 | |
| MESH:D006333 | Heart Failure | Plant Extracts | 15.89 | 18097624 | |
| MESH:D006333 | Heart Failure | Propranolol | 15.89 | 20082655 | |
| MESH:D006333 | Heart Failure | Selenium | 15.89 | 17162251 | |
| MESH:D006333 | Heart Failure | Zinc | 15.89 | 17162251 | |
| MESH:D006335 | Heart Injuries | Zinc | 4.51 | 17074742 | |
| MESH:D016481 | Helicobacter Infections | Zinc | 3.37 | 17241300 | |
| MESH:D006390 | Hemangioendothelioma | 2-Acetylaminofluorene | 9.02 | 6705139 | |
| MESH:D006390 | Hemangioendothelioma | Razoxane | 9.02 | 15380572 | |
| MESH:D006391 | Hemangioma | imiquimod | 5.53 | 16302556 | |
| MESH:D006394 | Hemangiosarcoma | 2-Acetylaminofluorene | 5.65 | 6705139 | |
| MESH:D006394 | Hemangiosarcoma | Doxorubicin | 5.65 | 15692506 | |
| MESH:D006402 | Hematologic Diseases | Zidovudine | 3.55 | 12579204 | |
| MESH:D006463 | Hemolytic-Uremic Syndrome | Lipopolysaccharides | 3.26 | 16366002 | |
| MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 2.19 | 11000095 | |
| MESH:D006501 | Hepatic Encephalopathy | Indomethacin | 7.13 | 15633222 | |
| MESH:D006501 | Hepatic Encephalopathy | Thioacetamide | 7.13 | 18665440 17276928 15929193 | |
| MESH:D006505 | Hepatitis | Carbon Tetrachloride | 9.09 | 19110552 19900420 | |
| MESH:D006505 | Hepatitis | Thioacetamide | 9.09 | 16456712 | |
| MESH:D006505 | Hepatitis | Zymosan | 9.09 | 19110552 | |
| MESH:D019698 | Hepatitis C, Chronic | Indomethacin | 3.49 | 15135802 | |
| MESH:D006521 | Hepatitis, Chronic | Minocycline | 4.90 | 14986274 | |
| MESH:D006527 | Hepatolenticular Degeneration | Zinc | 7.30 | 17276780 | |
| MESH:D006527 | Hepatolenticular Degeneration | Zinc Sulfate | 7.30 | 17063115 | |
| MESH:D006529 | Hepatomegaly | Propranolol | 7.98 | 16371745 | |
| MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 7.98 | 12621046 15340226 16120746 | |
| MESH:D006529 | Hepatomegaly | zileuton | 7.98 | 8661344 | |
| MESH:D015417 | Hereditary Sensory and Motor Neuropathy | Curcumin | 3.82 | 17701891 | |
| MESH:D006548 | Hernia, Diaphragmatic | Dexamethasone | 2.47 | 7520565 | |
| MESH:D006558 | Herpes Genitalis | Estradiol | 3.77 | 15709030 | |
| MESH:D006561 | Herpes Simplex | Plant Extracts | 6.07 | 10715843 | |
| MESH:D006561 | Herpes Simplex | resveratrol | 6.07 | 16876885 | |
| MESH:D006628 | Hirsutism | Androgens | 4.82 | 16914592 17019078 | |
| MESH:D015658 | HIV Infections | abacavir | 8.66 | 17457083 11141242 12891065 | |
| MESH:D015658 | HIV Infections | Indinavir | 8.66 | 15388451 11363243 11141242 | |
| MESH:D015658 | HIV Infections | Plant Extracts | 8.66 | 12878215 | |
| MESH:D015658 | HIV Infections | Zidovudine | 8.66 | 11141242 11363243 11698656 20032539 17358032 | |
| MESH:D006689 | Hodgkin Disease | Doxorubicin | 3.97 | 17606976 18501091 15147373 | |
| MESH:D006689 | Hodgkin Disease | sodium arsenite | 3.97 | 12676792 | |
| MESH:D019584 | Hot Flashes | Estradiol | 6.22 | 17088409 | |
| MESH:D019584 | Hot Flashes | Plant Extracts | 6.22 | 14716179 16566672 17454163 | |
| MESH:D018327 | Hutchinson's Melanotic Freckle | imiquimod | 5.88 | 16302556 | |
| MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 2.79 | 8697196 18606429 16354765 15340226 16959395 | |
| MESH:D006930 | Hyperalgesia | Acetaminophen | 17.10 | 16870215 | |
| MESH:D006930 | Hyperalgesia | Ethanol | 17.10 | 18783367 | |
| MESH:D006930 | Hyperalgesia | Freund's Adjuvant | 17.10 | 16769263 | |
| MESH:D006930 | Hyperalgesia | Indomethacin | 17.10 | 12727271 | |
| MESH:D006930 | Hyperalgesia | Tretinoin | 17.10 | 16870215 | |
| MESH:D006930 | Hyperalgesia | zoledronic acid | 17.10 | 16769263 | |
| MESH:D034321 | Hyperamylasemia | Indomethacin | 4.46 | 17883296 | |
| MESH:D017588 | Hyperandrogenism | Androgens | 4.48 | 17019078 | |
| MESH:D006932 | Hyperbilirubinemia | Carbon Tetrachloride | 3.29 | 16899240 | |
| MESH:D006934 | Hypercalcemia | zoledronic acid | 3.90 | 19622757 18089816 | |
| MESH:D006937 | Hypercholesterolemia | Curcumin | 12.65 | 18704882 | |
| MESH:D006937 | Hypercholesterolemia | Dietary Fats | 12.65 | 21332399 | |
| MESH:D006937 | Hypercholesterolemia | Pravastatin | 12.65 | 17188708 | |
| MESH:D006937 | Hypercholesterolemia | resveratrol | 12.65 | 17188708 | |
| MESH:D006940 | Hyperemia | Hydrochloric Acid | 8.64 | 12646421 | |
| MESH:D006940 | Hyperemia | Indomethacin | 8.64 | 12524144 | |
| MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 3.35 | 16778211 | |
| MESH:D006943 | Hyperglycemia | Quercetin | 2.93 | 18262572 11834736 | |
| MESH:D020138 | Hyperhomocysteinemia | Homocysteine | 6.19 | 18234410 17292331 17369066 | |
| MESH:D020138 | Hyperhomocysteinemia | Plant Extracts | 6.19 | 16484555 | |
| MESH:D017488 | Hyperkeratosis, Epidermolytic | Arsenic | 3.33 | 17050553 | |
| MESH:D006949 | Hyperlipidemias | Dietary Fats | 12.63 | 21332399 | |
| MESH:D006949 | Hyperlipidemias | Indomethacin | 12.63 | 17546600 | |
| MESH:D006949 | Hyperlipidemias | Plant Extracts | 12.63 | 15268973 15975614 | |
| MESH:D006949 | Hyperlipidemias | resveratrol | 12.63 | 16873680 | |
| MESH:D006967 | Hypersensitivity | fexofenadine | 6.04 | 17910814 | |
| MESH:D006967 | Hypersensitivity | Toluene 2,4-Diisocyanate | 6.04 | 11019492 10880147 | |
| MESH:D006973 | Hypertension | Arsenic | 17.13 | 16076760 11953799 9931084 | |
| MESH:D006973 | Hypertension | carvedilol | 17.13 | 16640825 | |
| MESH:D006973 | Hypertension | Dexamethasone | 17.13 | 17042910 | |
| MESH:D006973 | Hypertension | Perindopril | 17.13 | 11427623 | |
| MESH:D006973 | Hypertension | Phenylephrine | 17.13 | 12717712 8949925 | |
| MESH:D006973 | Hypertension | Quercetin | 17.13 | 18356687 | |
| MESH:D006973 | Hypertension | Raloxifene | 17.13 | 17577099 15787275 | |
| MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 17.13 | 18850075 18670907 | |
| MESH:D006975 | Hypertension, Portal | Carbon Tetrachloride | 7.39 | 15338365 | |
| MESH:D006975 | Hypertension, Portal | Hydrochloric Acid | 7.39 | 16984587 | |
| MESH:D006976 | Hypertension, Pulmonary | cyclo(Trp-Asp-Pro-Val-Leu) | 8.14 | 16327149 | |
| MESH:D006976 | Hypertension, Pulmonary | Hydrochloric Acid | 8.14 | 19262391 | |
| MESH:D006976 | Hypertension, Pulmonary | zileuton | 8.14 | 14726295 | |
| MESH:D006984 | Hypertrophy | Ibuprofen | 11.32 | 16672835 | |
| MESH:D006984 | Hypertrophy | Isoproterenol | 11.32 | 12791704 | |
| MESH:D006984 | Hypertrophy | Phenylephrine | 11.32 | 18502941 12791704 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | phenylmethylpyrazolone | 7.05 | 15824197 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | resveratrol | 7.05 | 17488730 | |
| MESH:D006987 | Hypesthesia | Arsenic | 4.30 | 16093927 | |
| MESH:D006996 | Hypocalcemia | zoledronic acid | 4.93 | 12669777 | |
| MESH:D007021 | Hypospadias | Ethinyl Estradiol | 2.60 | 16945680 16569931 | |
| MESH:D007022 | Hypotension | Hydrochloric Acid | 12.37 | 11574821 | |
| MESH:D007022 | Hypotension | Isoproterenol | 12.37 | 6740701 | |
| MESH:D007022 | Hypotension | Propranolol | 12.37 | 6740701 | |
| MESH:D007022 | Hypotension | Zinc Sulfate | 12.37 | 7265320 | |
| MESH:D007077 | Ileal Diseases | Indomethacin | 3.77 | 18306037 10574470 | |
| MESH:D007079 | Ileitis | Indomethacin | 4.11 | 10651667 10647630 16133968 | |
| MESH:D007235 | Infant, Premature, Diseases | Ibuprofen | 10.03 | 16133044 | |
| MESH:D007235 | Infant, Premature, Diseases | Indomethacin | 10.03 | 16133044 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | marker/mechanism | 19309543 | ||
| MESH:D020244 | Infarction, Middle Cerebral Artery | Progesterone | 12.56 | 15869954 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | resveratrol | 12.56 | 17600658 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | zileuton | 12.56 | 19309543 | |
| MESH:D007246 | Infertility | Thiram | 4.65 | 6420938 | |
| MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 2.30 | 12013081 | |
| MESH:D007248 | Infertility, Male | alachlor | 8.33 | 12948887 16466525 17049205 | |
| MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 8.33 | 17937319 | |
| MESH:D007248 | Infertility, Male | Paraquat | 8.33 | 4850670 | |
| MESH:D007248 | Infertility, Male | sodium arsenite | 8.33 | 15346721 12646999 | |
| MESH:D007249 | Inflammation | Aluminum | 59.07 | 16052892 | |
| MESH:D007249 | Inflammation | Arachidonic Acid | 59.07 | 15177302 9831321 17371808 | |
| MESH:D007249 | Inflammation | Curcumin | 59.07 | 16956363 17151092 18403477 | |
| MESH:D007249 | Inflammation | Dexamethasone | 59.07 | 11099482 8960868 | |
| MESH:D007249 | Inflammation | Dietary Fats | 59.07 | 20412841 | |
| MESH:D007249 | Inflammation | Diethylnitrosamine | 59.07 | 18785209 | |
| MESH:D007249 | Inflammation | Flavonoids | 59.07 | 17296493 | |
| MESH:D007249 | Inflammation | Freund's Adjuvant | 59.07 | 16793879 | |
| MESH:D007249 | Inflammation | Hydrochloric Acid | 59.07 | 11574821 | |
| MESH:D007249 | Inflammation | Ibuprofen | 59.07 | 3291741 | |
| MESH:D007249 | Inflammation | Indomethacin | 59.07 | 7812673 12568917 3291741 | |
| MESH:D007249 | Inflammation | Lipopolysaccharides | 59.07 | 17237260 17963957 9205823 17255318 12878042 | |
| MESH:D007249 | Inflammation | Mustard Gas | 59.07 | 9260866 11402378 17524151 11428647 8975870 11428631 11428620 9357497 16001271 | |
| MESH:D007249 | Inflammation | pioglitazone | 59.07 | 16908763 | |
| MESH:D007249 | Inflammation | Plant Extracts | 59.07 | 15997105 16366677 12787963 19332304 | |
| MESH:D007249 | Inflammation | Progesterone | 59.07 | 15869954 | |
| MESH:D007249 | Inflammation | resveratrol | 59.07 | 16366677 | |
| MESH:D007249 | Inflammation | Tamoxifen | 59.07 | 19457130 | |
| MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 59.07 | 12200463 12878042 | |
| MESH:D007249 | Inflammation | Tetradecanoylphorbol Acetate | 59.07 | 7562506 15177302 11698051 8273558 7812673 | |
| MESH:D007249 | Inflammation | zileuton | 59.07 | 8621850 8960868 18295198 18059327 7812673 18309904 17118201 9831321 | |
| MESH:D007249 | Inflammation | Zymosan | 59.07 | 11289658 8014878 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Curcumin | 6.57 | 18596194 18200517 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Rutin | 6.57 | 15652231 | |
| MESH:D015212 | Inflammatory Bowel Diseases | zileuton | 6.57 | 15339030 | |
| MESH:D007251 | Influenza, Human | pyrrolidine dithiocarbamic acid | 16.58 | 18473937 | |
| MESH:D007251 | Influenza, Human | Quercetin | 16.58 | 16624496 | |
| MESH:D007251 | Influenza, Human | resveratrol | 16.58 | 16624496 | |
| MESH:D007251 | Influenza, Human | Selenium | 16.58 | 16624496 | |
| MESH:D007333 | Insulin Resistance | Dietary Fats | 4.24 | 11836018 18457598 | |
| MESH:D007333 | Insulin Resistance | Estradiol | 4.24 | 16393666 16627594 | |
| MESH:C535531 | Intervertebral disc disease | marker/mechanism | |||
| MESH:D007410 | Intestinal Diseases | Hydrochloric Acid | 13.74 | 11574821 | |
| MESH:D007410 | Intestinal Diseases | Indomethacin | 13.74 | 11713966 10210152 15831440 11855677 17329856 15610444 18236018 11686837 17994277 | |
| MESH:D007410 | Intestinal Diseases | pimagedine | 13.74 | 11713966 | |
| MESH:D007410 | Intestinal Diseases | Tretinoin | 13.74 | 17994277 | |
| MESH:D007414 | Intestinal Neoplasms | Curcumin | 6.39 | 10783313 | |
| MESH:D007414 | Intestinal Neoplasms | Plant Extracts | 6.39 | 12584176 12351151 12628509 | |
| MESH:D002532 | Intracranial Aneurysm | phenylmethylpyrazolone | 7.02 | 19381132 | |
| MESH:D002532 | Intracranial Aneurysm | Reactive Oxygen Species | 7.02 | 19381132 | |
| MESH:D019586 | Intracranial Hypertension | Indomethacin | 4.11 | 15241188 | |
| MESH:D019189 | Iron Metabolism Disorders | Lipopolysaccharides | 3.46 | 17255318 | |
| MESH:D043183 | Irritable Bowel Syndrome | Zymosan | 4.60 | 17553498 | |
| MESH:D007511 | Ischemia | morin | 11.51 | 16806951 | |
| MESH:D007511 | Ischemia | phenylmethylpyrazolone | 11.51 | 16301206 | |
| MESH:D007511 | Ischemia | Zinc | 11.51 | 16584753 | |
| MESH:D007569 | Jaw Abnormalities | Ethanol | 10.59 | 15513904 | |
| MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 10.59 | 16580747 | |
| MESH:D007569 | Jaw Abnormalities | Tretinoin | 10.59 | 15992940 17551590 | |
| MESH:D007579 | Jejunal Diseases | Indomethacin | 3.77 | 18306037 16133968 10574470 | |
| MESH:D007627 | Keloid | Quercetin | 3.74 | 17086741 | |
| MESH:D007642 | Keratosis | Arsenic | 9.43 | 16930632 12749816 | |
| MESH:D007642 | Keratosis | imiquimod | 9.43 | 16302556 | |
| MESH:D007674 | Kidney Diseases | Acetaminophen | 25.17 | 12587719 15629191 | |
| MESH:D007674 | Kidney Diseases | Acrolein | 25.17 | 12488133 | |
| MESH:D007674 | Kidney Diseases | Cadmium Chloride | 25.17 | 16962696 | |
| MESH:D007674 | Kidney Diseases | Doxorubicin | 25.17 | 15699352 15369732 16775033 | |
| MESH:D007674 | Kidney Diseases | Estradiol | 25.17 | 15618244 | |
| MESH:D007674 | Kidney Diseases | Indomethacin | 25.17 | 17190690 | |
| MESH:D007674 | Kidney Diseases | phenylmethylpyrazolone | 25.17 | 18085390 | |
| MESH:D007674 | Kidney Diseases | Quercetin | 25.17 | 16962696 | |
| MESH:D007674 | Kidney Diseases | sodium arsenite | 25.17 | 20008137 | |
| MESH:D007674 | Kidney Diseases | Zinc | 25.17 | 16960431 | |
| MESH:D007676 | Kidney Failure, Chronic | Doxorubicin | 14.56 | 16707910 | |
| MESH:D007676 | Kidney Failure, Chronic | Hydrogen Peroxide | 14.56 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Selenium | 14.56 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Zinc | 14.56 | 16518626 | |
| MESH:D007680 | Kidney Neoplasms | Estradiol | 9.17 | 15610895 | |
| MESH:D007680 | Kidney Neoplasms | Fluorouracil | 9.17 | 16985049 | |
| MESH:D007680 | Kidney Neoplasms | Tamoxifen | 9.17 | 18625569 | |
| MESH:D007680 | Kidney Neoplasms | Zidovudine | 9.17 | 12579204 | |
| MESH:D007818 | Laryngeal Diseases | Hydrochloric Acid | 5.10 | 16498863 | |
| MESH:D007826 | Laryngismus | Hydrochloric Acid | 5.10 | 11510729 | |
| MESH:D007855 | Lead Poisoning | marker/mechanism | 16700817 | ||
| MESH:D007859 | Learning Disorders | Ethanol | 3.03 | 15451040 | |
| MESH:D007889 | Leiomyoma | Curcumin | 7.28 | 18555241 | |
| MESH:D007889 | Leiomyoma | Raloxifene | 7.28 | 16973256 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Allopurinol | 8.14 | 12207774 9314461 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Indomethacin | 8.14 | 10320625 12228301 11703811 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Zinc Sulfate | 8.14 | 15237267 | |
| MESH:D007898 | Leishmaniasis, Visceral | Allopurinol | 4.13 | 7498017 10449224 11332679 | |
| MESH:D007938 | Leukemia | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 24.22 | 12970779 | |
| MESH:D007938 | Leukemia | alachlor | 24.22 | 14769641 | |
| MESH:D007938 | Leukemia | arsenic trioxide | 24.22 | 15070760 | |
| MESH:D007938 | Leukemia | Azacitidine | 24.22 | 19148494 | |
| MESH:D007938 | Leukemia | Curcumin | 24.22 | 18462866 | |
| MESH:D007938 | Leukemia | Genistein | 24.22 | 18980019 17468513 | |
| MESH:D007938 | Leukemia | metacept-1 | 24.22 | 19148494 | |
| MESH:D007938 | Leukemia | Quercetin | 24.22 | 17468513 | |
| MESH:D007938 | Leukemia | Tretinoin | 24.22 | 17143497 | |
| MESH:D004915 | Leukemia, Erythroblastic, Acute | Doxorubicin | 3.90 | 16085563 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Disulfiram | 3.49 | 17026967 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | arsenic trioxide | 13.92 | 12560223 17077332 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Curcumin | 13.92 | 16106398 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Zidovudine | 13.92 | 20370541 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | zoledronic acid | 13.92 | 18089816 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | anthra(1,9-cd)pyrazol-6(2H)-one | 18.10 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | arsenic trioxide | 18.10 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | PD 98059 | 18.10 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | U 0126 | 18.10 | 16972261 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic trioxide | 8.36 | 14633726 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Indomethacin | 8.36 | 10785260 16572323 15631656 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | zileuton | 8.36 | 19823023 19503090 | |
| MESH:D007951 | Leukemia, Myeloid | arsenic trioxide | 9.52 | 19077051 | |
| MESH:D007951 | Leukemia, Myeloid | Azacitidine | 9.52 | 19077051 | |
| MESH:D007951 | Leukemia, Myeloid | Tretinoin | 9.52 | 19285840 16482212 16932348 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | arsenic trioxide | 5.07 | 20471514 17050201 16467208 16968895 19850784 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Azacitidine | 5.07 | 17596541 18720364 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Indomethacin | 5.07 | 18360721 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 5.07 | 16294345 19850784 17596541 | |
| MESH:D054429 | Leukemia, Myelomonocytic, Juvenile | Azacitidine | 4.02 | 19299654 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Arsenic | 10.41 | 17339181 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | arsenic trioxide | 10.41 | 15213294 17217047 17107899 16331271 16966277 16330433 19075265 15336539 17869043 15622746 16891316 12018890 11468182 15748426 12712474 12679006 11161223 16112521 17712046 16823087 19642359 19225113 17649720 9834237 19035177 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | resveratrol | 10.41 | 16087638 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 10.41 | 19642359 16891316 16140955 17339181 19225113 17712046 19029980 12679006 17301526 17107899 16331271 16823087 16935935 17361223 17217047 17649720 15748426 17294898 16766008 9834237 17368321 17506722 19035177 16788101 19075265 | |
| MESH:D015458 | Leukemia, T-Cell | arsenic trioxide | 7.76 | 16882451 | |
| MESH:D015458 | Leukemia, T-Cell | Curcumin | 7.76 | 16106398 | |
| MESH:D007964 | Leukocytosis | Indomethacin | 4.11 | 16537180 | |
| MESH:D007969 | Leukomalacia, Periventricular | Indomethacin | 4.46 | 17980183 | |
| MESH:D007970 | Leukopenia | Lipopolysaccharides | 3.47 | 15821434 | |
| MESH:D007972 | Leukoplakia, Oral | Fenretinide | 4.78 | 16707609 | |
| MESH:D017880 | Limb Deformities, Congenital | Disulfiram | 8.10 | 17676605 | |
| MESH:D017880 | Limb Deformities, Congenital | Ethanol | 8.10 | 17676605 | |
| MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 8.10 | 9224671 | |
| MESH:D008064 | Lipidoses | Tamoxifen | 2.19 | 17567588 15342952 | |
| MESH:D008080 | Liposarcoma | Paclitaxel | 3.65 | 17353645 | |
| MESH:D008101 | Liver Abscess, Amebic | Indomethacin | 4.46 | 11479899 | |
| MESH:D008103 | Liver Cirrhosis | arsenite | 21.66 | 18296743 | |
| MESH:D008103 | Liver Cirrhosis | Carbon Tetrachloride | 21.66 | 11903743 16221502 17334410 16943688 16239168 11408273 17157831 17174718 21278145 | |
| MESH:D008103 | Liver Cirrhosis | Dietary Fats | 21.66 | 18296743 | |
| MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 21.66 | 18665156 18522880 20032147 18407596 19638242 | |
| MESH:D008103 | Liver Cirrhosis | EMD 527040 | 21.66 | 18221819 | |
| MESH:D008103 | Liver Cirrhosis | Ethanol | 21.66 | 15289165 | |
| MESH:D008103 | Liver Cirrhosis | Hydrochloric Acid | 21.66 | 16984587 | |
| MESH:D008103 | Liver Cirrhosis | Plant Extracts | 21.66 | 17157831 | |
| MESH:D008104 | Liver Cirrhosis, Alcoholic | Ethanol | 3.86 | 18295389 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | marker/mechanism | 15095483 | ||
| MESH:D008106 | Liver Cirrhosis, Experimental | Carbon Tetrachloride | 39.42 | 18418968 15925388 17640975 14620537 18187930 16015684 18339082 16136751 18395095 15370692 18205269 14724832 18481824 14748882 15996030 17481882 16033810 12666154 17714472 17557913 15362042 17869086 17631135 18472332 16027843 15673190 18420326 20821823 18279442 11481614 12609069 18472094 15057751 14512876 17766677 18277467 17565644 17761835 12586293 18054572 17525996 12546737 14716833 17823541 13678700 18210741 18395914 15730626 18251166 16248980 17976157 15650968 17944888 15931870 12958196 15893842 18429990 12389079 15876570 15338365 15959796 14716496 12667390 12649538 18263696 17805973 16097048 18006644 16011737 17708605 12445421 16638106 18376398 12445418 18317297 12898905 17721639 12632514 16192424 17698563 12741479 17922224 10355542 18412020 18166357 15123356 18156304 17900296 12632512 16116963 15052691 15818738 18705752 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Curcumin | 39.42 | 18705752 17355460 18006644 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dexamethasone | 39.42 | 16718785 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dimethylnitrosamine | 39.42 | 18567088 12918455 16627068 18629640 18637143 15504291 16169303 15733078 15383259 15138612 15479170 15763062 15577212 18210741 15161499 17881167 14643895 17432682 18239293 15086199 16009107 17348192 15591649 16042886 17203207 17640959 16570917 15339415 14568256 15081153 17465448 15942678 16603200 18672772 17534399 16270385 15571005 16544323 17724770 15744066 17198567 18364076 14726149 15864749 15369754 12925901 17201889 15723089 15798949 18095165 17719030 15793283 15099470 17196135 14659978 14709902 15366600 18371158 17036385 15298665 18237412 17666798 15492853 15067225 15842777 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Doxorubicin | 39.42 | 16595196 16439617 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | epigallocatechin gallate | 39.42 | 17481882 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 39.42 | 14659978 14716833 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Ethanol | 39.42 | 18166357 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | farnesylthiosalicylic acid | 39.42 | 15288472 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Genistein | 39.42 | 17823541 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Indomethacin | 39.42 | 18194892 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Lipopolysaccharides | 39.42 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Melatonin | 39.42 | 15925388 15298665 16703270 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | morin | 39.42 | 18629640 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Perindopril | 39.42 | 15619341 16097048 16596278 16872305 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pioglitazone | 39.42 | 15052691 16484506 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Plant Extracts | 39.42 | 15479170 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pyrrolidine dithiocarbamic acid | 39.42 | 15078482 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Quercetin | 39.42 | 12741479 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 39.42 | 18564211 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 39.42 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Thioacetamide | 39.42 | 17127702 18295389 12085344 15716488 14739098 11172339 15362042 15075984 10677585 11682029 18395095 15474484 18416461 18031379 15288472 12531686 18606216 18380797 16511523 15334695 12679928 15078482 12891558 16248980 11481614 18032466 17050028 15158331 16343077 18458672 16098781 17629604 12557150 17292413 15465738 15095483 18615449 15288473 16489207 15316131 16097051 16126171 17355460 18263696 12175628 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 39.42 | 16248980 18397230 | |
| MESH:D008107 | Liver Diseases | marker/mechanism | 19784758 | ||
| MESH:D008107 | Liver Diseases | Acetaminophen | 10.71 | 12969438 12587719 19784758 16610002 19014921 11587558 19460945 16611625 | |
| MESH:D008107 | Liver Diseases | Arsenic | 10.71 | 11134558 | |
| MESH:D008107 | Liver Diseases | Carbon Tetrachloride | 10.71 | 16246199 17285989 15830285 15720792 16964402 | |
| MESH:D008107 | Liver Diseases | Curcumin | 10.71 | 16956363 | |
| MESH:D008107 | Liver Diseases | Diethylnitrosamine | 10.71 | 17034775 | |
| MESH:D008107 | Liver Diseases | Plant Extracts | 10.71 | 17034775 | |
| MESH:D008107 | Liver Diseases | Thioacetamide | 10.71 | 16337175 18374380 15158337 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Ethanol | 3.44 | 17347304 17207112 | |
| MESH:D017093 | Liver Failure | Carbon Tetrachloride | 2.95 | 15123358 | |
| MESH:D017114 | Liver Failure, Acute | Acetaminophen | 14.15 | 17185352 16871587 | |
| MESH:D017114 | Liver Failure, Acute | Carbon Tetrachloride | 14.15 | 14706259 16899240 | |
| MESH:D017114 | Liver Failure, Acute | Dimethylnitrosamine | 14.15 | 17457977 | |
| MESH:D017114 | Liver Failure, Acute | Thioacetamide | 14.15 | 15633222 12479984 17276928 15313186 | |
| MESH:D008113 | Liver Neoplasms | 2-Acetylaminofluorene | 40.14 | 16273603 11376686 18001218 14678523 10672840 10737359 | |
| MESH:D008113 | Liver Neoplasms | 2-aminofluorene | 40.14 | 20452335 20492335 19499222 19850985 | |
| MESH:D008113 | Liver Neoplasms | Arsenic | 40.14 | 16368122 | |
| MESH:D008113 | Liver Neoplasms | arsenic trioxide | 40.14 | 14682389 | |
| MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 40.14 | 21137059 20195826 | |
| MESH:D008113 | Liver Neoplasms | Carbon Tetrachloride | 40.14 | 19294768 | |
| MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 40.14 | 18644402 20501860 18648771 20118626 20101389 16942905 12112319 19996281 20452335 20434301 19690152 18978307 12771043 21071580 18977376 19090486 19254457 20583210 20137499 10737359 19812893 19427195 15175105 19642983 18754104 19551842 19638242 20492335 19499222 9163691 21278145 19255062 19426721 15885732 19256749 19073162 2422723 19850985 21167192 19294768 20405173 2862719 21047994 19833225 | |
| MESH:D008113 | Liver Neoplasms | Dimethylnitrosamine | 40.14 | 3113478 15890375 | |
| MESH:D008113 | Liver Neoplasms | Fluorouracil | 40.14 | 15113037 18383874 17045692 16603448 | |
| MESH:D008113 | Liver Neoplasms | Plant Extracts | 40.14 | 19168119 | |
| MESH:D008113 | Liver Neoplasms | Quercetin | 40.14 | 18980244 | |
| MESH:D008113 | Liver Neoplasms | resveratrol | 40.14 | 19812893 19321006 20405173 19073162 | |
| MESH:D008113 | Liver Neoplasms | sodium arsenite | 40.14 | 15276417 16712894 | |
| MESH:D008113 | Liver Neoplasms | Tamoxifen | 40.14 | 16684651 | |
| MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 40.14 | 16984957 | |
| MESH:D008113 | Liver Neoplasms | Urethane | 40.14 | 17093202 17559639 16391232 | |
| MESH:D008113 | Liver Neoplasms | zerumbone | 40.14 | 20452335 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 2-Acetylaminofluorene | 26.82 | 1399818 6150874 534488 | |
| MESH:D008114 | Liver Neoplasms, Experimental | arsenic trioxide | 26.82 | 20377131 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Butadienes | 26.82 | 12562636 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Carbon Tetrachloride | 26.82 | 15583823 12014681 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 26.82 | 17174075 18544905 18164116 18079962 9362446 18775883 19004024 18093689 17942915 16267830 18282651 19009564 19539802 17854601 19519916 18308698 19126423 18253720 2563599 16842330 3124819 21159647 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Dimethylnitrosamine | 26.82 | 15603536 1848544 6150874 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Doxorubicin | 26.82 | 17085340 16842330 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Hexachlorobenzene | 26.82 | 1423854 | |
| MESH:D008114 | Liver Neoplasms, Experimental | morin | 26.82 | 19539802 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Quercetin | 26.82 | 19519916 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 26.82 | 12151625 | |
| MESH:D008133 | Long QT Syndrome | arsenic trioxide | 2.35 | 15213294 | |
| MESH:D008171 | Lung Diseases | Acetylcysteine | 23.95 | 12815614 | |
| MESH:D008171 | Lung Diseases | Acrolein | 23.95 | 11504702 | |
| MESH:D008171 | Lung Diseases | Aluminum | 23.95 | 16052892 | |
| MESH:D008171 | Lung Diseases | Asbestos, Serpentine | 23.95 | 17200189 | |
| MESH:D008171 | Lung Diseases | Hydrochloric Acid | 23.95 | 16784557 | |
| MESH:D008171 | Lung Diseases | Mustard Gas | 23.95 | 18702808 18161513 | |
| MESH:D008171 | Lung Diseases | Ozone | 23.95 | 19066396 8266340 | |
| MESH:D008171 | Lung Diseases | sodium arsenite | 23.95 | 19095001 | |
| MESH:D055370 | Lung Injury | Asbestos, Crocidolite | 19.83 | 17365036 | |
| MESH:D055370 | Lung Injury | Hydrochloric Acid | 19.83 | 18339021 21311175 15044056 15607125 19644408 18573544 16129981 15090967 20597076 17627322 11395602 19262391 21114838 18497604 | |
| MESH:D055370 | Lung Injury | Lipopolysaccharides | 19.83 | 21114838 | |
| MESH:D055370 | Lung Injury | Oxygen | 19.83 | 18339021 | |
| MESH:D055370 | Lung Injury | Ozone | 19.83 | 20417186 | |
| MESH:D055370 | Lung Injury | pyrrolidine dithiocarbamic acid | 19.83 | 16129981 | |
| MESH:D008175 | Lung Neoplasms | 2-Acetylaminofluorene | 61.10 | 11376686 | |
| MESH:D008175 | Lung Neoplasms | Acetaldehyde | 61.10 | 17372256 | |
| MESH:D008175 | Lung Neoplasms | Arsenic | 61.10 | 17976673 17306315 19168569 | |
| MESH:D008175 | Lung Neoplasms | arsenic trioxide | 61.10 | 11798837 19825857 | |
| MESH:D008175 | Lung Neoplasms | arsenite | 61.10 | 16809336 | |
| MESH:D008175 | Lung Neoplasms | Asbestos, Serpentine | 61.10 | 11198217 | |
| MESH:D008175 | Lung Neoplasms | Azacitidine | 61.10 | 21224363 | |
| MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 61.10 | 18569708 6695378 18816296 18520028 20464547 17053015 20869020 20064080 20135361 | |
| MESH:D008175 | Lung Neoplasms | Budesonide | 61.10 | 16885199 12117777 17163412 | |
| MESH:D008175 | Lung Neoplasms | Butadienes | 61.10 | 12562636 | |
| MESH:D008175 | Lung Neoplasms | Curcumin | 61.10 | 19359593 16243823 18462866 | |
| MESH:D008175 | Lung Neoplasms | deguelin | 61.10 | 16288123 19336726 | |
| MESH:D008175 | Lung Neoplasms | Dexamethasone | 61.10 | 11195469 15824018 | |
| MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 61.10 | 20970405 21163286 20512841 6695378 | |
| MESH:D008175 | Lung Neoplasms | Dimethylnitrosamine | 61.10 | 16061637 11884234 19555203 | |
| MESH:D008175 | Lung Neoplasms | Doxorubicin | 61.10 | 17418594 6189445 | |
| MESH:D008175 | Lung Neoplasms | Fluorouracil | 61.10 | 15246190 | |
| MESH:D008175 | Lung Neoplasms | Humic Substances | 61.10 | 19686714 | |
| MESH:D008175 | Lung Neoplasms | Indomethacin | 61.10 | 11497255 16537180 11053908 | |
| MESH:D008175 | Lung Neoplasms | Isotretinoin | 61.10 | 15899809 | |
| MESH:D008175 | Lung Neoplasms | Melatonin | 61.10 | 17195641 | |
| MESH:D008175 | Lung Neoplasms | Mustard Gas | 61.10 | 3148597 8781369 | |
| MESH:D008175 | Lung Neoplasms | Ozone | 61.10 | 7614698 8597069 | |
| MESH:D008175 | Lung Neoplasms | Plant Extracts | 61.10 | 20869020 | |
| MESH:D008175 | Lung Neoplasms | Quercetin | 61.10 | 16280456 | |
| MESH:D008175 | Lung Neoplasms | sodium arsenite | 61.10 | 17306315 17077188 16712894 15276417 19931552 | |
| MESH:D008175 | Lung Neoplasms | Tamoxifen | 61.10 | 18625569 | |
| MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 61.10 | 19555203 11884234 | |
| MESH:D008175 | Lung Neoplasms | Tetradecanoylphorbol Acetate | 61.10 | 11807781 | |
| MESH:D008175 | Lung Neoplasms | Urethane | 61.10 | 17195641 10997738 11074608 12466968 14587096 17255336 11062179 16007126 11893704 10822126 16337739 6695378 11246140 10530776 12117781 16788158 11497255 11992545 12957351 15166089 17093202 15136453 7750092 15902970 16289808 16204055 10779650 11544531 16391232 11323394 11307925 12765245 11552296 11807781 16926031 | |
| MESH:D008175 | Lung Neoplasms | Zidovudine | 61.10 | 18800350 | |
| MESH:D008178 | Lupus Erythematosus, Cutaneous | Fluorouracil | 3.55 | 15086387 | |
| MESH:D008180 | Lupus Erythematosus, Systemic | Melatonin | 3.40 | 16373423 | |
| MESH:D008223 | Lymphoma | Curcumin | 7.15 | 18462866 | |
| MESH:D008223 | Lymphoma | Doxorubicin | 7.15 | 16098063 | |
| MESH:D008223 | Lymphoma | Doxycycline | 7.15 | 20133848 | |
| MESH:D016393 | Lymphoma, B-Cell | resveratrol | 3.14 | 17088997 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Doxorubicin | 8.44 | 17654614 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Paclitaxel | 8.44 | 14749477 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | resveratrol | 8.44 | 14749477 | |
| MESH:D016399 | Lymphoma, T-Cell | Curcumin | 7.54 | 16173963 | |
| MESH:D016399 | Lymphoma, T-Cell | Doxorubicin | 7.54 | 15621674 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Butadienes | 10.02 | 12562636 | |
| MESH:D015674 | Mammary Neoplasms, Animal | resveratrol | 10.02 | 15688416 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 10.02 | 19428831 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | 2,4-diaminotoluene | 37.36 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | celecoxib | 37.36 | 12104042 19196722 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Doxorubicin | 37.36 | 15458769 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 37.36 | 16891317 17203775 11807958 11408345 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Fenretinide | 37.36 | 10697514 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Genistein | 37.36 | 14578162 12929590 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Ibuprofen | 37.36 | 10697514 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Progesterone | 37.36 | 11408345 17203775 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | resveratrol | 37.36 | 8985016 11606380 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Selenium | 37.36 | 15318939 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 37.36 | 16827153 11731420 19196723 14580682 19196722 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tetradecanoylphorbol Acetate | 37.36 | 8985016 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Zinc | 37.36 | 12773700 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | zoledronic acid | 37.36 | 17312309 | |
| MESH:C535705 | Mandibuloacral dysplasia with type A lipodystrophy | marker/mechanism | 18554282 | ||
| MESH:D020149 | Manganese Poisoning | Estradiol | 8.49 | 19453300 | |
| MESH:D020149 | Manganese Poisoning | Tamoxifen | 8.49 | 19453300 | |
| MESH:D008527 | Medulloblastoma | Tretinoin | 2.11 | 17453147 | |
| MESH:D008545 | Melanoma | Curcumin | 24.50 | 18462866 17885582 | |
| MESH:D008545 | Melanoma | Disulfiram | 24.50 | 15367699 | |
| MESH:D008545 | Melanoma | Doxorubicin | 24.50 | 16827129 | |
| MESH:D008545 | Melanoma | epigallocatechin gallate | 24.50 | 17992120 11746506 | |
| MESH:D008545 | Melanoma | farnesylthiosalicylic acid | 24.50 | 12535206 | |
| MESH:D008545 | Melanoma | Fenretinide | 24.50 | 16270382 | |
| MESH:D008545 | Melanoma | Isotretinoin | 24.50 | 17237267 | |
| MESH:D008545 | Melanoma | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | 24.50 | 16487513 | |
| MESH:D008545 | Melanoma | Paclitaxel | 24.50 | 16342250 12040289 12025231 | |
| MESH:D008545 | Melanoma | Reactive Oxygen Species | 24.50 | 17992120 | |
| MESH:D008545 | Melanoma | resveratrol | 24.50 | 17992120 | |
| MESH:D008545 | Melanoma | sodium arsenite | 24.50 | 19082730 16487513 | |
| MESH:D008545 | Melanoma | Tamoxifen | 24.50 | 12393984 19393235 | |
| MESH:D008545 | Melanoma | Tretinoin | 24.50 | 16752155 | |
| MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 2.95 | 15990972 | |
| MESH:D008546 | Melanoma, Experimental | Acetaminophen | 11.74 | 19513568 | |
| MESH:D008546 | Melanoma, Experimental | Acrolein | 11.74 | 10803710 | |
| MESH:D008546 | Melanoma, Experimental | Gallic Acid | 11.74 | 19577552 | |
| MESH:D008569 | Memory Disorders | Curcumin | 9.34 | 17263510 | |
| MESH:D008569 | Memory Disorders | Ethanol | 9.34 | 18411066 15451040 | |
| MESH:D008569 | Memory Disorders | Methylmercury Compounds | 9.34 | 18436314 | |
| MESH:D008591 | Meningomyelocele | Homocysteine | 8.39 | 16602021 | |
| MESH:D008591 | Meningomyelocele | Tretinoin | 8.39 | 16940565 | |
| MESH:D008654 | Mesothelioma | Asbestos, Crocidolite | 8.62 | 16166281 18303189 16966607 | |
| MESH:D008654 | Mesothelioma | Doxorubicin | 8.62 | 17638057 | |
| MESH:D008654 | Mesothelioma | Selenium | 8.62 | 15107826 | |
| MESH:D008654 | Mesothelioma | zoledronic acid | 8.62 | 16675582 | |
| MESH:D008659 | Metabolic Diseases | phenylmethylpyrazolone | 7.24 | 16301206 | |
| MESH:D008659 | Metabolic Diseases | resveratrol | 7.24 | 17112576 | |
| OMIM:613073 | METAPHYSEAL ANADYSPLASIA 2 | marker/mechanism | |||
| MESH:D008679 | Metaplasia | Ozone | 3.85 | 10496685 | |
| MESH:D008708 | Methemoglobinemia | Nitroglycerin | 3.60 | 3537620 | |
| MESH:D048629 | Micronuclei, Chromosome-Defective | Zidovudine | 4.58 | 17358032 | |
| MESH:D008881 | Migraine Disorders | Indomethacin | 2.73 | 11903285 | |
| MESH:D020326 | Migraine without Aura | Nitroglycerin | 3.94 | 14659530 | |
| MESH:D028361 | Mitochondrial Diseases | Doxorubicin | 3.35 | 15792986 | |
| MESH:D018200 | Mixed Tumor, Mullerian | Raloxifene | 4.29 | 15863610 | |
| MESH:D009006 | Monosomy | Azacitidine | 4.82 | 19299654 | |
| MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 12.09 | 16381670 | |
| MESH:D009062 | Mouth Neoplasms | Fenretinide | 12.09 | 16274795 | |
| MESH:D009062 | Mouth Neoplasms | Fluorouracil | 12.09 | 16757204 18986760 | |
| MESH:D009062 | Mouth Neoplasms | Indomethacin | 12.09 | 12636206 | |
| MESH:D009069 | Movement Disorders | Methylmercury Compounds | 4.16 | 18436314 | |
| MESH:D052016 | Mucositis | Doxorubicin | 8.32 | 17415656 | |
| MESH:D052016 | Mucositis | irinotecan | 8.32 | 17159606 | |
| MESH:D009101 | Multiple Myeloma | alachlor | 34.59 | 14769641 | |
| MESH:D009101 | Multiple Myeloma | arsenic trioxide | 34.59 | 14977855 19417148 11468182 15949261 19549372 | |
| MESH:D009101 | Multiple Myeloma | Azacitidine | 34.59 | 18443271 19549372 | |
| MESH:D009101 | Multiple Myeloma | celecoxib | 34.59 | 16123214 | |
| MESH:D009101 | Multiple Myeloma | Curcumin | 34.59 | 19372569 | |
| MESH:D009101 | Multiple Myeloma | Dexamethasone | 34.59 | 16118317 15867202 15744524 | |
| MESH:D009101 | Multiple Myeloma | lonafarnib | 34.59 | 16996129 | |
| MESH:D009101 | Multiple Myeloma | Paclitaxel | 34.59 | 14749477 | |
| MESH:D009101 | Multiple Myeloma | Raloxifene | 34.59 | 16497877 | |
| MESH:D009101 | Multiple Myeloma | resveratrol | 34.59 | 16267019 16490592 17164350 17935668 14749477 17049120 | |
| MESH:D009101 | Multiple Myeloma | zoledronic acid | 34.59 | 18089719 16996129 19621390 | |
| MESH:D009102 | Multiple Organ Failure | marker/mechanism | 15259001 | ||
| MESH:D009102 | Multiple Organ Failure | Zymosan | 4.05 | 15834315 18160304 17724436 10479408 10890648 12130978 15213630 15241586 15259001 12879239 | |
| MESH:D020528 | Multiple Sclerosis, Chronic Progressive | Aluminum | 5.12 | 17086897 | |
| MESH:D020529 | Multiple Sclerosis, Relapsing-Remitting | Aluminum | 10.75 | 17086897 | |
| MESH:D020529 | Multiple Sclerosis, Relapsing-Remitting | Minocycline | 10.75 | 11835378 | |
| MESH:D009134 | Muscular Atrophy, Spinal | Curcumin | 14.06 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | epigallocatechin gallate | 14.06 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | resveratrol | 14.06 | 17962980 | |
| MESH:D009164 | Mycobacterium Infections | Indinavir | 4.17 | 21442799 | |
| MESH:D009182 | Mycosis Fungoides | arsenic trioxide | 3.42 | 18349030 | |
| MESH:D009190 | Myelodysplastic Syndromes | arsenic trioxide | 10.36 | 16105982 16882451 | |
| MESH:D009190 | Myelodysplastic Syndromes | Azacitidine | 10.36 | 17611569 17596541 19805378 18720364 | |
| MESH:D009190 | Myelodysplastic Syndromes | Dexamethasone | 10.36 | 9809623 | |
| MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 10.36 | 17596541 | |
| MESH:D009203 | Myocardial Infarction | abacavir | 25.70 | 18753925 | |
| MESH:D009203 | Myocardial Infarction | Doxorubicin | 25.70 | 19429709 15857846 | |
| MESH:D009203 | Myocardial Infarction | Genistein | 25.70 | 17141266 | |
| MESH:D009203 | Myocardial Infarction | Homocysteine | 25.70 | 17412321 | |
| MESH:D009203 | Myocardial Infarction | Hydrochloric Acid | 25.70 | 18534312 | |
| MESH:D009203 | Myocardial Infarction | Isoproterenol | 25.70 | 16538859 16584858 17052832 19595682 16697266 19172585 15740881 | |
| MESH:D009203 | Myocardial Infarction | Nitroglycerin | 25.70 | 14729435 | |
| MESH:D009203 | Myocardial Infarction | Pravastatin | 25.70 | 17188708 | |
| MESH:D009203 | Myocardial Infarction | Quercetin | 25.70 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | resveratrol | 25.70 | 16317513 16525036 17015251 17188708 16456233 17125593 | |
| MESH:D017202 | Myocardial Ischemia | Arsenic | 9.18 | 15371236 | |
| MESH:D017202 | Myocardial Ischemia | resveratrol | 9.18 | 17015251 17125593 | |
| MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 9.18 | 12213967 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 8.29 | 16810080 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Genistein | 8.29 | 17141266 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Quercetin | 8.29 | 19207477 | |
| MESH:D009205 | Myocarditis | resveratrol | 3.53 | 17322642 | |
| MESH:D009232 | Myxoma | Raloxifene | 4.29 | 16343187 | |
| MESH:D009298 | Nasal Polyps | zileuton | 4.97 | 10665187 | |
| MESH:D009336 | Necrosis | Melatonin | 4.24 | 12195237 | |
| MESH:D009361 | Neoplasm Invasiveness | arsenic trioxide | 25.12 | 16624393 | |
| MESH:D009361 | Neoplasm Invasiveness | bis(4-hydroxycinnamoyl)methane | 25.12 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | Curcumin | 25.12 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | demethoxycurcumin | 25.12 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | Disulfiram | 25.12 | 18047805 | |
| MESH:D009361 | Neoplasm Invasiveness | tetracycline CMT-3 | 25.12 | 11172680 11172682 | |
| MESH:D009362 | Neoplasm Metastasis | marker/mechanism | 16475674 | ||
| MESH:D009362 | Neoplasm Metastasis | Acetylcysteine | 33.43 | 14720322 | |
| MESH:D009362 | Neoplasm Metastasis | clopidogrel | 33.43 | 11875746 | |
| MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 33.43 | 3581430 9029167 | |
| MESH:D009362 | Neoplasm Metastasis | Disulfiram | 33.43 | 15367699 | |
| MESH:D009362 | Neoplasm Metastasis | Doxorubicin | 33.43 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | Indomethacin | 33.43 | 11239499 11053908 16537180 | |
| MESH:D009362 | Neoplasm Metastasis | irinotecan | 33.43 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | norcantharidin | 33.43 | 15711181 | |
| MESH:D009362 | Neoplasm Metastasis | Paclitaxel | 33.43 | 15867366 | |
| MESH:D009362 | Neoplasm Metastasis | punarnavine | 33.43 | 19171408 | |
| MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 33.43 | 19393235 | |
| MESH:D009362 | Neoplasm Metastasis | zoledronic acid | 33.43 | 19139120 17312309 15867366 | |
| MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 1.94 | 19410462 | |
| MESH:D009369 | Neoplasms | Acrolein | 19.67 | 17329238 | |
| MESH:D009369 | Neoplasms | Benzo(a)pyrene | 19.67 | 11141357 | |
| MESH:D009369 | Neoplasms | deguelin | 19.67 | 17764071 | |
| MESH:D009369 | Neoplasms | Disulfiram | 19.67 | 17079463 | |
| MESH:D009369 | Neoplasms | Fenretinide | 19.67 | 17353921 15958647 | |
| MESH:D009369 | Neoplasms | Fluorouracil | 19.67 | 18600527 16928823 18239605 | |
| MESH:D009369 | Neoplasms | Quercetin | 19.67 | 15185748 | |
| MESH:D009369 | Neoplasms | sodium arsenite | 19.67 | 11559025 | |
| MESH:D009369 | Neoplasms | Tretinoin | 19.67 | 16946489 16594593 | |
| MESH:D009369 | Neoplasms | Urethane | 19.67 | 15625555 | |
| MESH:D009374 | Neoplasms, Experimental | Asbestos, Serpentine | 24.50 | 11704859 | |
| MESH:D009374 | Neoplasms, Experimental | erythritol anhydride | 24.50 | 10925838 | |
| MESH:D009374 | Neoplasms, Experimental | Indomethacin | 24.50 | 15625704 10663608 | |
| MESH:D009374 | Neoplasms, Experimental | resveratrol | 24.50 | 8985016 | |
| MESH:D009374 | Neoplasms, Experimental | sodium arsenite | 24.50 | 20056578 | |
| MESH:D009374 | Neoplasms, Experimental | Toluene 2,4-Diisocyanate | 24.50 | 1670384 | |
| MESH:D009374 | Neoplasms, Experimental | Urethane | 24.50 | 15582191 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | celecoxib | 11.23 | 19196722 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Curcumin | 11.23 | 12497104 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 11.23 | 19189210 19200415 19196722 | |
| MESH:D009389 | Neovascularization, Pathologic | arsenite | 10.11 | 15738583 | |
| MESH:D009389 | Neovascularization, Pathologic | Disulfiram | 10.11 | 15367699 | |
| MESH:D009389 | Neovascularization, Pathologic | Estradiol | 10.11 | 17289903 | |
| MESH:D009393 | Nephritis | Acrolein | 5.03 | 12653641 | |
| MESH:D009395 | Nephritis, Interstitial | Ibuprofen | 7.32 | 6375363 | |
| MESH:D009395 | Nephritis, Interstitial | Minocycline | 7.32 | 435818 444868 | |
| MESH:D009401 | Nephrosis | Doxorubicin | 3.55 | 16636307 16899518 | |
| MESH:D009404 | Nephrotic Syndrome | Doxorubicin | 2.91 | 16889571 15640375 | |
| MESH:D009410 | Nerve Degeneration | Ibuprofen | 8.23 | 10961664 | |
| MESH:D009410 | Nerve Degeneration | Paraquat | 8.23 | 16893418 | |
| MESH:D009410 | Nerve Degeneration | Rotenone | 8.23 | 18619942 15790535 17356569 | |
| MESH:D009421 | Nervous System Malformations | Benomyl | 18.42 | 14502586 | |
| MESH:D009421 | Nervous System Malformations | Estradiol | 18.42 | 11399458 16427766 | |
| MESH:D009421 | Nervous System Malformations | Genistein | 18.42 | 16427766 | |
| MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 18.42 | 14600291 | |
| MESH:D009421 | Nervous System Malformations | Tretinoin | 18.42 | 9125849 | |
| MESH:D009423 | Nervous System Neoplasms | Curcumin | 4.37 | 18462866 | |
| MESH:D009436 | Neural Tube Defects | Acetylcysteine | 12.82 | 19446573 | |
| MESH:D009436 | Neural Tube Defects | Arsenic | 12.82 | 16620997 | |
| MESH:D009436 | Neural Tube Defects | arsenic trioxide | 12.82 | 10525206 | |
| MESH:D009436 | Neural Tube Defects | sodium arsenite | 12.82 | 12854658 | |
| MESH:D009436 | Neural Tube Defects | Tretinoin | 12.82 | 9142499 | |
| MESH:D019954 | Neurobehavioral Manifestations | Plant Extracts | 3.97 | 17168769 | |
| MESH:D009447 | Neuroblastoma | Doxorubicin | 6.77 | 15555623 | |
| MESH:D009447 | Neuroblastoma | irinotecan | 6.77 | 8761367 | |
| MESH:D009447 | Neuroblastoma | Isotretinoin | 6.77 | 17368321 | |
| MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 15.12 | 18514411 | |
| MESH:D019636 | Neurodegenerative Diseases | Acrolein | 15.12 | 11342003 | |
| MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 15.12 | 20387270 | |
| MESH:D019636 | Neurodegenerative Diseases | Indomethacin | 15.12 | 12349958 | |
| MESH:D019636 | Neurodegenerative Diseases | resveratrol | 15.12 | 17652729 | |
| MESH:D017599 | Neuroectodermal Tumors | irinotecan | 3.50 | 8761367 | |
| MESH:D020078 | Neurogenic Inflammation | Arsenic | 11.11 | 17056641 | |
| MESH:D020078 | Neurogenic Inflammation | Quercetin | 11.11 | 17929310 | |
| MESH:D020078 | Neurogenic Inflammation | resveratrol | 11.11 | 17929310 | |
| MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 3.86 | 20387270 | |
| MESH:D009472 | Neuronal Ceroid-Lipofuscinoses | Fenretinide | 4.44 | 16303764 | |
| MESH:D020258 | Neurotoxicity Syndromes | Disulfiram | 5.27 | 11005259 | |
| MESH:D020258 | Neurotoxicity Syndromes | Fluorouracil | 5.27 | 16436463 | |
| MESH:D009503 | Neutropenia | Mustard Gas | 2.83 | 7688884 16761898 | |
| MESH:D009669 | Nose Neoplasms | alachlor | 3.63 | 16178123 11127290 15580706 16698726 14563481 | |
| MESH:D009765 | Obesity | Curcumin | 4.46 | 19297423 | |
| MESH:D009765 | Obesity | Dietary Fats | 4.46 | 19632207 18457598 21332399 20518802 17217161 20132043 18674790 11836018 16723640 | |
| MESH:D009765 | Obesity | Plant Extracts | 4.46 | 19056576 20132043 | |
| MESH:D007752 | Obstetric Labor, Premature | Indomethacin | 3.91 | 6374098 | |
| MESH:D009784 | Occupational Diseases | Hydrochloric Acid | 6.15 | 12378975 | |
| MESH:D009784 | Occupational Diseases | Toluene 2,4-Diisocyanate | 6.15 | 6091945 18394133 6091946 3040596 11077013 8156442 12585506 | |
| MESH:D014009 | Onychomycosis | terbinafine | 5.58 | 18360572 9382559 | |
| MESH:D009914 | Oral Submucous Fibrosis | marker/mechanism | 16311067 | ||
| MESH:D010003 | Osteoarthritis | Doxycycline | 7.66 | 17267227 | |
| MESH:D010003 | Osteoarthritis | Ibuprofen | 7.66 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Indomethacin | 7.66 | 7009135 | |
| MESH:D010009 | Osteochondrodysplasias | Thiram | 4.50 | 15899490 17954590 15518828 | |
| MESH:D010014 | Osteolysis | Paclitaxel | 8.19 | 15867366 | |
| MESH:D010014 | Osteolysis | zoledronic acid | 8.19 | 15867366 | |
| MESH:D010024 | Osteoporosis | Curcumin | 9.45 | 18719352 | |
| MESH:D010024 | Osteoporosis | Genistein | 9.45 | 19401787 | |
| MESH:D010024 | Osteoporosis | Raloxifene | 9.45 | 17882678 19059307 15775268 | |
| MESH:D010024 | Osteoporosis | zoledronic acid | 9.45 | 17882678 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Genistein | 14.58 | 16169203 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Quercetin | 14.58 | 19495926 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Raloxifene | 14.58 | 17893378 17823083 15579764 15758505 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | resveratrol | 14.58 | 17513867 | |
| MESH:D012516 | Osteosarcoma | Disulfiram | 6.80 | 18047805 | |
| MESH:D012516 | Osteosarcoma | Doxorubicin | 6.80 | 15930896 | |
| MESH:D010033 | Otitis Media | retinol palmitate | 5.62 | 17303254 | |
| MESH:D010051 | Ovarian Neoplasms | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 49.23 | 16211241 | |
| MESH:D010051 | Ovarian Neoplasms | Arsenic | 49.23 | 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | arsenic trioxide | 49.23 | 12452020 19769630 16624393 | |
| MESH:D010051 | Ovarian Neoplasms | Curcumin | 49.23 | 18462866 19020741 | |
| MESH:D010051 | Ovarian Neoplasms | Disulfiram | 49.23 | 17026967 | |
| MESH:D010051 | Ovarian Neoplasms | Estradiol | 49.23 | 19401270 | |
| MESH:D010051 | Ovarian Neoplasms | Fenretinide | 49.23 | 16133793 | |
| MESH:D010051 | Ovarian Neoplasms | Genistein | 49.23 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Luteolin | 49.23 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Medroxyprogesterone Acetate | 49.23 | 17393432 | |
| MESH:D010051 | Ovarian Neoplasms | Mifepristone | 49.23 | 16525653 | |
| MESH:D010051 | Ovarian Neoplasms | Paclitaxel | 49.23 | 11161223 | |
| MESH:D010051 | Ovarian Neoplasms | Progesterone | 49.23 | 17393432 16525653 | |
| MESH:D010051 | Ovarian Neoplasms | Quercetin | 49.23 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | sodium arsenite | 49.23 | 15276417 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | Tretinoin | 49.23 | 16936753 | |
| MESH:D010051 | Ovarian Neoplasms | U 0126 | 49.23 | 16211241 | |
| MESH:D010051 | Ovarian Neoplasms | Urethane | 49.23 | 16391232 | |
| MESH:D010146 | Pain | Acetaminophen | 13.02 | 16870215 | |
| MESH:D010146 | Pain | Ibuprofen | 13.02 | 3291741 | |
| MESH:D010146 | Pain | Indomethacin | 13.02 | 3291741 13679232 17627676 17440234 | |
| MESH:D010146 | Pain | Tretinoin | 13.02 | 16870215 | |
| MESH:D010146 | Pain | zileuton | 13.02 | 15935457 | |
| MESH:D010146 | Pain | zoledronic acid | 13.02 | 16475674 | |
| MESH:D010149 | Pain, Postoperative | Ibuprofen | 7.34 | 16678543 | |
| MESH:D010149 | Pain, Postoperative | Indomethacin | 7.34 | 12538197 18702446 | |
| MESH:D010190 | Pancreatic Neoplasms | arsenic trioxide | 33.82 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Curcumin | 33.82 | 17440100 19196508 19401701 | |
| MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 33.82 | 16540662 | |
| MESH:D010190 | Pancreatic Neoplasms | Ethanol | 33.82 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | Fenretinide | 33.82 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Fluorouracil | 33.82 | 16500647 16929163 15113037 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | gemcitabine | 33.82 | 16929163 11504793 18992248 17440100 18383843 | |
| MESH:D010190 | Pancreatic Neoplasms | Ibuprofen | 33.82 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | 33.82 | 11504793 | |
| MESH:D010190 | Pancreatic Neoplasms | Quercetin | 33.82 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Reactive Oxygen Species | 33.82 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Tetradecanoylphorbol Acetate | 33.82 | 15976015 | |
| MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 33.82 | 15976015 | |
| MESH:D010195 | Pancreatitis | Indomethacin | 5.31 | 17883296 15028970 | |
| MESH:D010195 | Pancreatitis | phenylmethylpyrazolone | 5.31 | 20035747 | |
| MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 2.52 | 11578682 | |
| MESH:D010212 | Papilloma | Hydrogen Peroxide | 8.86 | 12065085 | |
| MESH:D010212 | Papilloma | Plant Extracts | 8.86 | 16517061 15173996 | |
| MESH:D010212 | Papilloma | Tetradecanoylphorbol Acetate | 8.86 | 12065085 18922899 18404319 8330346 | |
| MESH:D010235 | Paraganglioma | arsenic trioxide | 2.99 | 19927285 | |
| MESH:D010257 | Paraneoplastic Syndromes | Indomethacin | 4.46 | 16537180 | |
| MESH:D010300 | Parkinson Disease | Acrolein | 6.78 | 17690948 | |
| MESH:D010300 | Parkinson Disease | Homocysteine | 6.78 | 16275827 | |
| MESH:D010300 | Parkinson Disease | Paraquat | 6.78 | 15451049 16140633 11445065 15824117 12911755 11181820 16510128 11124998 | |
| MESH:D010300 | Parkinson Disease | Rotenone | 6.78 | 15451049 18191903 11445065 19232380 11535288 18619942 19114014 16412576 16140633 | |
| MESH:D010302 | Parkinson Disease, Secondary | Paraquat | 3.22 | 16190885 | |
| MESH:D020734 | Parkinsonian Disorders | Indomethacin | 9.03 | 12349958 | |
| MESH:D020734 | Parkinsonian Disorders | Melatonin | 9.03 | 15574749 | |
| MESH:D020734 | Parkinsonian Disorders | Rotenone | 9.03 | 15574749 15795934 15927086 18197244 | |
| MESH:D051302 | Paroxysmal Hemicrania | Indomethacin | 4.46 | 11903285 | |
| MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 2.99 | 12520081 | |
| MESH:D010391 | Pemphigoid, Bullous | Doxycycline | 5.31 | 11026799 | |
| MESH:D010437 | Peptic Ulcer | Indomethacin | 3.91 | 11148446 | |
| MESH:D010518 | Periodontitis | Indomethacin | 3.66 | 17225004 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Arsenic | 3.01 | 16093927 | |
| MESH:D016491 | Peripheral Vascular Diseases | Arsenic | 3.75 | 15371236 6392382 16905509 | |
| MESH:D010538 | Peritonitis | Melatonin | 14.40 | 15707874 | |
| MESH:D010538 | Peritonitis | Ozone | 14.40 | 16369182 | |
| MESH:D010538 | Peritonitis | zileuton | 14.40 | 17371808 | |
| MESH:D010538 | Peritonitis | Zymosan | 14.40 | 11985352 19088179 18977430 15259001 17371808 15979727 14761945 19641140 18760300 18557954 17826846 | |
| MESH:D010787 | Photosensitivity Disorders | Acrolein | 4.48 | 11550810 | |
| MESH:D003557 | Phyllodes Tumor | Doxorubicin | 3.90 | 17983394 | |
| MESH:D010911 | Pituitary Neoplasms | Urethane | 4.20 | 16391232 | |
| MESH:D010954 | Plasmacytoma | Selenium | 3.63 | 15087411 | |
| MESH:D010995 | Pleural Diseases | Asbestos, Crocidolite | 8.62 | 10923243 | |
| MESH:D010995 | Pleural Diseases | Asbestos, Serpentine | 8.62 | 10923243 | |
| MESH:D010997 | Pleural Neoplasms | Doxorubicin | 3.90 | 17638057 | |
| MESH:D011014 | Pneumonia | Lipopolysaccharides | 11.50 | 12224865 11605937 | |
| MESH:D011014 | Pneumonia | Ozone | 11.50 | 18007984 18929643 18381685 | |
| MESH:D011014 | Pneumonia | Paraquat | 11.50 | 12504350 | |
| MESH:D011015 | Pneumonia, Aspiration | Hydrochloric Acid | 4.14 | 15970105 18497604 18573544 15607125 | |
| MESH:D011020 | Pneumonia, Pneumocystis | terbinafine | 5.78 | 11796365 | |
| MESH:D011041 | Poisoning | Mustard Gas | 2.68 | 15727166 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Hexachlorobenzene | 7.16 | 9918132 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 7.16 | 18163543 | |
| MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 5.58 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Quercetin | 5.58 | 19056647 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Dexamethasone | 2.70 | 21297632 | |
| MESH:D011225 | Pre-Eclampsia | Zinc | 3.14 | 17114810 | |
| MESH:D047928 | Premature Birth | Indomethacin | 3.91 | 17000239 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Isotretinoin | 13.42 | 18769834 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Methylmercury Compounds | 13.42 | 18436314 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | resveratrol | 13.42 | 16679765 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 13.42 | 11118676 11399792 11222880 11896295 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 2.74 | 20887781 | |
| MESH:D011471 | Prostatic Neoplasms | marker/mechanism | 16606632 | ||
| MESH:D011471 | Prostatic Neoplasms | Androgens | 19.42 | 17909013 15389811 16998812 | |
| MESH:D011471 | Prostatic Neoplasms | Arsenic | 19.42 | 16140617 | |
| MESH:D011471 | Prostatic Neoplasms | arsenic trioxide | 19.42 | 19131511 | |
| MESH:D011471 | Prostatic Neoplasms | Azacitidine | 19.42 | 18324645 | |
| MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 19.42 | 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | biochanin A | 19.42 | 12111696 | |
| MESH:D011471 | Prostatic Neoplasms | celecoxib | 19.42 | 15570007 17908994 | |
| MESH:D011471 | Prostatic Neoplasms | Curcumin | 19.42 | 11398177 18226269 15129424 18769126 18156803 10851300 12497104 | |
| MESH:D011471 | Prostatic Neoplasms | Disulfiram | 19.42 | 19789329 | |
| MESH:D011471 | Prostatic Neoplasms | Doxorubicin | 19.42 | 16868541 16729912 15749863 16888761 18437689 15897917 | |
| MESH:D011471 | Prostatic Neoplasms | Estradiol | 19.42 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | farnesylthiosalicylic acid | 19.42 | 16780807 | |
| MESH:D011471 | Prostatic Neoplasms | Fenretinide | 19.42 | 17024972 | |
| MESH:D011471 | Prostatic Neoplasms | Fluorouracil | 19.42 | 19082440 18626508 | |
| MESH:D011471 | Prostatic Neoplasms | Genistein | 19.42 | 15256057 15378649 16925846 | |
| MESH:D011471 | Prostatic Neoplasms | Hyaluronic Acid | 19.42 | 16864594 | |
| MESH:D011471 | Prostatic Neoplasms | Ibuprofen | 19.42 | 17409433 | |
| MESH:D011471 | Prostatic Neoplasms | Paclitaxel | 19.42 | 16729912 17172428 16356831 17136230 | |
| MESH:D011471 | Prostatic Neoplasms | Plant Extracts | 19.42 | 17804756 14666653 | |
| MESH:D011471 | Prostatic Neoplasms | pyrrolidine dithiocarbamic acid | 19.42 | 16139439 | |
| MESH:D011471 | Prostatic Neoplasms | Quercetin | 19.42 | 14715546 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | Raloxifene | 19.42 | 16536755 15731164 16220300 | |
| MESH:D011471 | Prostatic Neoplasms | resveratrol | 19.42 | 17718901 17636462 15767336 17804756 16731767 17675339 | |
| MESH:D011471 | Prostatic Neoplasms | sodium arsenite | 19.42 | 16039940 | |
| MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 19.42 | 15067354 | |
| MESH:D011471 | Prostatic Neoplasms | tetracycline CMT-3 | 19.42 | 11172682 11857423 | |
| MESH:D011471 | Prostatic Neoplasms | Thiram | 19.42 | 19789329 | |
| MESH:D011471 | Prostatic Neoplasms | Zinc | 19.42 | 16700911 16606632 16517595 12429649 | |
| MESH:D011471 | Prostatic Neoplasms | zoledronic acid | 19.42 | 19103299 12438248 | |
| MESH:D011507 | Proteinuria | Arsenic | 16.72 | 21343184 | |
| MESH:D011507 | Proteinuria | Ibuprofen | 16.72 | 6375363 | |
| MESH:D011507 | Proteinuria | Indomethacin | 16.72 | 11849393 | |
| MESH:D011507 | Proteinuria | pioglitazone | 16.72 | 16687628 | |
| MESH:D011507 | Proteinuria | Tretinoin | 16.72 | 16636307 | |
| MESH:D011537 | Pruritus | Ethinyl Estradiol | 13.21 | 15861022 16919318 | |
| MESH:D011537 | Pruritus | fexofenadine | 13.21 | 17133778 | |
| MESH:D011537 | Pruritus | Mustard Gas | 13.21 | 18058305 | |
| MESH:D011537 | Pruritus | zileuton | 13.21 | 17827870 19657356 | |
| MESH:D011596 | Psychomotor Disorders | Isotretinoin | 4.68 | 18769834 | |
| MESH:D011625 | Pterygium | Tretinoin | 3.55 | 16723453 | |
| MESH:D001261 | Pulmonary Atelectasis | Hydrochloric Acid | 4.76 | 20597076 | |
| MESH:D011654 | Pulmonary Edema | Hydrochloric Acid | 11.19 | 15090967 | |
| MESH:D011654 | Pulmonary Edema | Isoproterenol | 11.19 | 10903255 | |
| MESH:D011654 | Pulmonary Edema | zileuton | 11.19 | 18309904 | |
| MESH:D011656 | Pulmonary Emphysema | Curcumin | 3.40 | 19168576 | |
| MESH:D011657 | Pulmonary Eosinophilia | Toluene 2,4-Diisocyanate | 4.37 | 14606601 | |
| MESH:D011658 | Pulmonary Fibrosis | Asbestos, Crocidolite | 7.47 | 17365031 17975199 17322281 15814490 | |
| MESH:D011658 | Pulmonary Fibrosis | Asbestos, Serpentine | 7.47 | 15511213 18569384 | |
| MESH:D011658 | Pulmonary Fibrosis | Mustard Gas | 7.47 | 17720292 17894541 17620002 10334151 17266442 | |
| MESH:D011658 | Pulmonary Fibrosis | Paraquat | 7.47 | 16324872 17997886 | |
| MESH:D011693 | Purpura | Raloxifene | 4.29 | 15770314 | |
| MESH:D012004 | Rectal Neoplasms | Fluorouracil | 2.91 | 16160472 15538739 18722050 18286688 | |
| MESH:D051437 | Renal Insufficiency | Acrolein | 6.60 | 12732208 | |
| MESH:D051437 | Renal Insufficiency | Doxorubicin | 6.60 | 17922066 | |
| MESH:D051436 | Renal Insufficiency, Chronic | resveratrol | 4.32 | 16325855 | |
| MESH:D015427 | Reperfusion Injury | phenylmethylpyrazolone | 6.67 | 16753835 15948865 16041266 14654979 15629865 15086910 | |
| MESH:D015427 | Reperfusion Injury | resveratrol | 6.67 | 16314181 17520802 15827377 17058453 16317513 | |
| MESH:D015427 | Reperfusion Injury | zileuton | 6.67 | 9865762 15266012 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Acetylcysteine | 24.81 | 12210543 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Curcumin | 24.81 | 10666014 18379247 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Dexamethasone | 24.81 | 18379247 11700416 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Hydrochloric Acid | 24.81 | 18549715 18339021 17627322 16784557 16129981 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Oxygen | 24.81 | 17627322 18339021 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Paraquat | 24.81 | 11700416 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | pyrrolidine dithiocarbamic acid | 24.81 | 16129981 | |
| MESH:D012130 | Respiratory Hypersensitivity | Acetylcholine | 8.27 | 9413022 | |
| MESH:D012130 | Respiratory Hypersensitivity | Lipopolysaccharides | 8.27 | 10835634 | |
| MESH:D012130 | Respiratory Hypersensitivity | Toluene 2,4-Diisocyanate | 8.27 | 20219652 7692837 16940033 | |
| MESH:D012133 | Respiratory Paralysis | Hydrochloric Acid | 5.10 | 11510729 | |
| MESH:D012135 | Respiratory Sounds | alachlor | 6.08 | 11874814 | |
| MESH:D012135 | Respiratory Sounds | Paraquat | 6.08 | 11874814 | |
| MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 2.64 | 18990726 | |
| MESH:D012140 | Respiratory Tract Diseases | Hydrochloric Acid | 7.09 | 20516732 | |
| MESH:D012140 | Respiratory Tract Diseases | Toluene 2,4-Diisocyanate | 7.09 | 18447907 | |
| MESH:D012162 | Retinal Degeneration | Fenretinide | 9.20 | 16303925 | |
| MESH:D012162 | Retinal Degeneration | Paraquat | 9.20 | 16458197 | |
| MESH:D012162 | Retinal Degeneration | Zinc | 9.20 | 16584753 | |
| MESH:D012170 | Retinal Vein Occlusion | clopidogrel | 4.90 | 19371211 | |
| MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 2.93 | 16283617 16116481 | |
| MESH:D012220 | Rhinitis | Acetaldehyde | 8.44 | 17050345 | |
| MESH:D012220 | Rhinitis | Toluene 2,4-Diisocyanate | 8.44 | 19050374 | |
| MESH:D012220 | Rhinitis | zileuton | 8.44 | 20332717 | |
| MESH:D012221 | Rhinitis, Allergic, Perennial | Toluene 2,4-Diisocyanate | 4.03 | 12617775 15015336 | |
| MESH:D006255 | Rhinitis, Allergic, Seasonal | Toluene 2,4-Diisocyanate | 4.26 | 19075512 | |
| MESH:D012468 | Salivary Gland Neoplasms | Progesterone | 2.23 | 18045962 | |
| MESH:D012509 | Sarcoma | Curcumin | 5.86 | 18462866 | |
| MESH:D012509 | Sarcoma | Doxorubicin | 5.86 | 15675481 16767912 18313854 17203757 15625365 17710206 | |
| MESH:D012512 | Sarcoma, Ewing's | arsenic trioxide | 10.53 | 16646077 | |
| MESH:D012512 | Sarcoma, Ewing's | Doxorubicin | 10.53 | 16326096 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | zoledronic acid | 10.53 | 16121404 | |
| MESH:D012514 | Sarcoma, Kaposi | Doxorubicin | 8.84 | 17846226 | |
| MESH:D012514 | Sarcoma, Kaposi | imiquimod | 8.84 | 16302556 | |
| MESH:D012554 | Schistosomiasis japonica | Quercetin | 4.28 | 16862918 | |
| MESH:D012559 | Schizophrenia | Homocysteine | 2.90 | 16641680 | |
| MESH:D012640 | Seizures | Ethanol | 2.38 | 9754883 | |
| MESH:D018805 | Sepsis | marker/mechanism | 16003065 | ||
| MESH:D018805 | Sepsis | Curcumin | 9.63 | 18389075 | |
| MESH:D018805 | Sepsis | tetracycline CMT-3 | 9.63 | 15489642 16003065 | |
| MESH:D018805 | Sepsis | Zymosan | 9.63 | 11441115 | |
| MESH:D012852 | Sinusitis | Phenylephrine | 7.49 | 7327846 | |
| MESH:D012852 | Sinusitis | zileuton | 7.49 | 10665187 | |
| MESH:D012871 | Skin Diseases | Arsenic | 3.34 | 19834688 17938729 16702368 15952646 17548696 17453740 17050553 16353154 6392382 18709164 16759981 | |
| MESH:D012871 | Skin Diseases | Mustard Gas | 3.34 | 16961503 12880345 15451306 | |
| MESH:D012878 | Skin Neoplasms | marker/mechanism | 18572023 | ||
| MESH:D012878 | Skin Neoplasms | Arsenic | 39.00 | 17029826 17976673 19538983 15504454 17050553 16251483 | |
| MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 39.00 | 19755658 10029692 | |
| MESH:D012878 | Skin Neoplasms | deguelin | 39.00 | 16041863 | |
| MESH:D012878 | Skin Neoplasms | Doxorubicin | 39.00 | 15692506 | |
| MESH:D012878 | Skin Neoplasms | Fenretinide | 39.00 | 16467112 | |
| MESH:D012878 | Skin Neoplasms | gingerol | 39.00 | 19481070 | |
| MESH:D012878 | Skin Neoplasms | Hydrogen Peroxide | 39.00 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | Plant Extracts | 39.00 | 15173996 16517061 | |
| MESH:D012878 | Skin Neoplasms | resveratrol | 39.00 | 15837718 8985016 | |
| MESH:D012878 | Skin Neoplasms | sodium arsenite | 39.00 | 19524636 18572023 | |
| MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 39.00 | 16192470 | |
| MESH:D012878 | Skin Neoplasms | Tetradecanoylphorbol Acetate | 39.00 | 8330346 12065085 8985016 11807781 18404319 | |
| MESH:D012878 | Skin Neoplasms | Tretinoin | 39.00 | 16467112 | |
| MESH:D012878 | Skin Neoplasms | Urethane | 39.00 | 11807781 | |
| MESH:D020181 | Sleep Apnea, Obstructive | zileuton | 4.62 | 19118273 | |
| MESH:D012893 | Sleep Disorders | Melatonin | 4.24 | 16919138 16897403 18182647 | |
| MESH:D020178 | Sleep Disorders, Circadian Rhythm | Melatonin | 5.37 | 18078449 19452292 | |
| MESH:D007319 | Sleep Initiation and Maintenance Disorders | Melatonin | 4.03 | 18078449 | |
| MESH:D012912 | Sneezing | Toluene 2,4-Diisocyanate | 4.26 | 19050374 19075512 | |
| MESH:D012983 | Soft Tissue Neoplasms | Doxorubicin | 3.35 | 15625365 17203757 16767912 | |
| MESH:D013088 | Spermatocele | Ethinyl Estradiol | 7.41 | 16709447 | |
| MESH:D013088 | Spermatocele | Tamoxifen | 7.41 | 16709447 | |
| MESH:D013119 | Spinal Cord Injuries | Progesterone | 11.56 | 16503802 15862959 | |
| MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 11.56 | 19457130 | |
| MESH:D013119 | Spinal Cord Injuries | zileuton | 11.56 | 18059327 | |
| MESH:D016135 | Spinal Dysraphism | sodium arsenite | 2.75 | 12854658 | |
| MESH:D013158 | Splenic Diseases | Dimethylnitrosamine | 4.01 | 12587719 | |
| MESH:D013272 | Stomach Diseases | Dexamethasone | 6.31 | 15472012 | |
| MESH:D013272 | Stomach Diseases | Indomethacin | 6.31 | 18545984 10486359 10192188 10215738 16184426 15472012 17638125 17160473 16113693 17207306 16280098 18209964 15038085 | |
| MESH:D013274 | Stomach Neoplasms | arsenic trioxide | 16.22 | 17007042 | |
| MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 16.22 | 20155912 2093021 | |
| MESH:D013274 | Stomach Neoplasms | Butadienes | 16.22 | 12562636 | |
| MESH:D013274 | Stomach Neoplasms | celecoxib | 16.22 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 16.22 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Dimethylnitrosamine | 16.22 | 16033868 | |
| MESH:D013274 | Stomach Neoplasms | Ethanol | 16.22 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Fluorouracil | 16.22 | 19084572 19015929 18396642 16951190 16424979 18567086 17522103 15786421 17172411 17498489 | |
| MESH:D013274 | Stomach Neoplasms | Indomethacin | 16.22 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | irinotecan | 16.22 | 15723263 | |
| MESH:D013274 | Stomach Neoplasms | Paclitaxel | 16.22 | 18506536 18396642 | |
| MESH:D013274 | Stomach Neoplasms | Tretinoin | 16.22 | 17261132 | |
| MESH:D013274 | Stomach Neoplasms | Zidovudine | 16.22 | 17696246 | |
| MESH:D013276 | Stomach Ulcer | Acetylcysteine | 27.42 | 17918041 | |
| MESH:D013276 | Stomach Ulcer | bis(4-hydroxycinnamoyl)methane | 27.42 | 19188055 | |
| MESH:D013276 | Stomach Ulcer | Curcumin | 27.42 | 19188055 16631530 | |
| MESH:D013276 | Stomach Ulcer | Dexamethasone | 27.42 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | Ethanol | 27.42 | 9211565 16755016 17189318 17918041 9562338 11906479 | |
| MESH:D013276 | Stomach Ulcer | Hydrochloric Acid | 27.42 | 15309881 16755016 17189318 | |
| MESH:D013276 | Stomach Ulcer | Indomethacin | 27.42 | 18431645 16631530 16397915 16934674 11906479 16169175 16150113 11595415 10750652 17977527 12077510 17895592 16252198 11595431 15138204 11523592 1323529 11729361 10423059 18726076 17918041 18181030 18543354 12498302 15104355 18209962 17135157 18237397 12500499 14567935 17627676 12787963 16755016 18299717 11145282 18193104 10878458 17654042 18087811 15255614 17657623 12467913 | |
| MESH:D013276 | Stomach Ulcer | Melatonin | 27.42 | 12500499 16150113 11523592 | |
| MESH:D013276 | Stomach Ulcer | pimagedine | 27.42 | 18209962 | |
| MESH:D013276 | Stomach Ulcer | Plant Extracts | 27.42 | 12787963 18237397 15255614 18193104 17135157 | |
| MESH:D020521 | Stroke | Acrolein | 5.59 | 16269634 | |
| MESH:D020521 | Stroke | Raloxifene | 5.59 | 16837676 | |
| OMIM:601367 | STROKE, ISCHEMIC | resveratrol | 3.35 | 16321402 | |
| MESH:D013375 | Substance Withdrawal Syndrome | Ethanol | 3.14 | 9754883 | |
| MESH:D013398 | Sudden Infant Death | Oxygen | 4.30 | 12563064 | |
| MESH:D024801 | Tauopathies | Paclitaxel | 3.58 | 16930453 | |
| MESH:D013705 | Temporomandibular Joint Disorders | Plant Extracts | 4.22 | 17997062 | |
| MESH:D013921 | Thrombocytopenia | Lipopolysaccharides | 3.05 | 15821434 | |
| MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 2.45 | 11994571 | |
| MESH:D013927 | Thrombosis | Ethinyl Estradiol | 2.07 | 15669648 | |
| MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 2.65 | 12697716 | |
| MESH:D013964 | Thyroid Neoplasms | alachlor | 14.95 | 8812207 | |
| MESH:D013964 | Thyroid Neoplasms | arsenic trioxide | 14.95 | 19014326 | |
| MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 14.95 | 7505956 | |
| MESH:D013964 | Thyroid Neoplasms | Doxorubicin | 14.95 | 16010429 17909728 | |
| MESH:D013964 | Thyroid Neoplasms | Indomethacin | 14.95 | 11352223 14736730 18791128 | |
| MESH:D013964 | Thyroid Neoplasms | Tretinoin | 14.95 | 16026305 17045167 | |
| MESH:D013978 | Tibial Fractures | Estradiol | 9.55 | 19048282 | |
| MESH:D013978 | Tibial Fractures | Raloxifene | 9.55 | 19048282 | |
| MESH:D014062 | Tongue Neoplasms | Fluorouracil | 14.53 | 16280240 | |
| MESH:D014062 | Tongue Neoplasms | resveratrol | 14.53 | 16227395 | |
| MESH:D014062 | Tongue Neoplasms | Tretinoin | 14.53 | 16051514 | |
| MESH:D014062 | Tongue Neoplasms | Zinc | 14.53 | 16543248 | |
| MESH:D016171 | Torsades de Pointes | arsenic trioxide | 2.74 | 15213294 | |
| MESH:D014376 | Tuberculosis | Tretinoin | 2.32 | 16040207 | |
| MESH:D014456 | Ulcer | Indomethacin | 3.66 | 17380554 10574470 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 2-Acetylaminofluorene | 24.91 | 15867355 1399818 15289314 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Arsenic | 24.91 | 11144890 17306315 17976673 19429237 18640142 15987713 19322015 | |
| MESH:D001749 | Urinary Bladder Neoplasms | arsenic trioxide | 24.91 | 11780464 20435036 12845720 12973940 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 24.91 | 17053015 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Curcumin | 24.91 | 18593936 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Doxorubicin | 24.91 | 17653716 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Fenretinide | 24.91 | 16720286 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Quercetin | 24.91 | 16720314 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Raloxifene | 24.91 | 17572228 | |
| MESH:D001749 | Urinary Bladder Neoplasms | sodium arsenite | 24.91 | 16712894 16452187 17306315 11723127 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 24.91 | 16712894 17572228 8653321 | |
| MESH:D014565 | Urogenital Neoplasms | Curcumin | 4.02 | 18462866 | |
| MESH:D014581 | Urticaria | Acetaminophen | 1.85 | 10982225 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Fenretinide | 22.65 | 16154183 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Fluorouracil | 22.65 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | indole-3-carbinol | 22.65 | 16082211 | |
| MESH:D002583 | Uterine Cervical Neoplasms | resveratrol | 22.65 | 17473185 | |
| MESH:D002583 | Uterine Cervical Neoplasms | sodium arsenite | 22.65 | 11813266 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 22.65 | 16129372 | |
| MESH:D014594 | Uterine Neoplasms | Butadienes | 13.46 | 12562636 | |
| MESH:D014594 | Uterine Neoplasms | celecoxib | 13.46 | 18645019 | |
| MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 13.46 | 14692618 | |
| MESH:D014594 | Uterine Neoplasms | resveratrol | 13.46 | 17044934 | |
| MESH:D014604 | Uveal Neoplasms | Tretinoin | 3.35 | 16752155 | |
| MESH:D014605 | Uveitis | Dexamethasone | 8.14 | 1336536 | |
| MESH:D014605 | Uveitis | Zymosan | 8.14 | 11006244 | |
| MESH:D014625 | Vaginal Neoplasms | Zidovudine | 3.55 | 12579204 | |
| MESH:D014652 | Vascular Diseases | Arsenic | 7.76 | 17056641 | |
| MESH:D014652 | Vascular Diseases | sodium arsenite | 7.76 | 17056641 | |
| MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 3.33 | 12125929 | |
| MESH:D019043 | Vascular Neoplasms | Urethane | 4.65 | 10620525 | |
| MESH:D020301 | Vasospasm, Intracranial | Ibuprofen | 3.96 | 19057314 | |
| MESH:D054556 | Venous Thromboembolism | Raloxifene | 3.95 | 16837676 | |
| MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 2.40 | 14671159 15869587 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Doxorubicin | 14.68 | 17334414 16364871 17678736 17638931 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Isoproterenol | 14.68 | 18097624 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Plant Extracts | 14.68 | 18097624 | |
| MESH:D018487 | Ventricular Dysfunction, Left | resveratrol | 14.68 | 17488730 | |
| MESH:D020257 | Ventricular Remodeling | Isoproterenol | 8.77 | 18097624 | |
| MESH:D020257 | Ventricular Remodeling | Plant Extracts | 8.77 | 18097624 | |
| MESH:D014820 | Vitiligo | Tretinoin | 2.87 | 16761959 | |
| MESH:D014839 | Vomiting | Indomethacin | 3.50 | 11897121 | |
| MESH:D014846 | Vulvar Neoplasms | Raloxifene | 4.29 | 16343187 | |
| MESH:D014860 | Warts | imiquimod | 5.53 | 16368197 | |
| MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 2.99 | 15886252 | |
| MESH:D015430 | Weight Gain | Dietary Fats | 2.64 | 16723640 | |
| MESH:D009396 | Wilms Tumor | Tretinoin | 2.86 | 16287080 | |
| MESH:D014947 | Wounds and Injuries | bacoside A | 8.73 | 20213670 | |
| MESH:D014947 | Wounds and Injuries | Plant Extracts | 8.73 | 20213670 19894650 | |
| MESH:D014947 | Wounds and Injuries | tetracycline CMT-8 | 8.73 | 11172683 11983005 |
| Pathway ID | Pathway Name |
|---|---|
| KEGG:05219 | Bladder cancer |
| KEGG:04670 | Leukocyte transendothelial migration |
| KEGG:05200 | Pathways in cancer |
| Releated gene ID | Related gene Name |
|---|---|
| PA24910 | APP |
| PA36498 | THBS2 |
| Releated disease ID | Related disease Name |
|---|---|
| PA444101 | Esophageal Neoplasms |
| PA443635 | Cardiovascular Diseases |
| PA443250 | Acquired Immunodeficiency Syndrome |
| PA446213 | HIV Infections |
| PA161614136 | Lumbar Disc Herniation |
| PA445398 | Pre-Eclampsia |
| Releated drug ID | Related drug Name |
|---|---|
| PA449014 | cisplatin |
| PA128406956 | fluorouracil |
| PA448478 | l-arginine |
| PA450635 | nitric oxide |
| PA448871 | celecoxib |
| PA451283 | rosiglitazone |
| Drugbank ID | Action | Drug Name | Description |
|---|---|---|---|
| DB00786 | antagonist | Marimastat | Antineoplastic Agents;Enzyme Inhibitors |
| DB01017 | inhibitor | Minocycline | Anti-Bacterial Agents;Tetracyclines |
| DB01197 | antagonist | Capozide | Antihypertensive Agents;Angiotensin-converting Enzyme Inhibitors |
| DB01296 | antagonist | Glucosamine | |
| DB01949 | - | 2-Amino-N,3,3-Trimethylbutanamide | |
| DB03683 | - | 2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid | |
| DB07117 | - | 5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE | |
| DB07246 | - | (2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE | |
| DB07285 | - | (3R)-4,4-DIFLUORO-3-[(4-METHOXYPHENYL)SULFONYL]BUTANOIC ACID |
| No data |
| No data |
| No data |